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ABSTRACT 
The definitive haemopoietic system consists of a complex hierarchy of cells, 
all of which arise from the definitive haemopoietic stem cell. The initial generation 
of definitive haemopoietic stem cells in the embryo occurs in the aorta, gonads, 
mesonephros region. However, the establishment of definitive haemopoiesis is a 
multi-step process involving the migration of definitive haemopoietic stem cells to 
the foetal liver and finally to the bone marrow, where definitive haemopoiesis occurs 
during adult life. 
a401 integrin, or VLA-4, is an important adhesion molecule implicated in 
many processes during the onset and maintenance of the definitive haemopoietic 
system. In the absence of 131 integrin definitive haemopoiesis is completely inhibited, 
although it is not clear at which time this block is occurring. In the absence of ct4 
integrin, definitive haemopoiesis is not completely inhibited but shows severe defects 
which become more apparent as development progresses. In addition, studies with 
blocking antibodies have shown that the 131 and ct4 integrin subunits are involved in 
the migration and homing of haemopoietic progenitor cells and in their 
differentiation and proliferation. 
The aim of this thesis is to further define the roles of a4 integrin and 31 
integrin in the definitive haemopoietic system, more specifically in the initial stages 
of its establishment. We show that 131 integrin and a4 integrin are expressed on 
definitive haemopoietic stem cells from the embryonic day 11 aorta, gonads, 
mesenephorous region, day 13 foetal liver, day 13 peripheral blood and adult bone 
marrow, which represent the major developmental stages of the definitive 
haemopoietic system. In the day 13 foetal liver and adult bone marrow some u4 
integrin negative definitive haemopoietic stem cells are also detected. Therefore, the 
expression of a4 integrin may be modulated as definitive haemopoietic stem cells 
mature in the later haemopoietic organs. By studying the generation of definitive 
haemopoietic stem cells in a4 integrin knockout embryos, a role for cr4 integrin in 
the correct localisation and/or development of definitive haemopoietic stem cells in 
the foetal liver was revealed. In addition, these studies showed that the increasing 
defects observed in ct4 integrin knockout mice are likely due to progressive defects 
in definitive haemopoietic stem cells as they develop in different haemopoietic 
microenvironments. Attempts to generate a reversible 131 integrin knockout which 
would enable identification of the time point at which (31 integrin is essential for 
definitive haemopoiesis is also discussed. 
In conclusion the data presented here supports previous studies on the role of 
(31 and ct4 integrin in adult and embryonic definitive haemopoiesis and gives further 
information as to the time points at which these molecules are essential for the 
establishment of the definitive haemopoietic system and during its maintenance. 
Chapter 1: INTRODUCTION 
1.1 Mouse Haemopoiesis 
1.1.1. Adult/Definitive Haemopoietic System 
The adult or definitive haemopoietic system is a complex hierarchy of cells, with 
varying degrees of maturity and lineage commitment, all of which derive from the long 
term repopulating haemopoietic stem cell (LTR-HSC) (Abramson et al., 1977; Morrison 
et al., 1995b; Orkin, 1995), see figure I.I. LTR-HSC have a number of properties: 
ability to self renew; high proliferative potential; pluripotency for all haemopoietic 
lineages; ability to stably and fully reconstitute the entire haemopoietic system of a 
lethally irradiated recipient (Jordan et al., 1990; Keller et al., 1985; Lemischka et al., 
1986; Micklem et al., 1966; Smith et al., 1991). Although several markers have been 
identified that are expressed on LTR-HSCs, there is no marker, or combination of 
markers, that is specific to haemopoietic stem cells (Morrison and Weissman, 1994; 
Sprangude et al., 1988). Therefore, the ability of haemopoietic stem cells to reconstitute 
the haemopoietic system of irradiated recipients is used as the defining assay for their 
presence. 
Downstream of LTR-HSCs in the haemopoietic hierarchy are short term 
repopulating stem cells (STR-HSCs) (Zhao et al., 2000; Zhong et al., 1996) and colony 
forming unit spleen (CFU-S) cells (Till and McCulloch, 1961). STR-HSC are capable 
of reconstituting all haemopoietic lineages, and CFU-S the myeloid and erythroid 
lineages, of irradiated adult recipients, but progeny from these cells appear earlier than 
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Figure 1.1: Adult or definitive haemoyoietic system 
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from LTR-FISCs, implying that they are more mature cells. However, STR-HSC 
(Morrison and Weissman, 1994) and some CFU-S are capable of self-renewal (Magli et 
al., 1982). STR-HSC and CFU-S give rise to multipotent, lineage committed progenitors 
- the common lymphoid progenitor (CLP) (Kondo et al., 1997) and the common 
myeloid progenitor (CMP) (Akashi et al., 2000). CLP and CMP give rise to several 
different haemopoietic cell types but are restricted to either the lymphoid or myeloid 
lineages and are not capable of self-renewal. 
The immediate progeny of these multipotent progenitors are committed 
progenitors, the CFU-Cs (colony forming unit cell) (Metcalf, 1984) and B and T cell 
progenitors (Ikuta, 1993; Whitlock and Witte, 1982), which are the precursors of fully 
differentiated cells. These cells are committed to produce only one or two types of 
differentiated progeny. For example, CFU-GM give rise exclusively to macrophages and 
neutrophils. CFU-Cs are detected in in vitro assays where they give rise to colonies of 
differentiated cells in the presence of relevant growth factors after 7-14 days (Metcalf, 
1984). 
The constant production of haemopoietic cells that is required on a daily basis 
and the complex hierarchy of progenitor cells, show that the balance of self renewal, 
proliferation and differentiation in the haemopoietic system has to be tightly regulated 
(Coulombel et al., 1997; Morrison et al., 1995b; Orkin, 1995). LTR-HSCs and most 
progenitor cells are specifically localised in the bone marrow (BM) during adult life and 
at specific stages of maturation they can migrate within this environment or into the 
circulation and secondary haemopoietic organs (Coulombel etal., 1997; Verfaille, 1998; 
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Wilson, 1997). For example, T cell progenitors produced in the BM colonise the thymus, 
where they then develop, via a number of intermediates, into mature thymocytes (Ikuta, 
1993; von Boehmer, 1988). 
The BM provides a unique microenviromnent for the development of 
haemopoietic cells from LTR-HSCs. Interactions with stromal cells and the extracellular 
matrix (ECM) are important for promoting the self-renewal, proliferation or 
differentiation of LTR-HSCs and progenitor cells. As haemopoietic cells mature they 
migrate within the BM, encountering different microenvironments or 'niches', where 
cytokines and chemokines which promote certain cell fates are presented to cells 
(Morrison et al., 1997; Verfaille, 1998; Waft and Hogan, 2000; Wilson, 1997). 
1.1.2. Embryonic Haemopoietic System 
The embryonic origin of the definitive haemopoietic system is controversial and 
investigations into embryonic haemopoiesis have revealed a significantly more 
complicated system than that observed in the adult (Dzierzak and Medvinsky, 1995). 
The main site of adult-type or definitive haemopoiesis before the BM takes over shortly 
after birth, is the fetal liver (FL). However, no haemopoiesis is thought to originate de 
novo in the FL and it can therefore be regarded as a secondary haemopoietic organ 
(Johnson, 1975). Investigations into the primary source of definitive haemopoiesis in the 
embryo revealed that haemopoiesis during development appears to occur in two distinct 
phases - primitive and definitive (Dzierzak and Medvinsky, 1995). 
11. 
1.1.2.1. Generation of Haemopoietic Cells During Development 
The first visible haemopoietic cells in the embryo are primitive nucleated 
erythrocytes which appear at approximately E7.5 in the blood islands of the extra-
embryonic yolk sac (YS), (Russell and Bernstein, 1966). Progenitor cells are also 
present in the YS at this early stage (Moore and Metcalfe, 1970; Palis ci al., 1999). The 
initial appearance of blood cells in the YS led to the hypothesis that the YS was the 
source of definitive haemopoietic stem cells (LTR-HSC), which colonised the fetal liver 
at mid-gestation (Moore and Metcalfe, 1970). However, further analysis of the mouse 
embryo and comparisons to other vertebrate systems have led this model to be 
questioned. In non-mammalian vertebrates the adult haemopoietic system originates in 
the embryo body rather than the YS (Section 1.1.2.4.). More extensive analysis of mouse 
embryos (described below) suggested that this may also be the case for the murine 
haemopoietic system. 
Primitive erythroid progenitor cells are identified in the YS from E7.0-E9.0. This 
is a transitory population of cells and these progenitors are not observed in other 
haemopoietic sites in the embryo (Palis ci al., 1999). Direct analysis of pre-circulation 
embryos revealed the presence of BFU-E, CFU-E and primitive macrophage progenitors 
(Mac-CFC) solely in the YS (Palis ci al., 1999). These progenitor types were only 
observed in the embryo body after the onset of the circulation (Palis ci al., 1999). 
However, a different study, in which YS and the para-aortic splanchnopleure (pSp) 
region of the embryo body were isolated prior to the onset of circulation and cultured for 
several days before analysis, showed that progenitor cells arise in both the YS and the 
pSp (Cumano ci al., 1996). In addition, the progenitors generated in the pSp region have 
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wider differentiation potential than those from the YS. Most notably, progenitors from 
the YS were unable to give rise to lymphoid cells or mixed myeloid colonies, whereas 
those from the pSp were. These types of progenitors only appeared in the YS after the 
onset of circulation between intra- and extra-embryonic regions, suggesting that 
precursors from the pSp seed the YS (Cumano et al., 1996). The numbers of these 
multipotent progenitors increases in the YS and pSp after the onset of circulation until 
E9.5 (Godin et al., 1995) and at E9.0 similar cells are detected in the fetal liver 
(Johnson, 1975; Palis etal., 1999). These progenitor cells presumably migrate to the FL 
from either the YS, or the pSp, or both. 
The multipotent progenitors present in the YS, pSp and liver at E7.5-9.0 are not 
capable of generating spleen colonies or of long-term reconstitution of irradiated adult 
recipients (Cumano etal., 1996; Yoder et al., 1997b) and are therefore relatively mature 
haemopoietic cells. However, multi-lineage reconstitution by E9.0 YS and pSp cells has 
been reported in new-born recipients (Yoder ci al., 1997b). When bone marrow from 
reconstituted new-born recipients was transplanted to secondary adult recipients, donor 
cells could then reconstitute the haemopoietic system (Yoder ci al., 1997b). This 
suggests that progenitors from the YS and pSp may be able to mature into LTR-HSC in 
the FL environment of new-born recipients where the FL is still an active site of 
haemopoiesis (Wolf et al., 1995). 
The first definitive-type progenitor cells, as identified by in vivo assays in adult 
recipient mice, are definitive CFU-S which appear simultaneously in the YS and the 
aorta, gonads and mesonephros (AGM) region, which develops from the pSp, at late 
E9.0. These cells are then apparent in the FL at Ell.O (Medvinsky ci al., 1993). 
on 
Definitive LTR-HSC, capable of reconstituting the haemopoietic system of adult 
recipients, are not identified in the embryo until late E1O.0 when they appear exclusively 
in the AGM region. This is followed at El 1.0 by the appearance of these cells in the FL, 
YS and peripheral blood (PB) (Muller ci al., 1994); (Kumaravelu, P. ci al., unpublished 
data). 
Due to the interchange of cells via the circulation and possibly through 
interstitial migration, the primary source of these definitive haemopoietie cells was not 
immediately clear. An in vitro organ culture system was used to answer this question 
(Medvinsky and Dzierzak, 1996). In these experiments, haemopoietic organs were 
explanted and placed separately in culture for 2-3 days. The organs were then 
dissociated and injected into recipient mice, which were later analysed for the formation 
of spleen colonies or for long-term reconstitution. This revealed that the number of 
CFU-S in cultured AGM region exceeds that in the YS at early to mid E10.0 by 
approximately 9 fold. Similarly, at El 1.0 CFU-S numbers in the AGM exceed those in 
the YS and FL by 3-5 fold. Comparison of uncultured and cultured organs showed that 
only the AGM region was capable of increasing the numbers of CFU-S during culture. 
The YS and FL were able to maintain numbers but not to expand the initial population 
of CFU-S. Analysis of LTR-HSC gave similar results. The AGM region is the only 
organ capable of generating long term reconstituting cells at El 0.0 and the efficiency of 
repopulation is greatly increased after organ culture, suggesting that the AGM is capable 
of expanding the number of LTR-HSC cells, either by multiplying already existing stem 
cells or by generating new LTR-HSC from a precursor, i.e. a pre-definitive stem cell 
(Section 1.1.2.5.). At El1.0 cells from the AGM, YS, FL and PB are capable of long 
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term reconstitution. However, only the AGM region is capable of expanding the number 
of HSCs in culture. Therefore, the AGM alone is capable of autonomously generating 
and amplifying LTR-HSC and is therefore likely to be the primary site of definitive 
haemopoiesis in the developing embryo. However it can not be ruled out that pre-HSC 
develop at another site and migrate to the AGM. The presence of LTR-HSCs in the PB 
at the time of FL colonisation suggests that this is the route by which LTR-HSCs 
migrate from the AGM region to the FL (Kumaravelu, P. et al., unpublished data). 
The number of LTR-HSCs in the E12.0 AGM region is slightly higher than at 
El 1.0 but it loses the ability to expand these cells in culture (Kumaravelu, P. et al, 
unpublished data). Conversely, the E12.0 YS appears to acquire the ability to increase 
the number of LTR-HSCs in culture (Kumaravelu, P. et al, unpublished data). Therefore, 
there is a possibility that the YS starts to generate LTR-HSCs at this stage. Alternatively, 
the increase may be due to expansion of a population of cells that migrated there from 
the AGM region. Either way it is possible that YS LTR-HSCs also seed the FL. From 
E12 to E16 the numbers of LTR-HSCs continuously increase in the FL (Ema and 
Nakaouchi, 2000), (Kumaravelu, P. et a!, unpublished data), accompanied by the first 
generation of several definitive haemopoietic lineages. Although LTR-HSCs develop in 
the AGM, no extensive differentiation occurs there. The thymus and the spleen also 
become active around this time and are seeded with progenitor cells from the FL (Ikuta, 
1993). From E16 onwards the number of stem cells decreases in the FL, consistent with 
the start of haemopoiesis in the BM at this time (Ema and Nakaouchi, 2000). However, 
the FL remains a site of haemopoiesis until shortly after birth (Wolf et al., 1995). 
1.1.2.2. Model for Embryonic Haemopoiesis 
The above findings led to the proposal of a model of mouse embryonic 
haemopoiesis which differs from the classical view that definitive HSC arise in the YS 
and migrate to the FL (Moore and Metcalfe, 1970). This new model proposes two 
phases of embryonic haemopoiesis, primitive and definitive (Dzierzak and Medvinsky, 
1995), figure 1.2. The first phase, primitive haemopoiesis, originates in the YS or pSp 
with the generation of committed progenitors and differentiated cells that seed the FL at 
E9.0. This is a transitory phase and primitive haemopoietic cells are not thought to 
contribute to the adult haemopoietic system. The second phase, definitive haemopoiesis 
is the origin of the adult haemopoietic system. Definitive haemopoiesis is initiated in the 
AGM region with the generation of definitive LTR-HSC. These stem cells then seed the 
FL at El 1.0 and this becomes the major haemopoietic organ until shortly after birth. 
1.1.2.3. Changes in the Functional and Molecular Properties of llaemopoietic Cells 
During Development 
In addition to the sequential appearance of haemopoietic cells in the different 
haemopoietic organs described above (section 1.1.2.1.) molecular and functional 
analysis of embryonic haemopoietic cells has also supported the above proposed model 
of embryonic haemopoiesis. 
The generation of several knockout' mice, using gene targeting techniques, has 
revealed differences in gene function between primitive and definitive haemopoiesis 
reviewed in (Medvinsky and Dzierzak, 1998). Several genes have been shown to affect 
definitive but not, or only partly, YS haemopoiesis. These include the transcription 
factors AML-1 (Okuda etal., 1996; Wang et al., 1996a; Wang etal., 1996b), the 
.01 
Figure 1.2: Two phase model of embryonic haemonoiesis 
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receptor tyrosine kinase c-kit (Bernex ci al., 1996; Lyman and Jacobsen, 1998), its 
ligand KL (Lyman and Jacobsen, 1998; Witte, 1990) and the a4 (Arroyo ci al., 1999; 
Arroyo ci al., 1996),(seetion 1.3.3) and j31 integrin subunits (Hirsch ci al., 
1996),(section 1.3.2.). 
The expression of cell surface antigens also shows differences between adult 
BM, FL, AGM region, and YS/pSp haemopoietic stem cells (Morrison ci al., 1995a; 
Morrison and Weissman, 1994; Sanchez ci at, 1996; Yoder ci al., 1997a). Early E11.0 
AGM region and FL LTR-FISC bear similar surface markers to late FL and adult BM 
LTR-HSC, including expression of c-kit, Sca-1 and to some extent CD34 (Ikuta and 
Weissman, 1992; Morrison ci al., 1995a; Morrison and Weissman, 1994; Sanchez ci al., 
1996; Sato ci al., 1999). Early YS progenitors/stem cells are positive for AA4.1 and 
CD34 but are negative for Sca-1 (Godin ci al., 1995; Yoder ci al., 1997a). These 
phenotypic characterisations suggest that LTR-HSC from the AGM and FL are directly 
related to definitive HSC of late FL and adult BM. However the expression of some 
surface antigens varies as development progresses. A proportion of AGM LTR-HSCs 
and all FL LTR-HSCs express the integrin Mac-i (Morrison ci al., 1995a; Sanchez ci 
al., 1996). However, BM LTR-HSCs are negative for Mac-I expression (Morrison and 
Weissman, 1994). FL LTR-HSC also express AA4.i(Jordan et al., 1990), whereas adult 
BM LTR-HSC are both positive and negative for AA4.1(Rebel ci al., 1996; Trevisan 
and Iscove, 1995). 
Functional differences between primitive and definitive haemopoietic cells have 
been largely discussed above (section 1.1.2.1.). They include the production of nucleated 
erythrocytes in the YS (Russell and Bernstein, 1966), a difference in the method of 
generation and the morphology of macrophage cells (Naito et al., 1996), the different 
morphology of spleen colonies derived from YS as compared to AGM or FL cells 
(Medvinsky et al., 1996) and the ability of stem cells from the YS and pSp  to 
reconstitute the haemopoietic system of new-born but not adult recipients (Cumano et 
al., 1996; Yoder et al., 1997b). However, definitive HSCs also change their properties to 
some extent during development. For example, fetal liver HSCs are capable of 
generating I cell progenitors which give rise to I cells expressing I-cell receptor (ICR) 
V13 and Vy4 transcripts which are expressed in the foetus and can also give rise to the 
adult type Vyl and V72 rearrangements. However, adult BM HSCs are only capable of 
giving rise to Vii and V72 expressing T cells. Introduction of adult HSCs into the fetal 
thymic environment revealed that these cells were unable to reprogram to fetal-type 
expression (Ikuta, 1993). Therefore, adult definitive HSCs lose some of the 
developmental potential of FL HSCs. Fetal liver HSCs also have a higher self-renewal 
and proliferative potential as well as being more potent at long-term reconstitution than 
adult BM HSCs (Ema and Nakaouchi, 2000; Morrison etal., 1995a). 
1.1.2.4. Non-mammalian Vertebrate Haemopoiesis 
Studies in non-mammalian vertebrates also support the two phase model of 
embryonic haemopoiesis. In the avian system, the generation of chimeric chick-quail 
embryos revealed that haemopoietic cells generated in the YS do not contribute to adult 
haemopoiesis, although they do contribute at a low level to fetal haemopoiesis in the 
embryo body. The adult haemopoietic system is derived solely from cells generated in 
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the embryo body (Dieterlen-Lievre, 1975). High numbers of clonogenic progenitors are 
first observed in the aorta and para-aortic regions, suggesting that this region may be the 
origin of the definitive haemopoietic system (Dieterlan-Lievre and Douarin, 1993). In 
Xenopus, haemopoietic cells from the ventral blood islands (analogous to the YS) 
contribute to primitive haemopoiesis and to a lesser extent definitive haemopoiesis (Kau 
and Turpen, 1983). However, haemopoietie cells derived from the dorsal lateral plate 
(DLP), which includes the pronephros and dorsal aorta, contribute exclusively to 
definitive haemopoiesis (Turpen etal., 1997). Recently, it has been shown that the origin 
of the two haemopoietic hierarchies is distinct and that the DLP is most likely the origin 
of the first definitive haemopoietic stem cells in the Xenopus (Ciau-Uitz etal., 2000). 
This data shows that, to some extent, the development of the definitive 
haemopoietic system is conserved between species and that definitive haemopoiesis is 
initiated in mice, chick and Xenopus, in or around the dorsal aorta. 
1.1.2.5. Pre-definitive Haemopoietic Stem Cells 
Although it seems clear that the first definitive HSCs originate in the AGM 
region, the origin of these stem cells has not been determined (Medvinsky and Dzierzak, 
1996). The initial generation of haemopoietic cells in the blood islands of the YS, where 
they are in close conjunction with endothelial cells, led to the hypothesis, early in the 
century, of the existence of a common precursor for haemopoietic and endothelial cells, 
termed the haemangioblast (Risau and Flamme, 1995). Since then, several lines of 
evidence have suggested the existence of such a cell. Firstly, knockout studies have 
shown that mice lacking the genes Flk-1 (Shalaby et al., 1995) and Sca-1 (Robb et al., 
1996; Shivdasani et al., 1995) have severe defects in development of both the 
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haemopoietic and endothelial systems, supporting the hypothesis that these two lineages 
may originate from a common precursor. Secondly, in the human, mouse and chick, 
CD45+ haemopoietic cells are observed to bud from the floor of the dorsal aorta 
(Jaffredo €1 al., 1998; North et al., 1999; Tavian et al., 1996) and labelling of endothelial 
cells in the dorsal aorta of the chick, prior to the emergence of these haemopoietic 
clusters showed that when they formed, they were also labelled (Jaffredo et al., 1998). 
This suggests that haemopoietic cells may develop from endothelial cells or a common 
precursor. Thirdly, in vitro studies have also provided evidence for the existence of the 
haemangioblast. Lymphohaemopoietic cells have been generated from endothelial cells 
isolated from E9.5 YS and embryo body (Nishikawa et al., 1998) and the generation of 
both haemopoietic and endothelial cells from single ES cell-derived cells has been 
demonstrated (Choi et al., 1998). However, restriction to these two lineages was not 
rigorously proved. 
Despite the above evidence, the existence of the haemangioblast as a precursor 
for definitive HSCs remains uncertain. The fact that multipotent haemopoietic 
progenitor cells in the E9.0 YS and pSp can develop into definitive HSCs when they are 
transplanted into new-born recipients (Yoder etal., 1997b) suggests that definitive HSCs 
could arise from these cells during the development of the haemopoietic system. 
1.1.3. ES Cells As a Model for Haemopoiesis 
ES cells are pluripotent cells derived from the inner cell mass of E3.5 mouse 
blastocysts (Robertson, 1987). They can be maintained in an undifferentiated state in 
vitro in the presence of embryonic fibroblast feeder cells or leukaemia inhibitory factor 
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(LIF) (Williams, 1988). When ES cells are introduced into recipient blastocysts they are 
able to contribute to all tissues of resulting chimaeras and can be transmitted through the 
germline (Bradley etal., 1984; Robertson etal., 1986). ES cells can also differentiate in 
vitro to a number of cell lineages upon the removal of LIF and in some cases the 
addition of specific growth factors reviewed in (Keller, 1995). In particular, ES cells can 
be differentiated in vitro by a variety of methods to produce many types of haemopoietic 
cell (Hole, 1999). 
When ES cells are grown in embryoid bodies (EB5) in suspension culture they 
spontaneously differentiate to form primitive nucleated erythrocytes and macrophages, 
without the addition of exogenous growth factors (Doetschman et al., 1985). ES cells 
differentiated in semi-solid methylcellulose in the presence of exogenous growth factors 
such as 11-3, 11-6 and erythropoietin can generate embryoid bodies, containing 
erythrocytes both nucleated and enucleated, macrophages, mast cells and neutrophils 
(Wiles and Keller, 1991). Bi- and multi-potential myeloid progenitor cells, including 
CFU-Mix, have also been identified in these EBs (Burkert et al., 1991), as well as the 
more immature CFU-A progenitor cells. CFU-A are progenitors, identified in in vitro 
colony forming assays and are thought to be analogous to CFU-S cells (Pragnell, 1988). 
Mature lymphoid cells, as identified by the expression of markers such as B220, 
Thy-1 and RAG genes, have also been generated from ES cells, either by co-culturing 
EB derived cells with stromal cells (Nakano, 1994), or by growing embryoid bodies in 
low oxygen levels (Potocnik, 1994). In addition, lymphoid precursors, capable of short-
term reconstitution of the lymphoid population of RAG deficient mice, are produced 
(Potocnik and Nerz, 1997). Lymphoid cells are not detected until relatively late in the 
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differentiation of embryoid bodies and the efficiency of generation of lymphoid cells is 
lower than that of myeloid and erythroid cells. 
The question as to whether definitive haemopoietic stem cells can be generated 
in vitro from ES cells remains unclear. Multi-lineage reconstitution of irradiated 
recipients with ES cell-derived haemopoietie stem cells has been reported (Hole and 
Graham, 1996; Palacios, 1995). However, in one case haemopoietic stem cells were only 
obtained after culturing ES cells with a haemopoietic supporting BM stromal cell line 
(Palacios, 1995) and in the second ease the reconstitution, although multi-lineage and 
long-term was at a low level, less than 5% (Hole and Graham, 1996). Therefore, these 
haemopoietic stem cells may have more in common with the stem cells that have been 
identified in the YS and pSp of E9 and ElO embryos that are capable of long-term 
reconstitution of new-born recipients but not of adult recipients (Yoder et al., 1997b). 
Recently it has been reported that a putative haemangioblast, a cell capable of giving rise 
to both haemopoietic and endothelial lineages (section 1.1.2.5.), has been identified in 
differentiating EBs at an early stage (Choi et al., 1998). However it has not been 
rigorously proved that these cells are restricted to the haemopoietic and endothelial 
lineages and therefore they could represent mesodermal cells. 
In addition to the ability of ES cells to differentiate to the haemopoietic cell types 
described above, the order of their appearance during the differentiation of EBs, 
suggests that this is a good model for what happens in the early embryo, more 
specifically in the YS. As ES cells differentiate down the haemopoietic lineages, 
primitive erythrocytes are generated first, followed by macrophages. Progenitor cells, 
mature myeloid and enucleated erythrocytes follow later, with lymphoid cells being 
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generated last. This is similar to the order of events observed in the YS in vivo (Keller, 
1993),(section 1.1.2.). The orderly expression of relevant genes is also recapitulated in 
these EBs, in that mesodermal markers are expressed first, followed by markers such as 
Flk-1 which are expressed by both endothelial and haemopoietic precursors and finally 
markers specific for haemopoietic lineages (Keller, 1993). In addition, when ES cells, 
modified by gene targeting to knock out certain genes, are differentiated in vitro they 
often show similar phenotypes in regard to haemopoietic development as seen in the 
knockout embryos or chimaeric mice. Examples include GATA-1 (Weiss, 1994), 
GATA-2 (Tsai, 1994), and SCL (Porcher et al., 1996). 
Therefore it can be seen that the differentiation of ES cells in vitro can be a 
useful model for haemopoietic events in the early mouse embryo. In particular ES cells 




Integrins are a family of transmembrane glycoproteins that mediate cell-
extracellular matrix (ECM) and cell-cell interactions (Hynes, 1992). These adhesive 
interactions play roles in the migration, differentiation, proliferation and survival of cells 
and as a consequence are implicated in a number of processes, including embryonic 
development (Fassler et al., 1996), tumour cell growth (Varner and Cheresh, 1996), 
programmed cell death (Giancotti, 1997) and leukocyte homing (Dunon et al., 1996). 
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Integrins are heterodimers of a and 3 subunits. There are currently 16 known 
a and 8 known P subunits and these combine to generate about 22 different integrin 
molecules. The extracellular domains of the a and 3 subunits combine to form the 
ligand binding site lying near or at the interface of the subunits. Integrin ligands include 
the ECM proteins fibronectin, vitronectin, laminin, collagen and proteins of the 
immunoglobulin superfamily I-CAM and V-CAM, by which integrins mediate cell-cell 
interactions (Hynes, 1992). In general, integrins can recognise more than one ligand and 
similarly most ligands have more than one integrin receptor. In addition, integrin 
specificities may vary depending on which cell type they are expressed and in some 
cases the activation state of the cell (Clark and Brugge, 1995; Hynes, 1992). 
As well as being adhesion molecules, integrins are now also considered to be 
signalling molecules (Giancotti and Ruoslahti, 1999). Integrins can transmit signals in 
two ways - by outside-in and inside-out signalling. In the first case the binding of an 
integrin to its ligand results in the transmission of a signal into the cell, resulting in 
changes in cell behaviour, for example causing proliferation (Clark and Brugge, 1995; 
Giancotti and Ruoslahti, 1999). In the case of inside-out signalling, the activation state 
of the cell modulates the affinity of integrins on the cell surface for their ligands, 
resulting in changes in the adhesion of cells to the ECM or to other cells (Clark and 
Brugge, 1995; Kolanus and Seed, 1997). 
1.2.2. Adhesion/Migration 
The binding of most integrins to their ligands results in the association of the 
integrin cytoplasmic domains with cytoskeletal proteins, most commonly in the 
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formation of focal contacts, in which integrins link to intracellular cytoskeletal 
complexes and bundles of actin filaments (Clark and Brugge, 1995; Schaller and 
Parsons, 1994), see figure 1.3a.. The organisation of actin filaments into larger stress 
fibres results in more integrin clustering, which in turn results in stronger attachment and 
intracellular organisation by integrins, in a positive feedback system (Miyamoto et al., 
1995). Actin binding proteins that co-localise with integrins in focal adhesions include 
a-actinin, talin, vinculin and tensin (Clark and Brugge, 1995; Giancotti and Ruoslahti, 
1999). It seems that the P subunit cytoplasmic domain contains localisation signals for 
the targeting of integrins to focal contacts whereas the a cytoplasmic domain plays a 
regulatory role, preventing unbound integrins localising to focal contacts (Sastry and 
Horwitz, 1993). These assemblies of structural proteins are believed to play important 
roles in stabilising cell adhesion and regulating cell shape, morphology and mobility. 
When cells migrate they extend filipodia and lamellipodia on the ECM 
(Lauffenburger, 1996). These protrusions are stabilised by the formation of focal 
adhesions, initiated by the binding of integrins to ECM ligands, resulting in strong 
adhesion. The adhesive forces generated provide the traction necessary for the migration 
of cells. In order for the cell to advance, adhesive interactions at the rear of the cell then 
have to be disrupted (Lauffenburger, 1996). 
Signalling by integrins (outside-in, section 1.2.3.1.) may also affect migration of 
cells by the activation of the rho family of GTP binding proteins: cdc42 induces 
filipodia, rac induces lamellipodia and rho induces focal adhesion complexes (Giancotti 
and Ruoslahti, 1999) 
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Figure 1.3 a: Association of proteins with integrins in Focal Adhesions. 




Figure 1.3b: Major integrin-mediated signalling pathways and interaction with 
signalling through growth factors. 
Taken from (Giancotti and Ruoslahti, 1999) 
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In addition, the activation of P1CC and P13-K, both of which can be induced by integrin 
binding have an effect on actin polymerisation and therefore changes in cell shape which 
are required for migration (Giancotti and Ruoslahti, 1999),(Clark and Brugge, 1995). 
Integrins may also promote migration by associating with and possibly activating serine-
and metallo-proteinases. These molecules are involved in reorganisation and degradation 
of the ECM required for migration. In some cases signalling by integrins has also been 
associated with the up regulation of proteinase expression (Chapman, 1997; Murphy and 
Gavrilovic, 1999). 
The expression levels and activation state of integrins, and the concentration of 
their extracellular ligands are all important factors in determining the ability of cells to 
migrate and the efficiency of their migration (Huttenlocher et al., 1996; Palecek et al., 
1997). For example, in some cells if integrin molecules are constitutively active, cells 
are unable to migrate, presumably because they are unable to release strong integrin 
mediated attachments at the rear of the cell. Therefore, for effective migration there has 
to be asymmetry in the cell, from the front to the rear, in terms of the strength of its 
adhesive interactions. This is in part mediated by the modulation of integrin activity by 
the cell itself (inside-out signalling; section 1.2.3.2.), either by affecting the avidity of 
integrins for ECM ligands or by affecting their interactions with the cytoskeleton. 
Several intracellular signals have been implicated in this process, including high Ca 2 
levels, which inhibit actin polymerisation; tyrosine phosphorylation, which may directly 
affect integrins or other proteins involved in the formation of focal adhesions; activation 
of the GTP-binding protein rho; and signalling from the FAKlsrc complex present in 
focal contacts (section 1.2.3.1.) which can promote the disassembly of focal adhesions at 
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the rear of the cell (Giancotti and Ruoslahti, 1999; Lauffenburger, 1996). Myosin 
mediated contractile forces also affect adhesion at the rear of the cell by physically 
disrupting adhesive interactions, either by disrupting integrin/ECM binding or 
integrin/cytoskeletal interactions(Lauffenburger, 1996). 
As can be seen from the above discussion, multiple signals are required to 
generate the adhesive forces required to initiate cell migration and to disrupt adhesion 
forces at the rear of the cell. This is partly achieved by the modulation of integrin 
activity by the cell in response to intracellular signals generated by growth factors and 
chemokines, and partly through signalling from integrins themselves. These signalling 
mechanisms are described below, along with their roles in other cellular functions. 
1.2.3. Integrin Signalling 
1.2.3.1. Outside - in Signalling 
Intracellular signalling as a result of integrin binding brings about many of the 
cellular responses associated with integrin engagement, such as cell proliferation, 
differentiation, survival and migration. Integrin cytoplasmic domains do not contain any 
enzymatic activity and therefore signals are transmitted via associations with other 
signalling molecules. It is believed that focal adhesions serve as a framework for the 
association of signalling molecules involved in effecting the changes in gene expression, 
proliferation and differentiation that are associated with integrin mediated adhesion 
(Clark and Brugge, 1995; Giancotti and Ruoslahti, 1999) 
One of the first biochemical events following integrin engagement is protein 
phosphorylation (Clark and Brugge, 1995; Hynes, 1992). Focal adhesion kinase (FAK) 
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(Banks et al., 1992; Schaller and Parsons, 1994) is a tyrosine kinase that localises to 
focal adhesions, either directly by association with the cytoplasmic tail of 0 integrins, or 
via the cytoskeletal proteins talin and paxillin, and autophosphorylates in response to 
integrin binding (Guan and Shalloway, 1992; Schaller and Parsons, 1994). The 
autophosphorylation of FAK generates a binding site for the SH2 domain of Src and 
possibly Fyn proteins (Gianeotti and Ruoslahti, 1999; Schaller et al., 1994). Src in turn 
phosphorylates other proteins present in the focal adhesion complex, including the 
signalling molecules paxillin, talin and the docking protein p13 
OCAS  (Schaller and 
Parsons, 1994), (Howe et al., 1998). Src also phosphorylates FAK, providing binding 
sites for the Grb-2/mSOS complex (Schlaepfer et al., 1994). This links integrin 
signalling with the Ras-MAPK pathway, which results in the activation of transcription 
factors responsible for cell proliferation, such as c-fos (Clark and Brugge, 1995). FAK 
may also be implicated in bringing about cytoskeletal changes induced upon integrin 
engagement by associating with and activating P1-3K (Clark and Brugge, 1995). Some 
31 integrins can also activate Fyn, via the membrane adapter protein caveolin which 
links Fyn to the a subunit of the integrin heterodimer (Wary etal., 1996). Activated Fyn 
is able to bind to Shc, which in turn feeds into the Ras-MAPK pathway, again resulting 
in the activation of transcription factors important for cell proliferation. The activation of 
the Rho family of GTPases in response to integrin binding has also been reported 
(Giancotti and Ruoslahti, 1999). As mentioned earlier this can result in cytoskeletal 
changes which are required for migration. Signalling through Rho can also feed into the 
Ras-MAPK pathway. Other cellular responses to integrin binding include an increase in 
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cellular C a2+ concentration, activation of protein kinase C and an increase in cellular pH 
(Clark and Brugge, 1995; Hynes, 1992). A representation of the signalling pathways 
initiated by integrins is shown in figure 1.3b. 
The signals generated by integrin binding are similar to the signals generated by 
the binding of some growth factors to their receptors (Giancotti and Ruoslahti, 1999; 
Howe et al., 1998), figure 1.3b. This may explain why cell adhesion is often required for 
proliferation; signals from both integrin and growth factor receptors might be required to 
generate a signal above the threshold level required to initiate cell proliferation. It has 
also been shown that integrins associate with growth factor receptors and that this 
association can lead to partial activation of these receptors (Howe etal., 1998; Sundberg 
and Rubin, 1996). This suggests a situation in which multiple receptors synergise to 
mediate cell proliferation, differentiation and migration, i.e. receptor cross talk. In 
addition particular integrins associate with particular growth factor receptors which may 
add another level of specificity to the signals received by cells (Giancotti and Ruoslahti, 
1999). 
In some cases, the binding of integrins to the ECM results in differentiation 
rather than proliferation of cells (Giancotti, 1997). These two events are mutually 
exclusive and the engagement of integrins that do not activate FAK and Shc or that are 
unable to interact with growth factor receptors, may result in cells withdrawing from the 
cell cycle and becoming permissive for differentiation. 
The adhesion of cells to the ECM via integrins also promotes the survival of cells 
and prevents them from undergoing apoptosis (Frisch and Ruoslahti, 1997; Giancotti, 
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1997). This could be in part through the interaction of FAK with P13-K (Khwaja et al., 
1997). P13-K activates the protein B/Act which in turn inactivates the apoptosis inducing 
proteins Bad and caspase 9, figure 1.3b. Some integrins may also prevent apoptosis of 
adherent cells by activating the anti-apoptotic protein Bcl-2 (Reed, 1995; Zhang et al., 
1995). It appears that the anti-apoptotic properties of integrins may be specific to certain 
integrins. This suggests a mechanism by which cells expressing these integrins survive 
in appropriate environments but if they become attached at inappropriate places, maybe 
through other integrins, they undergo apoptosis (Frisch and Ruoslahti, 1997). 
1.2.3.2. Inside-out Signalling 
Also important in integrin function is the modulation of integrin affinity by the 
cells themselves, so called inside-out signalling (Clark and Brugge, 1995; Kolanus and 
Seed, 1997). This is essential to ensure that cells do not attach at inappropriate times and 
are able to migrate when necessary (section 1.2.2). For example, the fibrinogen binding 
affinity of aIlbP3 integrin is upregulated on activated platelets after thrombin stimulation 
(Ginsberg et al., 1992; Hynes, 1992). This ensures that unactivated platelets do not 
attach in inappropriate places. The abnormal down and up regulation of integrins has 
been implicated in the proliferation and migration of cancer cells (Brakebusch et al., 
1997; Varner and Cheresh, 1996). Alterations in integrin binding affinity are thought to 
occur via conformational changes in the ligand binding domain, or by alterations in 
receptor clustering and these changes are mediated by the integrin cytoplasmic domain. 
Several studies show that both cx and P subunit cytoplasmic domains can affect integrin 
activation states (Kolanus and Seed, 1997; Sastry and Horwitz, 1993). Sequences in the 
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cytoplasmic tails close to the membrane spanning region may impart a basal level of 
activity on integrins whereas sequences in the more distal part of the cytoplasmic tail 
may be responsible for transmitting cell-state dependent signals to the integrin (Sastry 
and Horwitz, 1993). 
Signalling from cytokines and chemokines can affect the activation state of 
integrins on the cell surface. It seems that, in general, signals which activate protein 
kinase C and P13-K lead to the activation of integrins, although these proteins probably 
do not act on integrins directly (Kolanus and Seed, 1997). This is supported by the fact 
that in many cases integrins can be activated by treatment of cells with phorbol esters. 
Phorbol esters mimic the activity of DAG which is an upstream activator of protein 
kinase C (Kolanus and Seed, 1997). The modulation of integrin activity by chemokines 
suggests a way in which these molecules promote migration of cells and cytokine 
mediated integrin activation would explain the increase in proliferation seen when cells 
become adherent. Increased integrin binding would lead to increased integrin signalling 
(section 1.2.3.1.) and as many of the signals generated by cytokines and integrins are the 
same this could explain how cytokine and integrin receptors synergise to promote 
cellular proliferation. 
1.2.4. Role of Integrins in Haemopoiesis 
Integrins are implicated in many processes during development, where cell 
migration is important for the development of all tissues, and also in several processes in 
the adult organism (Fassler et al., 1996; Hynes, 1992). The dynamic and migratory 
nature of the haemopoietic system, both during development and in the adult, is a prime 
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example of the importance of cell adhesion and migration (Dzierzak and Medvinsky, 
1995; Quesenberry and Becker, 1998; Springer, 1994). In addition, the constant 
production of haemopoietic cells that is required on a daily basis and the complex 
hierarchy of progenitor cells, show that the balance of self renewal, proliferation and 
differentiation in the haemopoietic system has to be tightly regulated. Integrins have 
been implicated in many of these processes in the haemopoietic system and their roles 
illustrate many of the principles of integrin function outlined above (Verfaille, 1998; 
Wilson, 1997). 
In the following section the involvement of integrins in the migration and 
homing of haemopoietie cells and in their proliferation and differentiation are discussed, 
with particular emphasis on the PI and cz4 integrins. The majority of data available on 
the role of integrins in haemopoiesis is concerned with the adult haemopoietic system, 
although • the mechanisms may be common to developmental hacmopoiesis. However, 
both 131 integrin and a4 integrin have been knocked out in mice, which has revealed 
roles for these molecules in embryonic haemopoiesis, as well as giving further insights 
into their involvement in adult haemopoiesis. 131 intcgrin and a4 integrin knockouts are 
discussed in sections 1.3.2. and 1.3.3. 
1.2.4.1 Homing and Migration of Haemopoietic cells 
In the maintenance of normal haemopoiesis there is extensive migration and 
homing of haemopoietic cells (Coulombel etal., 1997; Springer, 1994; Verfaillc, 1998). 
Haemopoietic stem and progenitor cells are specifically localised in the bone marrow 
and at specific stages of maturation they migrate within this environment or emigrate to 
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secondary haemopoietic organs and the circulation. In addition, intravenously 
transplanted haemopoietic stem cells are able to home to the BM and establish full 
haemopoiesis in recipient hosts (Quesenberry and Becker, 1998). Circulating 
lymphocytes are able to home to sites of inflammation and also selectively recirculate 
through specific lymphoid tissues (Springer, 1994). Among the adhesion molecules 
involved in these processes it is thought that integrins play an important role. 
1.2.4.1.1. Leukocyte Homing and Migration 
The normal migration of lymphocytes from the blood stream, through lymph 
nodes and back to the blood stream and the homing of leukocytes to sites of infection are 
mediated by very similar processes (Dunon et al., 1996; Springer, 1994). Extensive 
studies both in vitro and in vivo have led to the proposal of a three step mechanism 
whereby leukocytes migrate from the blood stream into lymph nodes and sites of 
inflammation and suggests how the specificity of these interactions is achieved. 
i) Homing of leukocytes to sites of infection 
In order for leukocytes to leave the blood stream and enter sites of infection they 
must migrate across endothelial cell layers in the blood vessel walls. The first step in 
extravasation is rolling of leukocytes along the vessel wall which is mediated by 
relatively weak adhesive interactions through the selectin family of adhesion receptors 
(Frennette et al., 1996; Lawrence and Springer, 1991). Chemokines, expressed by the 
endothelium or underlying tissue, then activate integrins on the surface of the 
leukocytes, resulting in strong adhesion and arrest, an example of inside—out signalling 
(section 1.2.3.2.);(Dunon et al., 1996; Laudanna et al., 1996). This strong adhesion is 
further enhanced by the up regulation of ligands for leukocyte integrins such as ICAM-1 
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and VCAM- 1 on inflamed endothelium. Transmigration across the endothelium 
mediated by chemoattractants follows firm adhesion of leukocytes (Campbell et al., 
1996; Dunon ci' al., 1996). 
The 132 family of integrins (Larson and Springer, 1990), aL[32, ctM132 and aX[32, 
which are expressed, but inactive, on resting monocytes and neutrophils, become 
activated after rolling of these cells on endothelium, resulting in strong adhesion to the 
endothelium via interaction with ICAM-1. 131 integrins expressed on lymphocytes play a 
similar role, for example a4131 binds to V-CAM1 on activated endothelium. In general 
the levels of 131 integrins increase after antigen stimulation of lymphocytes, which 
increases their ability to mediate strong attachment to endothelium (Hemler, 1990). 
ii) Lymphocyte Recirculation 
The recirculation of lymphocytes from the blood stream, through tissue and 
lymph nodes and back to the blood appears to be mediated by similar processes to that 
of leukocyte homing to sites of infection (Dunon ci' al., 1996; Springer, 1994). 
Circulating lymphocytes roll along high endothelium venules (HEVS) (Girard and 
Springer, 1991), which are only present in lymphoid tissues and function as an entry site 
for lymphocytes, by selectin mediated adhesion. The presence of certain chemokines 
released by the lymphoid tissue then activates intcgrins, resulting in strong adhesion to 
the HEVS and migration into the tissue (Dunon ci al., 1996; Springer, 1994). It seems 
that lymphocytes preferentially recirculate through specific tissues and their associated 
lymphoid tissues (Mackay, 1992). This specificity is mediated by the presence of 
specific ligands on the lymphoid tissues and specific integrins on different lymphocyte 
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types. An example of this is the recirculation of lymphocytes through the gut associated 
Peyer's patches. Antibodies against cr4 and P7 and the ct4[37 ligand MadCAM (Berlin et 
al., 1993; Streeter et al., 1988), which is expressed on the HEVS of Peyer's patches, can 
block recirculation of lymphocytes to Peyer's patches by up to 50% but have no effect 
on recirculation to the peripheral lymph nodes (Hamann et al., 1991; Issekotz, 1991; 
Streeter et al., 1988). In addition, 137 knockout animals have no defect in lymphocyte 
development but the compartmentalisation of lymphocytes to the gut associated 
lymphoid tissue is severely compromised (Wagner et al., 1996). In a4 integrin ' 
chimaeras, it was found that cz4 integrin is absolutely required for the homing of T 
lymphocytes to the Peyer's patches (Arroyo et al., 1996). Therefore, the expression of 
cz4137 integrin on lymphocytes directs them to specifically recirculate through Peyer's 
patches by interaction with the ligand MadCAM. 
1.2.4.1.2. Homing and Migration of Haemopoietic Stem and Progenitor Cells 
The bone marrow microenvironment, the main site of haemopoiesis in the adult, 
consists of a network of stromal cells and extracellular matrix proteins (Wilson, 1997). 
This environment provides niches where stem cells quiesce, proliferate or differentiate 
according to the specific combinations of cytokines and/or extracellular ligands 
presented. It appears that both cell-cell and cell-ECM interactions are essential for the 
orderly expansion, self-renewal, migration and maturation of haemopoietic stem cells 
within this environment (Wilson, 1997). The specific localisation of stem and progenitor 
cells and their development in this environment is mediated in part by integrins. In 
addition, the mobilisation of progenitor/stem cells from the BM into the circulation at 
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appropriate stages of differentiation or in response to external stimuli such as 
chemotherapeutic drugs and cytokines also involve integrins (Verfaille, 1998). 
Expression of integrins on progenitor/stem cells 
Most immature haemopoietic progenitors express aM3i and a5(31 integrins and 
CD44 by which they can interact with different binding sites of fibronectin. a531 
integrin binds to an RGD site; a4f31 integrin binds to a site in the CS  peptide and two 
other sites in the CS5 peptide at a lower affinity; CDM binds to two sites in the FN-C/H-
I and —II peptides of the COOH terminal heparin-binding domain of FN. c14131 can also 
bind to V-CAM which is constitutively expressed on BM stromal and endothelial cells 
(Coulombel etal., 1997; Wilson, 1997). The expression of these integrins on LTR-HSCs 
has not been proved, although there is strong evidence that a5131 integrin is expressed 
on stem cells capable of long-term reconstitution of recipient mice and that a4f31 
integrin is expressed on CFU-S (van der Loo et al., 1998; Williams et al., 1991). 
Expression of cz41 and a51 integrins persists in immature myeloid cells, monocytes 
and some lymphocytes and also in erythroid progenitors. However, the adhesive 
properties and/or expression levels of these molecules change as the cells differentiate 
and this may allow cells at various stages of differentiation to interact with specific 
support loci within the bone marrow environment, or to migrate from the bone marrow 
at the appropriate time (Coulombel et al., 1997; Verfaille etal., 1991). 
Homing 
As haemopoiesis is not initiated de novo in the BM the localisation of 
haemopoietic cells in this environment requires the homing of stem cells; from the FL 
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during development, or in the case of transplanted cells, from the circulation. The 
process of stem/progenitor cell homing is thought to bear similarities to that of leukocyte 
homing in that it involves multiple steps, i.e. initial rolling or weak adhesive 
interactions, strong adhesion, and finally migration, which are mediated by different 
adhesion molecules (Quesenberry and Becker, 1998). 
Studies on progenitor/stem cell homing have consistently revealed a role for 
c4131 integrin in this process. The first study which showed this was the treatment of 
BM cells for transplant with anti-PI integrin antibodies (Williams et al., 1991). This 
resulted in a reduction of the number of spleen colonies formed and of CPU-Cs found in 
the BM, 7-14 days after transplant. However, the long time period after transplantation 
did not allow for a distinction between an inhibition of homing, or of 
proliferation/differentiation of transplanted progenitor/stem cells to be made (Williams 
etal., 1991). However, treatment of cells for transplant with blocking antibodies against 
a4 integrin and treatment of recipients with antibodies against the a41 ligand V-CAM, 
both result in an up to 80% reduction in the homing of CPU-S and CPU-c to the bone 
marrow, as analysed 3 hours after transplant. This is accompanied by an increase in the 
number of progenitors in the spleen and circulation, showing that the homing of 
progenitors to the spleen is unaffected (Papayannopoulou etal., 1995; Vermeulen etal., 
1998). In addition, it was shown that inhibition of homing by anti-VCAM-1 antibodies is 
never as strong as with anti-a4131 antibodies, suggesting that (API binding to 
fibronectin may also play a role in homing. Similarly, studies on the homing of human 
progenitors cells in the pre-immune sheep foetus show that pre-treating cells with anti- 
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ct4131 integrin results in a decrease of homing to BM and concomitant increase of 
progenitors in the PB (Zanjani et al., 1999). 
The effect of blocking antibodies against CD44 has also been investigated. Anti-
CD44 antibodies affect homing to both the BM and the spleen (Vermeulen et al., 1998). 
Anti-(t4131 or anti-CD44 antibodies can block homing to the BM by up to 80%, which 
shows that neither pathway can compensate for the other, suggesting a degree of co-
operation between these two adhesion molecules (Vermeulen et al., 1998). It has also 
been shown in vitro that there is co-operation between these two molecules in the 
binding of human progenitors to fibronectin (Verfaille et al., 1994). 
Antibodies against cz5 integrin or CS-1 IN peptides, which contain the FN 
binding site for a4PI integrin, had no effect on progenitor cell homing or mobilisation 
when recipients were analysed 3 hours after transplant (Craddock et al., 1997b). 
However, these molecules may be involved in later stages of lodgement and 
establishment of haemopoiesis. This is supported by the fact that the treatment of 
recipient animals with FN peptides which contain all three binding sites of FN, resulted 
in a decrease in the engrafimcnt of progenitors to the BM measured 10 days after 
transplant (van der Loo etal., 1998). Pre-treatment of BM cells for transplant with anti-
a51 antibodies also reduced the number of progenitor cells in the BM. No effect was 
seen with FN peptides which did not contain all 3 binding domains, suggesting that there 
is co-operation between a4l, a501 and CD44 in the localisation of progenitors to the 
BM and the establishment of haemopoiesis (van der Loo et al., 1998). 
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All the above data points to a crucial role for ct4131 integrin in the initial stages of 
progenitor cell homing but does not distinguish the mechanism in which it is involved. 
However studies on the role of other molecules in progenitor cell homing have revealed 
the processes in which a4131 is likely to be involved. The transplant of cells to P-selectin 
or E-selectin null mice results in a substantial decrease in the homing of HPPC cells to 
the bone marrow, as measured 14hrs after transplant, and this is compounded by pre-
treating recipient mice with anti-V-CAM antibody (Frennette et al., 1998). This shows 
that selectins play an important role in progenitor cell homing and that they are involved 
in a different process than a413  1 /VCAM- 1 interactions. 
The chemokine SDF-1 has been shown to activate a41, a5(31 and LFA-1 
integrins in vitro on CD34+ human progenitor cells, as demonstrated by their 
strengthened adhesion to VCAM-1, ICAM-1 and FN. a413l integrin and LFA-1 are also 
required for SDP-1 induced migration of progenitors across endothelium, whereas a41 
and a5131 are required for in vitro SDF-1 induced migration of cells on ECM (Peled et 
al., 2000). Similarly, the transendothelial migration of murine CPU-GM in vitro is 
dependent on SDF-1, VLA-4 and VCAM-1 (Imai et al., 1999). The receptor for the 
chemokine SDP-1, CXCR-4, has also been implicated in the homing of progenitor cells 
(Kawabata et al., 1999; Peled et al., 1999) to bone marrow of recipients and the 
establishment of long-term haemopoiesis. Kit ligand, acting through the c-kit receptor is 
thought to play a similar role to SDF-l. In vitro the presence of certain cytokines, 
including KL, can increase the adhesiveness of CD34+ haemopoietic cells to fibronectin 
via activation ofa43l and asI3i (Coulombel etal., 1997; Levesque etal., 1995). 
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The above findings suggest a mechanism for stem/progenitor cell homing very 
similar to that of leukocyte homing (Quesenberry and Becker, 1998; Springer, 1994). 
The initial step is the loose adhesion of cells to the BM endothelium via selectin 
mediated interactions. The presence of cytokines and chemokines such as KL and SDF-1 
then stimulate the activation of integrins, predominantly a4131, resulting in strong 
adhesion to the endothelium by binding to VCAM-1. This is followed by migration of 
cells across the endothelium in response to chemokines and chemoattractants, such as 
KL and SDF- 1, expressed in the BM extravascular space. Cells then migrate within the 
BM to 'niches' via interactions with the ECM and stromal cells mediated by ct51, 
(A1 and possibly CD44. These molecules probably also mediate strong adhesive 
interactions which retain stem/progenitor cells within the BM environment. 
iii) Mobilisation 
The administration of cytokines and chemotherapeutic drugs to normal 
individuals results in the mobilisation of haemopoietic stem and progenitor cells into the 
peripheral blood. It is not clear whether this is due to actual emigration of cells from the 
BM or to a block in the re-uptake of cells from the circulation. Investigations into this 
process have again shown that a413l integrin plays an important role. 
The administration of anti-04131 and anti VCAM-1 antibodies to primates, mice 
and sheep results in an up to 200-fold increase in circulating numbers of haemopoietic 
progenitors (Papayaimopoulou et al., 1995; Papayannopoulou and Nakamoto, 1993; 
Vermeulen ci al., 1998; Zanjani ci al., 1999). In the case of the treatment of sheep, a 
decrease in the numbers of progenitors in the BM was observed, suggesting for the first 
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time that mobilisation is a result of egress of progenitors from the BM and not purely an 
inhibition in re-uptake (Zanjani ci al., 1999). Treatment of mice with anti-CD44 
antibodies did not result in efficient mobilisation of progenitors from BM, suggesting 
that to some degree the mobilisation of progenitors and their homing are the result of 
different pathways (Vermeulen ci al., 1998). 
As mentioned above, the mechanisms of progenitor cell mobilisation are unclear; 
it seems unlikely that simple deadhesion is sufficient to promote migration of 
progenitors into the circulation. It has been shown that in vivo the co-administration of 
anti-a4131 antibodies and KL, flt-3 and G-CSF leads to an enhancement of mobilisation 
of haemopoietic progenitors into the circulation (Craddock ci al., 1997a). In addition, 
mobilisation by a41 requires functional kit receptor as no mobilisation is seen with 
anti-a41 antibodies in W/Wv  mice (Blouin and Bernstein, 1993), although mobilisation 
is normal in S/Sd  mice (Brannan ci al., 1991). In addition in me '/me' mice (Van Zant 
and Shultz, 1989) in which c-kit is constitutively active mobilisation is enhanced 
(Papayamiopoulou ci al., 1998). This suggests that signalling by c-kit is required for 
emigration from the BM, probably after the initial deadhesion step which is achieved by 
disrupting ct4131/VCAM-1  interactions. This is supported by the fact that KL has 
chemotactic and chemokinetic effects on human CD34' cell in vitro (Okumura ci al., 
1996). It may be that the disengagement of integrins leads to the abolition of an 
inhibitory signal. Signalling through kit may then lead to further modifications in 
integrin activity, resulting in the migration of cells. 
1.2.4.2. Proliferation/Differentiation of Haemopoietic Cells 
The localisation of stem/progenitor cells in the BM environment and in the 
spleen and thymus brings them into contact with specific cytokines which promote the 
proliferation and differentiation of these cells in a co-ordinated manner. It is thought that 
integrins are not only involved in the localisation of cells in these microenvironments 
(section 1.2.4.1.), but can also transmit signals themselves and synergise with cytokine 
mediated signalling (section 1.2.3.). 
1.2.4.2.1. Progenitor Cells 
Antibodies against 041 can inhibit lymphopoiesis and retard myelopoiesis in in 
vitro long term bone marrow cultures (Miyake etal., 1991; Ryan etal., 1992), although 
the point at which this inhibition occurs is not clear; i.e. whether proliferation or 
differentiation of progenitors is blocked. In vivo, the injection of anti-a413l integrin 
antibodies can lead to anaemia in the FL and this block in erythropoiesis seems to be 
mainly at the level of erythroblast development. Injection of anti-VCAM-1 antibodies 
have no effect, suggesting that IN is the a4j31 integrin ligand involved in this process 
(Hamamura etal., 1996). 
In addition to the above direct effects of integrin mediated adhesion on 
proliferation and differentiation, it is proposed that integrins synergise with growth 
factor receptors in promoting proliferation. The growth of haemopoietic progenitor cells 
on FN increases their responsiveness to cytokines (Schofield et al., 1998) and a strong 
correlation between the ability of cytokines, or combination of cytokines, to promote 
cell proliferation and adhesion has been shown (Levesque et al., 1996). This suggests 
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that cytokines can activate integrins on progenitor cells, leading them to bind ligands, 
such as FN, and transmit signals which synergise with those transmitted by the cytokine. 
In contrast to the above studies where it appears that a4131 integrin plays 
important roles in the promotion of proliferation/differentiation of progenitor cells, other 
studies have shown that adhesion of progenitors via a4f3 1 integrin inhibits progenitor 
cell proliferation. The production of CFU-GM in vitro from human CD34+ progenitors 
was delayed by 3 weeks when these cells were co-cultured with stromal cells. This 
inhibitory effect could be abrogated by the addition of anti-131 integrin antibodies 
(Gordon et at, 1997), suggesting that adhesion through 01 integrins signal for cell 
quiescence or for inhibition of differentiation. Similar results, again with human CD34+ 
progenitors, showed that their proliferation is reduced by adhesion to FN, stromal cells 
or stromal ECM. Anti-a4 integrin and FN peptides relieved this inhibition (Hurley et al., 
1995). Finally the cross-linking of ct41 integrin, in the absence of adhesion, also results 
in a decrease in the proliferation of CFU-Cs. This inhibition requires actin 
polymerisation as it is blocked by cytochalasin D (Hurley et al., 1997). 
The different effects on proliferation observed upon integrin mediated adhesion 
may be due to the different levels of cytokines present in the different assays used. For 
example, in stromal cell co-cultures cytokines are not added, whereas in other assays 
cells were grown in the presence of exogenous added growth factors. As it is proposed 
that integrin signalling can synergise with growth factor mediated signalling, the levels 
of cytokines present may be important. In the absence of high concentrations of 
cytokines the level of signalling may not be high enough to promote proliferation and 
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integrins may instead transmit survival signals. In addition, at low concentrations of 
cytokines, integrins may not be fully activated and therefore may not be transmitting 
signals to their full potential. In contrast, in the presence of higher concentrations of 
cytokines, integrins may become activated, promoting stronger adhesion and higher 
levels of signalling, which may result in signalling above a threshold level required for 
the initiation of proliferation. A co-operation in signalling between integrins and 
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cytokines has been observed, whereby the treatment of CD34+ cells attached to FN with 
KL, resulted in an increase in the level of FAK and paxillin phosphorylation. This was 
probably mediated via the activation of a401 and a5131 integrins by KL, resulting in 
increased integrin signalling, rather that direct signalling through c-kit (Takahira et al., 
1997). 
1.2.4.2.2. Leukocytes 
Integrins have also been implicated in promoting the proliferation of mature 
lymphocytes. In T cells, tigand engagement of several integrins of the P1 and 32 type 
can act as a co-stimulus, with cross-linking of the T cell receptor-CD3 receptor, in 
stimulating proliferation (Burkly et al., 1991; Hemler, 1990). In addition binding of T 
cells to fibronectin by a5Pl can induce the AP-1 transcription factor which stimulates 
11-2 transcription (Yamada etal., 1991). 
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1.3. Gene Targeting 
1.3.1. Background 
Recent developments which enable the generation of mice lacking, or harbouring 
mutations in, particular genes has led to great progress in understanding the roles of 
many genes during development and in the adult. The most common way of introducing 
mutations into specific locations in the mouse genome is by gene targeting. 
Gene targeting is the homologous recombination of DNA sequences residing in 
the chromosome, with newly introduced sequences in the form of a targeting vector 
(Thomas and Capecchi, 1986). Targeting vectors contain the desired mutation in a 
cloned genomic DNA fragment which is homologous both 5' and 3' to the target locus. 
There are two main types of targeting vector - replacement (Thomas et al., 1986) and 
insertional (Hasty et al., 1991). Replacement vectors are commonly used for generating 
'knockout mice', where an exogenous sequence, such as a selection cassette or reporter 
gene, replaces part of the coding sequence of the target gene, rendering it inactive. More 
subtle mutations which do not leave any residual exogenous sequences can be made 
using an insertional vector (Hasty et al., 1991). This requires a two step recombination 
process, termed 'hit and run' or 'in and out' targeting (Hasty et al., 1991). Most 
targeting vectors contain a selection cassette for the positive selection of cells which 
have incorporated the vector. However, this positive selection of cells does not 
distinguish between cells that have randomly integrated the vector and cells which have 
undergone homologous recombination. Therefore, many targeting vectors also contain a 
negative selection cassette, often the thymidine kinase gene. This cassette is placed 
outside the region of homology and therefore homologous recombination between 
MEI 
incoming and endogenous DNA excludes this cassette from the targeted genomic locus. 
If the thymidine kinase gene is used as a negative selection cassette, cells which have 
undergone homologous recombination will be resistant to gancyclovir, whereas cells in 
which the vector has integrated randomly will be sensitive to gancyclovir. Such 
positive/negative selection can greatly enrich for 
clones in which correct gene targeting 
has occurred (Mansour et al., 1988). 
In order to generate mice carrying a desired mutation, gene targeting is carried 
out in mouse embryonic stem cells (Thomas and Capecchi, 
1987). ES cells modified by 
gene targeting are identified by PCR and /or Southern blot analysis and injected into 
recipient blastocycts. ES 
cells can contribute to all lineages of the mouse, including 
germ cells (Bradley et al., 1984; 
Robertson et al., 1986). Therefore, by breeding the 
resultant ES
cell/wild-type chimaeras, the mutation can be transmitted through the germ 
line, generating mice containing the mutation in all cells. Since there are two copies of 
most genes, these mice normally have to be interbred to obtain mice homozygous for the 
mutation. 
Since the ablation of many genes results in early embryonic lethality, the 
function of genes later in development, or in particular organs can not always be 
investigated using simple knockout strategies. Therefore, several mechanisms have been 
designed to generate tissue and temporally specific gene knockouts. These strategies 
employ the Cre/loxP and Flp/frt 
site specific recombination systems (Chambers, 1994; 
O'Gorman et al., 
1991). The Crc recombinase enzyme, from b
acteriophage P1, can 
excise mammalian and bacterial DNA which is flanked by 
loxP sites in a head to tail 
orientation, by c
atalysing site specific recombination between the two loxP sites. This 
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leaves one loxP site in the resulting recombined DNA (Sternberg and Hamilton, 1981). 
Similarly, the FIp recombinase enzyme isolated from yeast, can excise DNA flanked by 
frt sites (Craig, 1988). Therefore, by engineering a gene or part of a gene, using 
homologous recombination, to be flanked by loxP/frt sites and then introducing Cre/FIp, 
into the system, the flanked DNA will be excised. By mating mice carrying loxP flanked 
DNA to mice carrying a Cre transgene under the control of a tissue specific promoter, 
the lo±P flanked DNA will only be excised in the tissue of interest (Lakso ci al., 1992; 
Orban ci al., 1992). Cre transgenes have also been placed under inducible promoters 
such as the tetracycline promoter (St-Onge ci al., 1996) and the inducible interferon 
responsive promoter (Kuhn ci al., 1995) which allow the expression of Cre to be 
temporally regulated. 
The generation of Cre-fusion proteins, consisting of the Cre enzyme fused to an 
inducible ligand binding domain, allows Cre activity to be both spatially and temporally 
regulated. For example, Crc has been fused to a mutated estrogen binding domain that 
binds the synthetic oestrogen analogue tamoxifen (Danielian ci al., 1998; Zhang ci al., 
1996). This Cre-TBD fusion protein is bound to heat shock proteins and inactive in the 
absence of tamoxifen. However, addition of tamoxifen to cells releases the heat shock 
proteins, allowing Cre to enter the nucleus and mediate site specific recombination 
(Mattioni ci al., 1994). Tamoxifen is effective in inducing Cre-TBD activity in vitro 
(Zhang et al., 1996) and in vivo in embryos by injection into pregnant mice (Danielian ci 
al., 1998). By placing Cre-TBD under the control of a tissue specific promoter, Cre will 
only be active in the tissue of interest and when tamoxifen is added, i.e. it can be 
spatially and temporally regulated. These Cre/Frt recombination systems can also be 
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used to remove selection cassettes from targeted ES cells prior to injection into 
blastocysts. 
Mother method of studying the later function of genes that are embryonic lethal 
is through the generation of chimaeras, by injection of ES cells homozygous for the 
mutation into recipient blastocysts (Rossant and Spence, 1998). The subsequent 
integration and behaviour of these ES cells in different organs and cells lineages can 
provide important information on gene function, while providing a wild-type 
environment. 
1.3.2. 01 integrin Knockout 
The 131 integrin subunit is one of the most widely expressed integrin subunits and 
it can dimerise with 10 different a integrin subunits (Hynes, 1992). Two different 
isoforms of 131 integrin, which differ in their cytoplasmic domains, have been identified 
in the mouse, MA and f3lD (Belkin et al., 1996). The 131A isoform is expressed in 
almost all tissues except skeletal and cardiac muscle which express filD isoform. 31 
integrins have been implicated in many processes during development and in the adult 
and therefore the generation of a 131 integrin knockout was very informative in 
confirming or questioning these postulated roles for 131 integrin (Brakebusch et al., 
1997). 
131 integrin knockout mice die at around E5.5. due to a defect in the development 
of the inner cell mass (1CM) (Fassler and Meyer, 1995; Stephens et al., 1995). 
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Therefore, to further study the role of 131 integrin later in development, chimaeric mice 
were generated by injecting 131 integrin ES cells into wild-type blastocysts. 
ES cells were targeted with a construct containing a 13geo (lacZ/neo fusion) 
cassette replacing part of exonil of 131 integrin and a line of 01 integrin " ES cells was 
isolated. These cells show morphological changes and reduced adhesion and migration 
in vitro as compared with wild type ES cells (Fassler et al., 1995). However, they are 
able to integrate into wild-type blastocysts, resulting in the generation of viable 
ehimaeric mice (Fassler and Meyer, 1995; Fassler et al., 1995). Two types of embryos 
became apparent when embryos were assessed at E8.5 onwards. The first have a low 
contribution of 131 integrin cells (5-10%, maximum 20-25%) and appeared to develop 
normally. The second type have a higher proportion of 131 integrin ' cells (30-70%) and 
are severely malformed (Fassler and Meyer, 1995). The numbers of chimaeric mice 
actually born is much lower than the number of chimaeras observed during embryonic 
stages e.g. 4/138 blastocysts injected, gave rise to adult chimaeric animals with 10-20% 
chimaerism as assessed by coat colour (Hirsch et al., 1998), whereas when analysed at 
E6.5 all embryos were chimaeric (Fassler and Meyer, 1995). This suggests that 131 
integrin ES derived cells are out-competed during development or are more liable to 
cell death, resulting in mainly wild-type pups being born. Extensive breeding of f31 
integrin' chimaeras to wild-type mates resulted in no gcrmline transmission. However 
131 integrin ES cells can form primordial germ cells (P005) but these fail to migrate 
normally to the gonads(Anderson et al., 1999). 
rird 
The extent of chimaerism varies between different tissues in 131 integrin' 
chimaeric embryos. At E8.5 131 integrin ES cells were present in all 3 germ layers. 
Analysis of tissues from adult chimaeras show that 131 integrin ' cells are present in 
several tissues, as shown by lacZ staining and GPI analysis, and are indistinguishable 
from wild-type cells (Fassler and Meyer, 1995). The presence of (31 integrin ' cells in 
muscle and tissues of the nervous system was particularly unexpected as (31 integrin has 
been implicated in the migration of myoblasts (Hirsch etal., 1998) and neural crest cells 
(Bronner-Fraser, 1993). (31 integrin ' cells were not detected in mature endoderm-
derived lineages such as the liver, gut or skin epithelium or in the adult haemopoietic 
organs - the spleen, blood, bone marrow and thymus (Fassler and Meyer, 1995; Hirsch et 
al., 1996), again as assessed by OPT analysis and lacZ staining. The generation of (31 
integrin ' IRAG2 ' chimaeras ruled out the possibility that the absence of (31 integrin 
lymphocytes was due to homing competition with wild type cells, as these chimaeras 
also showed no P  integrin cells in haemopoietic organs (Hirsch etal., 1996). 
The absence of (31 integrin ' cells from the adult haemopoietic organs clearly 
points to a crucial role for 31 integrin in definitive haemopoiesis. Analysis of embryonic 
haemopoietic organs revealed (31 integrin ' cells were present in the blood islands of the 
YS and in the fetal blood but not in the fetal liver (Hirsch et al., 1996). This shows that 
although definitive haemopoiesis is abolished in the absence of (31 integrin, primitive 
haemopoiesis appears to be normal. 
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Analysis of 31 integrin " haemopoietic cells found in YS and fetal blood in in 
vitro colony forming assays, showed that 01 integrin '  precursor cells can form colonies 
producing erythroblasts, granulocytes, monocytes and macrophages (Hirsch et al., 
1996). In addition differentiation of PI integrin ' ES cells under conditions that favour 
lymphocyte differentiation showed that the frequency at which f31 integrin ' B 
lymphocytes developed was the same as for wild type cells and that these B cells 
expressed RAG-1, RAG-2 and rearrangements in the immunoglobulin heavy and light-
chain genes (Hirsch etal., 1996). 
This data, along with the defects in the migratory ability of P1 integrin ES cells, 
led to the conclusion that 131 integrin is not required for the differentiation of 
haemopoietic stem cells and therefore that the block in definitive haemopoiesis in the 
absence of 31 integrin is in the migration and colonisation of the fetal liver by LTR-HSC 
(Hirsch et al., 1996). However, as mentioned previously, precursors from the YS have 
different properties from definitive LTR-HSC (section 1.1.2.1.) and the haemopoietic 
assays used in this study only detect relatively mature haemopoietic progenitors. 
Therefore, it can not be ruled out that 131 integrin haemopoietic stem cells are able to 
colonise the fetal liver but once there are unable to differentiate and/or proliferate in the 
absence of 31 integrin. Equally, the block in definitive haemopoiesis could be at the 
stage of generation or expansion of LTR-HSC within the AGM region, or at an even 
earlier time during development. 
Recently, these questions have been addressed to some extent by further studying 
131 integrin chimaeras and by the generation of a conditional 131 integrin. knockout 
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(Potocnik et al., 2000). At E8.5 and E10.5 similar numbers of haemopoietic progenitors 
are generated from 31 integrin ES cells, as compared to controls, in the YS and pSp of 
chimaeric embryos. These progenitors include BFU-E, CFU-GM and B cell precursors. 
However, when the embryonic circulation was assayed for the presence of haemopoietic 
precursors, it was found that progenitors that are lin and express the stem cell markers c-
kit and AA4.1 continuously decreased from E13.5-15.5 in controls, whereas in 131 
integrintlwt chimaeras 131 integrin'ilin7ki(/AA41.1 cells accumulated in the PB. This 
suggests that 131 integrin stem/progenitor cells are unable to home to the FL and as a 
consequence accumulate in the circulation. 
To test whether 131 integrin' cells were able to survive in the fetal liver 
microenvironment 131 integrin17c-kit cells from E15.5 PB were mixed with wild-type 
FL cells which had been depleted of haemopoietic cells and cultured in aggregate FL 
cultures for 12 days. B lymphoid, erythroid and myeloid cells were generated from 131 
integrin bells and there were no significant differences in the numbers of donor derived 
cells generated from 131 integrin compared to controls. These 131 integrin'ic-ki( 
progenitor cells were also tested for their ability to colonise fetal thymic lobes in culture, 
which they were unable to do. However, when the colonisation step was circumvented 
by performing reaggregation cultures, 131 integrin cells could differentiate into T cells, 
although differentiation was delayed as compared to 131 integnn -1+ cells. 
131 integrin7c-kit+ progenitors were injected into irradiated recipient mice to test 
for CFU-S activity. In this case f31 integrin cells formed spleen colonies whereas 
injection of even ten times as many 131 integrin cells resulted in no spleen colonies 
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being formed. However, when cells were injected directly into the spleen of recipient 
animals 31 integrin cells could form spleen colonies, although at significantly lower 
numbers that P  integñn cells. 
By generating conditional [31 integrin knockout mice, the role of [31 integrin in 
the homing of adult HSCs was studied (Potocnik et al., 2000). Adult BM cells were 
isolated from these mice and the [31 integrin gene removed in vitro following infection 
with a Cre expressing retrovirus. [31 integrin cells were isolated by FACS sorting and 
transplanted into irradiated recipients. These cells were unable to rescue the 
haemopoietie system of irradiated recipients, which strongly suggests that [31 integrin is 
required for the homing of definitive HSCs to the adult BM. However, it cannot be 
proved that true HSCs were transplanted. 
This data further suggests that [31 integrin is required for the migration of 
haemopoietic progenitors to haemopoietic organs, both within the embryo and in the 
adult. It also lends further support to the hypothesis that in the absence of [31 integrin 
HSCs are unable to migrate to and colonise the FL but are competent for differentiation 
and proliferation in the FL microenvironment. However, the cells isolated from the PB 
may not have been true definitive HSCs but instead immature progenitors cells, possibly 
derived from the YS. It is clear that HSCs from different organs and at different stages 
of development have different properties and therefore the ability of PB progenitor cells 
to differentiate in the FL environment does not necessarily mean that definitive HSCs 
could survive/develop normally in the absence [31 integrin. In addition, there is no 
evidence that definitive HSCs are able to develop in the AGM region in the absence of 
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I integrin or that the block in definitive haemopoiesis may be at an even earlier stage 
of development. 
1.3.3.. ct4 integrin Knockout 
Knocking out the a4 integrin gene is embryonic lethal due to two early but 
distinct defects (Yang, 1995). The first, which occurs in a proportion, approximately 
half, of a4 integrin embryos between E9.5 and 11.5, is a failure of the chorion and 
allontois to fuse, resulting in failure of the placenta to form properly. A second defect 
occurs at around E12.5. In these mice there is severe haemorrhaging around the heart 
region and abnormalities in cranio-facial structures. Histological analysis of these 
embryos showed that the epicardium was missing from the heart along with some of the 
coronary vessels. 
As a consequence of the relatively early death of a4 integrin mice, studies on 
the roles of a4 integrin in haemopoiesis were carried out in u4 -1- embryos up to E12 and 
after that in chimaeric animals generated by the injection of a4 integrin ES cells into 
wild type, RAG2 ' and RAG1 ' blastocysts (Arroyo et al., 1999; Arroyo et al., 1996). 
RAG2' (Shinkai €1 al., 1992) and RAGP' (Mombaerts et al., 1992) mice do not 
develop any mature lymphocytes and are therefore a good model for studying the role of 
genes in lymphocyte development. 
In the absence of ct4 integrin, primitive haemopoiesis appears to develop 
normally as shown by no major difference in histology or yield of cells from E9 to E12 
YS of u4 integrin null embryos. ct4 integrin' progenitors were isolated and were able to 
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differentiate normally. However, defects in FL erythropoiesis were observed in the 
absence of a4 integrin. At ElO, the ct4 integrin FL appeared normal but by Ell cz4 
integrin livers were significantly paler and smaller than wild-type livers. E12 a4 
integrin FL had a higher ratio of proerythroblasts to erythroblasts but some 
erythrocytes were present in FL and PB, showing that terminal differentiation can occur 
in the absence of cz4 integrin. When the numbers of CFU-E were assessed, there were 
similar numbers in ct4 integrin a4 integrin' and wild-type embryos. To study later FL 
erythropoiesis, chimaeric mice were analysed. The contribution of ct4 integrin ES cells 
to mature liver erythrocytes was lower than wild-type controls and it decreased from 
E14-E18. However, when the numbers of cz4 integrin BFU-E were assessed these were 
found to be constant throughout the period and at similar levels to the level of 
chimaerism in other tissues. This suggests that erythroid progenitors are unable to 
differentiate properly in the absence of ct4 integrin in vivo, whereas in vitro they can 
differentiate normally, implying a role for cz4 integrin in the interaction of these 
progenitors with the microenvironment rather than a requirement for ct4 integrin per se 
to differentiate. 
Similar results were obtained when myeloid and B lymphoid lineages were 
studied. Normal numbers of ct4 integrin progenitor cells were observed (CFU-Mix and 
pre-B lymphoid cell lines) and these could differentiate normally in vitro. However, the 
contribution of mature ct4 integrin myeloid and B lymphoid cells was lower than 
would be expected in E12 and E18 FL. This again suggests a defect in 
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differentiation/proliferation of ct4 integrin progenitors in vivo, probably due to a defect 
in the interaction of these cells with the FL microenvironment. 
In E18 BM and spleen there are approximately normal numbers of a4 integrin 
progenitors, as assessed by in vitro assays. The numbers of differentiated cells (myeloid 
and B lymphoid - B220) in vivo are close to but significantly lower than wild-type. This 
shows that ct4 integrin progenitors can migrate to BM and spleen and differentiate 
there. However, one month after birth the numbers of mature a4 integrin' cells has 
decreased dramatically and is almost undetectable. Analysis of the contribution of cz4 
integrin B cells in RAG-1' and RAG2 chimaeras revealed that B cell development 
was blocked before the pro-B cell stage. In addition, fetal liver but not adult BM ct4 
integrin '  cells were able to reconstitute the B cell population in normal recipients, 
suggesting that B cell development from fetal precursors can take place without cz4 
integnn. 
The numbers of mature cz4 integrin 7 erythrocytes in the BM and spleen are 
lower than controls and 1 week after birth no cx4 integrin erythrocytes are detectable. 
However, normal numbers of BFU-E and CFU-Mix are present. 
a4 integrin cells can contribute to all T cell lineages in the foetal thymic 
microenvironment, showing that ct4 integrin is not required for either the migration of T 
cell progenitors from the FL to the thymus or for their subsequent differentiation. 
However, the thymi of a4 integrin ' /wt chimaeras showed a gradual decrease in ci4 





integrin '  thymocytes were present. Consequently, in RAG1 and RAG2 ' chimaeras 
there were very few mature thymocytes 3 weeks after birth and the thymi became 
progressively atrophic. This suggests that the absence of a4 integrin results in a defect in 
the input of T cell precursors from the bone marrow to the thymus. Reconstitution 
experiments further point to a problem with the survival or maturation of ct4 integrin ' T 
cell progenitors within the bone marrow environment, since BM from cz4 integrin' 
chimaeras can provide short term thymic reconstitution. This shows that cM integriri' T 
cell progenitors are present and can colonise the thymus but presumably are not able to 
survive properly in the BM or migrate from it. 
It is proposed that the absence of a4 integrin affects the 
proliferation/differentiation balance of haemopoietic progenitors, probably by affecting 
the ability of these progenitors to interact with haemopoietic microenvironments. It was 
shown that cz4 integrin progenitors are unable to transmigrate beneath bone marrow 
stroma and proliferate normally in vitro. In vivo, this may affect the ability of progenitor 
cells to reach the correct compartment to come into contact with cytokines and complete 
expansion and/or differentiation (Arroyo etal., 1999). 
1.4. Summary 
All cells of the adult or definitive haemopoietic hierarchy arise from definitive 
haemopoietic stem cells (LTR-HSC). In the adult, LTR-HSC reside in the bone marrow, 
where interactions with the ECM and stromal cells control the orderly self-renewal, 
proliferation and differentiation of LTR-HSC5 and progenitor cells, required to maintain 
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the haemopoietic system. The origin of the definitive haemopoietic system during 
embryogenesis remains controversial. Although haemopoietic cells are observed in the 
YS and embryo body from E7.5, these cells are not thought to contribute to the adult 
haemopoietic system. The first definitive LTR-HSCs arise in the AGM region at late 
E10 and this can therefore be considered as the origin of the definitive haemopoietic 
system. LTR-HSC migrate from the AGM region to the FL, which becomes the main 
site of definitive haemopoiesis in the embryo from El2—E18. Shortly before birth, LTR-
HSCs migrate from the FL to the BM, where definitive haemopoiesis continues during 
adult life. 
Establishment and maintenance of the definitive haemopoietic system relies on 
the co-ordinated migration, homing, differentiation and proliferation of LTR-HSCs and 
haemopoietic progenitor cells. It is thought that integrins play important roles in many of 
these processes. Integrins are a family of adhesion molecules that have been implicated 
in many processes during development and in the adult. In addition to mediating cell 
adhesion and migration, integrins are also considered as signalling molecules, capable of 
transmitting signals from both outside and inside the cell, causing changes in cell 
proliferation, differentiation and survival. 
The a4(31 integrin in particular has been shown to have many roles in definitive 
haemopoiesis. In the adult, a4l integrin is involved in the correct localisation of 
haemopoietic progenitor cells in the BM and has been implicated in their differentiation 
and/or proliferation in vivo and in vitro. Knockouts of (31 integrin and a4 integrin have 
also revealed roles for these molecules early in the establishment of definitive 
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haemopoiesis during development. In the absence of j31 integrin, definitive 
haemopoiesis is completely blocked from the FL stage onwards. However, the role of P 1 
integrin in the generation of LTR-HSCs in the AGM region, or in their migration to the 
FL remains unclear. In the absence of cz4 integrin, defects in haemopoiesis become 
apparent in the E12 FL, although haemopoiesis is not completely inhibited. Indeed the 
generation of several lineages appears relatively normal during embryogenesis. 
However, defects in haemopoiesis becomes more pronounced as development 
progresses, until after shortly after birth when several terminally differentiated cell types 
are essentially absent. The erythroid and lymphoid lineages are the most severely 
affected. Despite the above information, as with p1 integrin, the point at which a4 
integrin is required for establishment of normal definitive haemopoiesis has yet to be 
identified. Therefore, further studies are required to determine the role of a4fil integrin 
in the onset of the definitive haemopoietic system. 
1.5. Aims and Objectives 
The aim of this thesis is to further characterise the roles of PI integrin and ct4 
integrin in the definitive haemopoietic system. In particular, we are interested in the 
origin of the definitive haemopoietic system, with the generation of haemopoietic stem 
cells in the AGM region and their migration to and colonisation of the foetal liver. Since 
mice in which P l integrin or ct4 integrin is knocked out show severe defects in definitive 
haemopoiesis, it is interesting to determine the role of these molecules in the initial 
stages of establishment of the definitive haemopoietic system. 
'Ti' 
To achieve this goal the expression of PI integrin and ct4 integrin on definitive 
haemopoietic stem cells from Eli AGM, E13 FL, E13 PB and adult BM will be 
determined. These time points and organs represent the major developmental stages of 
the definitive haemopoietic system and therefore investigations into the expression of 131 
integrin and a4 integrin on LTR-HSCs from these stages may give information as to the 
processes in which these integrins are involved. 
In order to determine more precisely the time points at which a4 integrin and 131 
integrin are required for the establishment of definitive haemopoiesis, knockout animals 
will be studied. Firstly, the generation of definitive haemopoietic stem cells in the 
haemopoietic organs of a4 integrin' embryos will be investigated. It is interesting to 
determine if fully functional LTR-HSCs can be generated in the absence of a4 integrin, 
since the absence of such cells could be the cause of the haemopoietic defects observed 
in a4 integrin mice. In addition, differences in LTR-HSC function between different 
a4 integrin' embryonic haemopoietic organs may be revealed, which would again give 
information about the stage at which ct4 integrin is required for definitive haemopoiesis. 
Secondly, to identify the time point at which 131 integrin is essential for the onset 
of definitive haemopoiesis, we aim to generate a reversible 131 integrin knockout. By 
reactivating 31 integrin at different stages of development and in different haemopoietic 
organs it should be possible to rescue definitive haemopoiesis and therefore determine 
the initial point at which 131 integrin is required. 
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Chapter 2: MATERIALS AND METHODS 
Unless otherwise stated, analytical grade chemicals were obtained from either Sigma 
or BDH Laboratory Supplies (Merck Ltd.). Analytical grade agarose was supplied by 
Biowhittaker Molecular Applications. All bacterial media components were supplied 
by DIFCO laboratories. Synthetic oligonucleotides were synthesised by OSWELL 
DNA Service (University of Southampton, U.K.). Radioisotopes were supplied by 
Amersham International plc (Little Chafont, U.K.). 
2.1 Molecular Biology Methods: 
General molecular biology techniques and the preparation of standard solutions 
was carried out according to Sambrook et al. 1989 unless otherwise stated. 
Restriction enzyme digests were performed as recommended by the suppliers (New 
Eng Biolabs and Roche). Digestion products were routinely analysed by agarose gel 
electrophoresis with gels cast and run in 1XTAE buffer (0.04M Tris-acetate; 0.001M 
EDTA) at an appropriate concentration containing 0.5tg/ml ethidium bromide. 
0.5 jig of 1kb DNA ladder (GibcoBRL) was loaded on each gel as a size standard. 
2.1.1 General Cloning Techniques 
DNA fragments were routinely subcloned by restriction enzyme digestion 
and cloning into plasmids. Taq polymerase PCR products (which have a 
deoxyadenosine added to the end) were subcloned using TOPO TA Cloning® kit 
(Invitrogen), according to manufacturers instructions. 
011 
2.1.1.1 Gel Purification of DNA 
Restriction fragments for subcloning, plasmid vectors and PCR products up 
to 8kb in size were purified as follows. DNA fragments were run on 1% agarose gels 
until suitable separation had occurred to isolate single bands. Bands of interest were 
excised from the gel using a scalpel under long wavelength TV illumination. DNA 
was purified from the gel slice using Qiaquick gel purification kit (Qiagen) according 
to manufacturers instructions. 
DNA fragments over 8kb were purified as follows. DNA fragments were run 
on 1% agarose gels until suitable separation had occurred to isolate single bands. A 
well was cut in the gel in front of the band of interest and filled with solution (25% 
sucrose; SOmMTris; 1mMEDTA). The gel was run further to allow the DNA band to 
run into the well. The solution was then removed from the well. 1/10 volume of 3M 
sodium acetate and 2 volumes of 100% ethanol was added and the mixture incubated 
at —200C overnight. Samples were centrifuged at 13,000 rpm for 30 minutes in a 
microfuge, the DNA pellet washed in 70% ethanol, air dried and resuspended in an 
appropriate volume of sterile 1420. 
2.1.1.2 Ligations 
For ligations, plasmid vectors were digested and gel purified. Restriction 
fragments were also gel purified (section 2.1.1.1.) 
Ligation reactions were set up with 1:3 vector:insert molarity ratio with 1 jil 
(lunit) of T4 DNA ligase (Boehringer) and 2jil of lOX ligase buffer (660mM 
Tris.HCI pH7.5; 50mM MgCl2; 10mM DTT; 10mM ATP; Boehringer) to a final 
volume of 20R1•  Cohesive end ligations were performed at room temperature for at 
least I hour, blunt end ligations were incubated overnight at room temperature. To 
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determine the background level of vector re-ligation, a control reaction containing 
vector alone was also set up. 
2.1.1.3 Transformation of Bacterial Cells 
Competent XL1-Blue bacteria were routinely used for heat shock 
transformations. Competent bacteria were prepared as follows. A single bacterial 
colony from a freshly streaked plate was used to inoculate 5 mls Luria Broth (LB) 
culture media (1% w/v tryptone (Difco); 0.5% wlv yeast extract (Difco); 85mM 
NaCl) which was grown at 37 0C overnight with shaking. 2 mIs of overnight culture 
was added to lOOml of SOB media (2% w/v tryptone (Difco); 0.5% yeast extract 
(Difco); 85mM NaCl; 2.5mM KCI; 10mM MgCl2  added fresh) and the culture grown 
to A295=0.346 to ensure the cells were in log phase. The cells suspension was split 
between two tubes and centrifuged at 3,000 rpm, in Sorvall SS-34 rotor, for 10 
minutes at 0°C. Each cell pellet was resuspended in 16.5 ml ice-cold, filtered TFBI 
solution (100mM RbCl; 50mM MnC12 ; 30mM KAc; 10mM CaCl2;  15% glycerol; 
pH adjusted to pH5.8 with 0.2M acetic acid) and incubated on ice for 90 minutes. 
The cells were then centrifuged at 3,000rpm for 10 minutes and resuspended in 2mls 
ice-cold, filtered TFBII solution (10mM MOPS pH7.0; 10mM RbC1 2 ; 75mM Cad 2 ; 
15% glycerol). Cells were dispensed into 50M1  aliquots in pre-chilled eppendorf tubes 
and snap frozen in liquid nitrogen before storage at —80 0C. 
Frozen competent bacteria were thawed on ice. 501.d cells was mixed with SIll 
of ligation reaction and incubated on ice for 20 minutes. The sample was then 
incubated at 42 0C for 90 seconds and transferred to ice for 2 minutes. 900jil of LB 
broth was added and the sample incubated at 37 0C for 1 hour. Appropriate dilutions 
were plated onto LB agar plates (1.5% w/v agar in LB) with lOOjig/ml ampicillin. 
W. 
2.1.1.4 Screening Transformants 
Recombinant bacterial colonies were screened for presence of inserts by 
plasmid DNA preparation (section 2.1.2.1.) and subsequent restriction enzyme 
analysis. 
2.1.2. Isolation of Nucleic Acids 
2.1.2.1. Plasmid Preparation 
Plasmid isolation was either performed using Qiagen plasmid isolation kit 
(Qiagen), Wizard miniprep kit (Amersham) according to manufacturers instructions, 
or by the following protocol. 
A single colony was picked with a sterile yellow Gilson tip into 5mls of LB 
with the appropriate antibiotic and the culture incubated overnight at 37 0C, with 
shaking. 1.5 ml of overnight culture was centrifuged for 5 minutes in an Eppendorf 
tube at 13,000rpm (microfuge) to pellet the cells. The supernatant was discarded and 
the pellet resuspended in lOO.xl of Solution I (50mM glucose; 10mM EDTA; 25mM 
TrisHCl pH8.0). 200tl of freshly made Solution II (0.2M NaOH; 1% SDS) was 
added, the tube inverted gently several times and incubated at room temperature for 5 
minutes. 150xl of ice cold Solution III (3M NaAc pH4.8) was added, the tube 
inverted several times and incubated on ice for 10 minutes. Samples were then 
centrifuged at 13,000rpm for 5 minutes. The supernatant was transferred to a fresh 
tube and two volumes of 100% ethanol added. Samples were vortexed and DNA 
pelleted by centrifugation at 13,000rpm for 30 minutes. The DNA pellet was washed 
in 70% ethanol, air dried and resuspended in 50M1  of H20. 
59 
DNA prepared in this way was of sufficient quality for diagnostic digest 
analysis. If DNA was to be used for sequencing (section 2.1.6.) it was prepared using 
Wizard miniprep kit. For all midi and maxi preps DNA was prepared using Qiagen 
plasmid purification kits. 
2.1.2.2. Isolation of Genornic DNA 
ES cells: 
ES cells grown to confluence in 24 well plates were rinsed twice with PBS 
(137mM NaCl; 2.7mM KC1; 4.3mM Na2HPO4 and 1.4mM KERN  and lysed 
overnight at 37 0C in 500jil of.lysis buffer (100mM TrisHCl pH 8.5; 5mM EDTA; 
0.2% SDS; 200mM NaCl; 100mg/ml Proteinase K (Boehringer) - added fresh). The 
lysate was transferred to an eppendorf and an equal volume of isopropanol added and 
the tube inverted several times until a DNA precipitate was visible. DNA was 
pelleted by centrifugation at 13,000rpm (microfuge) for 30 minutes, washed in 70% 
ethanol and resuspended in lOOiil of sterile H20. DNA concentration was determined 
by absorbance at 260nm. 
Tissue 
i) Tails 
Tail tips (0.5-1cm) from newly weaned animals were digested overnight at 55 0 C 
in 500jt1 of lysis buffer (100mM TrisHCl pH 8.5; 5mM EDTA; 0.2% SDS; 200mM 
NaCl; 100mg/mi Proteinase K (Boehringer) - added fresh) with agitation. The lysate 
was vortexed and centrifuged at 13,000rpm for 10 minutes to remove bones and hair. 
Genomic DNA was extracted from the resulting supernatant as described above for 
ES cells and resuspended in 200R1  of sterile H20 
Peripheral Blood 
1 Oojil of peripheral blood was collected from the tail vein of adult mice into 
500m1 of versene (PBS+200ig/ml EDTA). 700iil of Histopaque (Sigma) was 
underlayed, creating a density step, and samples centrifuged at 1,500rpm (Beckman 
GS-CR centrifuge) for 30 minutes at room temperature. Mononuclear cells which 
collect at the interface between the two layers were removed by pipetting and added 
to 800 jil PBS in a fresh eppendorf. Cells were pelleted by centrifugation at 2,000rpm 
(microfuge) for 10 minutes and lysed overnight at 55 0C in 100j11 of lysis buffer 
(100mM TrisHCl pH 8.5; 5mM EDTA; 0.2% SDS; 200mM NaCl; 100mg/mi 
Proteinase K (Boehringer) - added fresh) with agitation. Genomic DNA was isolated 
from the lysate as described above for ES cells. 
Bone Marrow, Spleen, Thymus and Lymph Nodes: 
Single cell suspensions were obtained from tissues as described (section 
2.4.1.) Cells were pelleted, lysed overnight and DNA extracted as described above 
for peripheral blood. 
2.1.2.3. Isolation of RNA 
Total RNA was isolated from ES cells using TotallyRNA kit (Ambion) 
according to manufacturers instructions. Briefly, ES cells were grown to confluence 
in 6 well plates. Cells were rinsed twice with PBS and trypsinised with 0.5ml 0.1% 
trypsin. After 5 minutes incubation at 37 0C, 9.5 mls of ES cell medium was added 
(section 1.2.1.4.) and the cell suspension centrifuged at 1,200 rpm (MSE Mistral 
2000 benchtop centrifuge) for 3 minutes. The cell pellet was resuspended in Smls 
PBS and the sample centrifuged again at 1,200 rpm for 5 minutes. The cell pellet was 
resuspended in 0.5ml of Denaturation Solution (Ambion; containing guanidine 
61 
thiocyanate) and an equal volume of phenol:chloroform:IAA added. The mixture was 
stored on ice for 5 minutes and then centrifuged at 13,000rpm for 5 minutes. The 
aqueous layer was transferred to a new tube and 1/10 volume of Sodium Acetate 
Solution and I volume of phenol:cholorform:IAA added. The mixture was stored on 
ice and centrifuges as above. The aqueous phase was again transferred to a fresh tube 
and an equal volume of isopropanol added. The preparation was stored at-20 0C 
overnight and then centrifuged at 13,000rpm for 15 minutes. The RNA pellet was 
resuspended in 40p1 of DEPC treated H20. 
The RNA concentration was determined by absorbance at 260nm and by gel 
electrophoresis. Samples were stored at —70 0C. 
2.1.3. Nucleic Acid Transfer to Membranes 
2.1.3.1. Restriction Enzyme Digestion of Genomic DNA 
Genomic DNA isolated from ES cells (section 2.1.2.2.) was digested as 
follows. To approximately 1 Oj.xg of DNA was added 80U restriction enzyme, 71AI 
1 OXBSA (1mg/mI), 7j.xl lox digestion buffer (Boehringer) and the volume adjusted 
to 70j.il with sterile H20. The reactions were incubated overnight at 37 °C and a 
further 40U enzyme added the next day. The reactions were incubated 2 hours at 
37 °C. 
2.1.3.2. Alkali Blotting 
Alkali blotting was routinely used for the transfer of restriction enzyme 
digested genomic DNA. Restriction enzyme digested genomic DNA was run on 
0.7% 1XTAE or 0.5xTBE (0.045M Tris-borate; 0.001M EDTA) agarose gel 
overnight. The gel was photographed and then placed on top of a piece of Hybond+ 
62 
nylon membrane (Amersham) cut to the size of the gel, placed on vacuum blot 
apparatus. The gel was wetted with alkali transfer buffer (0.4M NaOH: 0.6M NaCl) 
and subjected to vacuum of 60mBar for 90 minutes. The membrane was removed 
after blotting, rinsed twice in 2XSSC (0.3M NaCl: 0.03M trisodium citrate) and 
baked at 1200C for 15 minutes. 
2.1.4. Radiolabelling Probes 
DNA fragments were radiolabelled by random priming. DNA fragments were 
gel purified as described (section 2.1.1.1.) and the concentration determined by 
visualisation on an agarose gel. Random priming was performed using the 
DecaPrimell kit according to manufacturers instructions. 
To 25ng of DNA was added 2.591 lox Decamers Solution and the volume 
adjusted to 12.5pl with H20. The sample was incubated at 95 0C for 5 minutes and 
directly snap frozen in liquid nitrogen. The sample was thawed and 5jil of sx buffer 
-dCTP, 5tl of [cz 32P]dCTP, 1l.tl Klenow Fragment (3'-5' exo) (1U) and 15R1  H20 
added and the reaction incubated at 37 0C for 10 minutes. The reaction was stopped 
by addition of ipi of 0.5M EDTA pH8.0 and 24i1 of H20. Unincorporated 
nucleotides were removed by centrifugation of the reaction through a G-50 sephadex 
column at 2,000 x g for 2 minutes. A ijil aliquot from the labelled probe was used to 
determine the [ct 32P]dCTP incorporation. Prior to hybridisation the probe was 




The probe used in all hybridisations was isolated from plasmid pmintbl 13/1 
(Appendix 3) by digestion with BainHI and Sail and gel purification of the 2.9kb 
fragment. 
2.1.5. Hybridisation Conditions 
All hybridisations and washes were performed in Techne hybridisation 
bottles rotating in a Techne HB-1 oven using approximately 12 mIs hybridisation 
buffer per filter. Filters were hybridised overnight. Prehybridisation, hybridisation 
and washes were carried out at 65 0C. 
Filters were prehybridised for 1 hour in Church and Gilbert hybridisation 
buffer (0.5M Na2HPO4 pH 7.2; 70gIl SDS; 1mM EDTA). Radiolabelled probe was 
denatured at 100 0C, snap cooled on ice and added to the same hybridisation buffer 
(approx. 1.5x10 6 c.p.m./ml). Following hybridisation, filters were washed for 2 x 45 
minutes in wash buffer (O.1xSSC; lOg/I SDS). After washing, filters were wrapped in 
Saran Wrap and exposed to autoradiographic film at —70 0C for the appropriate length 
of time (1-7 days) for a signal to appear. 
2.1.6. DNA Sequencing 
The manipulation of raw sequence data was performed using Genejockeyll 
for Macintosh 
2.1.6.1. Automated Cycle Sequencing 
Automated cycle sequencing was performed using the Perkin-Elmer Taq 
DyeDeoxy Terminator Cycle Sequencing Kit (Applied Biosystems). The cycle 
ffIjA 
sequencing reaction is a modification of the dideoxy-termination method of Sanger et 
al., 1977. The four 2',3'-dideoxynucleoside5'triphosphates (ddNTPs) are covalently 
linked to different fluorescent dyes allowing the sequencing reaction to be carried out 
in a single tube. 
Plasmid DNA was prepared using Wizard miniprep or Qiagen miniprep kits. 
The DyeDeoxy terminator cycle sequencing reactions were carried out according to 
manufacturers instructions. To conserve reagents, half the amounts were used (200-
500ng plasmid DNA, 1 .6pM primer (Section 2.1.6.2.), 4p.l terminator ready reaction 
mix and sterile H20 to 10M1  volume). The reactions were subjected to 25 PCR cycles 
of 960C for 30 secs; 50 0C for 15 sees; 60 0C for 4 mins. The PCR products were 
precipitated with lp.tl 3M sodium acetate, pH4.6 and 2 volumes of 100% ethanol on 
ice for 15 minutes, followed by centrifugation at 13,000rpm for 30 minutes. The 
DNA pellet was washed in 70% ethanol, air dried and resuspended in 4p1 of loading 
buffer (5mM EDTA pH8.0; 10mg/mi Blue dextran in deionised formamide). The 
sequencing reactions were denatured at 95 0C for 2 minutes and 2j.11 run on a 
denaturing polyacrylamide gel (7M urea; 5% acrylamide (29:1 Biorad); 1 XTBE; 
0.6g/I ammonium persulphate; 15m1 TEMED per SOmI mix) in 1XTBE on the ABI 
PRISM 377 DNA Sequencer. Sequencing gels were prepared and run by either 
Andrew Sanderson (ICAPB) or David Kilvachen (CGR). 
2.1.6.2. Sequencing Primers 






M13 Fw 	GTAAAACGACGGCCAGT 
M13 Rev GGAAACAGCTATGACCATG 
P1 	TTCATCCTAGGTCTATAACAGAAAATG 
P2 	ATAGACCTAGGATGAATTTGCAACAGG 
2.1.7. Polymerase Chain Reaction (PCR) 
All PCR reactions were carried out on Biometra TJNOII Thermocycler. 
dNTPs were supplied by Boehringer and Taq Polymerase was supplied by Qiagen or 
Promega. 
2.1.7.1. Y Specific PCR (Medvinsky and Dzierzak 1996) 
To 300ng genomic DNA was added 5t1 lox PARR PCR buffer (containing 
15mM Mg2+; Cambio); 400ng primer YMT1; 400ng primer YMT2; 300ng primer 
MYOI; 300ng primer MY02; ljil 10mM dNTPs; O.Sil Taq (2.5 units) and the 
volume adjusted to 50pI with sterile H20. The PCR conditions were as follows: 95
0 C 
for 5 minutes; 35 cycles of 95 0C for 30 seconds; 60 0C for 30 seconds; 72 °C for 30 
seconds; followed by 72 0C for 10 minutes. PCR products were analysed directly on a 
2% agarose gel in 1xTAE. 
2.1.7.2. a4 integrin Knockout PCR (Arroyo etal. 1996) 
a) Genotyping of mice and embryos 
To 400ng of genomic DNA was added Sjil 10XPARR Buffer, lOOng primer 
ct4koFw; 1 OOng primer cz4korev; 1 SOng primer cx4wtfw; I SOng a4wtrev; I j.sl I 0mM 
dNTPs, 0.5U Taq (2.5U) and the volume adjusted to SOul with sterile H20, PCR 
me 
conditions were as follows: 95 0C 30 seconds; 60 0C 2 mins; 720C I min for 30 cycles; 
720C lOmins. 
b) Assessment of reconstitution of recipient mice with a4 integrin' donor cells 
To 400ng of genomic DNA was added 5l 1OXPARR Buffer, 200ng primer 
cz4koFw; 200ng primer a4korev; 1 OOng primer Myo 1; 1 OOng primer Myo2; 1 !i1 
10mM dNTPs, 0.5jil Taq and the volume adjusted to 50l with sterile H20. PCR 
conditions were as above. 
2.1.7.3. RT-PCR 
cDNA synthesis 
2.tg of RNA was made up to a volume of 8.5il with DEPC treated H20 in an 
eppendorf and 1 tl of oligodT (SOng) and 1 j.xl  of hexamer (20ng) added. the sample 
was incubated at 700C for 15 minutes and then chilled on ice. To the sample was 
added 4i.ti  of 5X first strand buffer (GibcoBRL), 2j.d dNTPs (10mM each), 2R1  DTT, 
0.5j.tl RNAsin (0.5U) and ijil (1U) Reverse Transcriptase. Samples were incubated 
at 42°C for 2 hours 
PCR 
To 121 of first strand cDNA reaction was added SpA I OxXPARR buffer 
(Cambio); 10 pmoles forward primer; 10 pmoles reverse primer; I xl dNTPs (10mM 
each); 0.5xl (2.5U) Taq polymerase and the volume adjusted to 50pA with H20. PCR 
amplification was carried out using 30 cycles of 95 0C for 1 mm; 63 °C for 30secs; 
720 C for 90 secs; followed by 72 0 C for 10 minutes. 
2.1.7.4. Primers used in PCR 
5' 	 3' 
YMT 1 	CTGGAGCTCTACAGTGATGA 
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YMT2 	CAGTTACCAATCAACACATCAC 






liActin S 	ATGGATGACGATATCGCT 
liActin A/S ATGAGGTAGTCTGTCAGGT 
131 Fw 	AAGCCGAGGTCCGCCGACACC 
131 Rev 	AGATCAATAGGGTAATCTTCAGCCC 
2.1.8. Generation of Constructs: 
2.1.8.1. pHH1.6 Targeting Construct, see Appendix 1. 
The pHH 1.1 plasmid containing 1kb of 131 integrin genomic sequence 
incorporating part of Intronl, all of Exon II and part of Intron II was obtained from 
Reinhard Fassler, Sweden. pHH 1.1 was digested with BamHI and SpeI, the ends 
filled in with Klenow fragment and religated, thus destroying the BamHI and Spel 
sites, generating plasmid pHH1 .2. An AvrII restriction site was introduced into the 
Intronl/ExonlI boundary by PCR. pHH1.2 was amplified with the primers P1 and 
Seqi and in a separate reaction P2 and Seq2. Primers P1 and P2 are homologous to 
the Introni/Exonil boundary and contain an overlapping region of I 6bp which 
contains the introduced AvrII site. The PCR conditions were: 30 cycles of 95 0C 60s; 
55 0C 60s; 72 0C 60s; followed by 72 0C 10 minutes. The PCR products were mixed 
and amplified in a second PCR reaction with T3 and T7 primers. Conditions were as 
above. The resulting PCR product was digested with EcoRI and AlioI and inserted 
into EcoRJ, N/wI digested pHH1 .2, generating plasmid pHH 1.3. pHH1 .3 was 
digested with AvrII and an AvrIJlAvrII fragment of pROSA containing two loxP sites 
in head to tail orientation inserted, generating plasmid pHH1.4. pHH1.4 was 
sequenced to ensure that the loxP sites were in the correct orientation and that there 
were no mutations in the coding region of 131 integrin introduced during PCR 
amplification. pHH1.4 was digested with BamHI, the ends filled in with Kienow 
fragment and then digested with SpeI. A 6kb XbaI, ScaT fragment of pI3Geo 
containing the lacZ/neo fusion gene and pA site was inserted into digested pHH1 .4, 
generating pHH 1.5. To generate the final targeting construct a 7kb BstEII/NheI 
fragment of pHITi .5, containing the foxed J3geo cassette was used to replace the 
equivalent fragment in pmintf3lRl plasmid which contains 7.8kb cloned 131 integrin 
genomic DNA spanning part of Intronl, ExonTI and part of Intronll. 
Plasmid DNA was linearised prior to electroporation into ES cells (section 
2.2.1.6.) with A7ioT. For purification of linearised DNA for an equal volume of 
phenol:choloroform was added to the restriction enzyme reaction, the sample 
vortexed and then centrifuged at 10,000 rpm (microfuge) for 5 minutes. The top 
aqueous layer was transferred to a fresh tube and 1/10 volume 3M sodium acetate 
and 2 volumes 100% ethanol added. The sample was vortexed and incubated at - 
800C for 30 minutes, then centrifuged at 13,000 rpm for 30 minutes. The DNA pellet 
was washed in 70% ethanol, air dried in a laminar flow hood and resuspended in an 
appropriate volume of sterile PBS. 
r'vJ 
2.1.8.2. Human 131 integrin Transgene, see Appendix 2 
A .3kb EcoPJIEcoRI fragment of pECEhu13la, containing human [31 integrin 
eDNA was inserted into an EcoRl site upstream of the Frt site of pBLFrt2, 
generating plasmid pFrt2[31A A 1kb AgeI/MluI fragment of pEGFP-C1(Promega) 
containing enhanced GFP gene and SV40 pA site was inserted into AgeI/BssHII 
digested pFrt2[31A, generating plasmid pFrt2f31AGFP. pFrt2[3IAGFP was partially 
digested with Sail and a 1.8kb Sail/fbI fragment of pFrtl j3ActP, containing the 
CMVIEE promoter upstream of a Frt site, was inserted, generating plasmid 
pActpFrt 1131 Afrt2GFP. A 1.9kb partial BssHII/BssHII fragment of pBSIRESPuro 
was inserted into the MluI site of pActpFrt131Afrt2GFP. This generated the final 
transgene, ph[31IRESPuro, containing the CMVIEE promoter upstream of [31 
integrin cDNA/IRESPur0 fit site flanked cassette. Downstream of this cassette is the 
enhanced GFP gene. 
Prior to electroporation into ES cells, phu[3IIRESPur0 was digested with PvuII to 
remove the plásmid backbone. The 8kb fragment containing the transgene was gel 
purified as described in section 2.1.1.1. 
2.2 Tissue Culture 
2.2.1. ES Cell Culture 
General methods for the manipulation of ES cells are based on Hogan ci al. 
1994. All ES cell manipulations were performed in laminar flow sterile hoods using 
a strict sterile technique which included wiping the hood down and spraying all items 
entering the hood with 70% industrial methylated spirits (IMS). ES cells were 
incubated at 7.5% CO2 at 37 0C in a humidified incubator (Heraeus). All solutions 
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were tested for sterility and pre-warmed to 37 0C prior to use. ES cells were examined 
using an inverted microscope (Olympus CK2) 
2.2.1.2. Reagents 
ES cells were maintained in 1XGMEM cell culture medium containing 10% 
FCS; 15% sodium bicarbonate; 0.1% MEM non-essential amino acids; 4mM 
glutamine; 2mM sodium pyruvate; 0.1mM 2-mercaptoethanol. All flasks were 
gelatinised (5mins with 0.1% gelatin) prior to addition of ES cells. ES cells were 
maintained in an undifferentiated state by addition of Differentiation Inhibiting 
Activity/Leukaemia Inhibitory Factor (DIA/LIF). Human DIAILIF expression 
plasmids were used to transiently express DIA/LIF in COS-7 cells using the 
previously described method (Smith 1991). Serial dilutions of the supernatant were 
tested on ES cells for their ability to maintain pluripotency. Routinely, I OOX the 
minimum concentration required to keep ES cells undifferentiated was used as the 
working concentration. All stock solutions were prepared by Douglas Colby and 
Derek Rout at the CGR. G418 was prepared at 1000X concentration required and 
Puromycin (Cambio) was prepared at a 5mg/mi stock solution and used at 2.0-3.0 
jig/ml. 4-hydroxytamoxifen (Sigma) was dissolved in 100% ethanol at a 
concentration of lmg/ml and stored at —20 0C. 
2.2.1.3. Thawing ES Cells 
Frozen ES cell vials were taken directly from the liquid nitrogen storage and 
quickly thawed in a 37 0C water bath. The cell suspension was transferred to a 20m1 
centrifuge tube and lOmIs of pre-warmed ES cell medium added drop-wise while 
shaking the tube. The cell suspension was centrifuged immediately at 1,200rpm for 
3 minutes (MSE Mistral 2000 benchtop centrifuge). The media was aspirated and the 
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cell pellet resuspended in lomls of ES cell culture medium, which was transferred to 
a gelatinised 25cm2  flask. The medium was changed the next day to remove any dead 
cells. 
24 well plates containing frozen adherent ES cells were removed from the - 
800C storage and thawed by holding between hands. imI of pre-warmed ES cell 
medium was added to thawed wells and approximately 80% was then aspirated. 
Mother lml of ES cell medium was then added to the well. Medium was changes 
the next day to remove dead cells. 
2.2.1.4. Passage and Expansion of ES Cells. 
Cultures were monitored every day to ensure that ES cells had not grown past 
confluence. Cells were normally passaged every two days. Culture medium was 
aspirated and cells rinsed with PBS. lml trypsin solution (0.025% trypsin (Gibco); 
0.1% chicken serum (Flow Labs); 1.3mM EDTA (Sigma) in PBS) for a 25cm 2 flask 
(0.2mls for 24 well plate, 2mls for 75cm 2 flask, 4 mIs for 175cm 2 flask) was added to 
the cells and incubated at 37 0C for 2-5 minutes until a single cell suspension was 
obtained. 9 mls of ES cell medium was added to neutralise the trypsin and the cell 
suspension centrifuged for 3 minutes at 1,200rpm (MSE Mistral 2000 benchtop 
centrifuge). The cell pellet was resuspended in ES cell medium and transferred to 
fresh gelatinised flasks or wells at a dilution of 1:10. 
2.2.1.5. Freezing ES Cells 
ES cells were frozen at approximately 5x 
106  cells per vial or directly in 24 
well plates. 
For freezing in vials, cells were trypsinised into a single cells suspension as 
above. The cell suspension was centrifuged at 1,200rpm (MSE Mistral 2000 
72 
benchtop centrifuge) for 3 minutes and the cell pellet resuspended in Imi of freezing 
solution (80% ES cell medium; 10% FCS; 10% DMSO) and rapidly transferred to 
Nunc cryotubes on ice. Cryotubes were transferred to —80 0C freezer and the next day 
moved to liquid nitrogen storage. Exposure of ES cells to DMSO is kept to a 
minimum as it is toxic to the cells and is an ES cell differentiation agent. 
For freezing in 24 well plates ES cells were grown to approximately 50-70% 
confluence. The medium!  was aspirated, cells washed twice in PBS and 0.4 mls of 
freezing solution added directly to the wells. Plates were transferred immediately to - 
200C freezer. They were moved the next day to —80 0C freezer for long term storage. 
2.2.1.6. Transfer of DNA to ES cells 
Exogenous DNA was routinely introduced into ES cells by electroporation. A 
single. cell suspension was obtained as above and cells centrifuged at 1,200rpm (MSE 
Mistral 2000 benchtop centrifuge) for 3 minutes. Cells were resuspended in ES cell 
medium and counted in a haematocytometer. The appropriate volume of cell 
suspension was then centrifuged again at 1,200xg for 3 minutes and the cell pellet 
resuspended in 500-7001J of ice-cold PBS. The cell suspension was transferred to an 
electroporation cuvette and linearised plasmid DNA in PBS (section 2.1.8.) added at 
10ig/107 cells. Cells were electroporated at (0.8V, 3jiF in BioRAd GenePulser) 
which would normally result in a time constant of 0.1s. The cells were then 
transferred to a fresh 20m1 centrifuge tube and 9 mIs of pre-warmed ES cell medium 
added. Cells were plated at 5x10 6/1Ocm plate. Medium was changed the next day to 
fresh medium containing the appropriate selection drug. 
After between 12 and 14 days of growth, drug resistant colonies were isolated 
and transferred to 24 well plates. Medium was aspirated and cells washed in PBS and 
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2 mIs PBS left on the plate. Individual colonies were stabbed with a yellow Gilson 
tip containing approximately SOjil of PBS. The yellow tip was then placed in a well 
of 96 well plate which contained 1 OOtl of trypsin and incubated at room temperature 
for 5 minutes. The contents of the well were then transferred to a well of a 24 well 
plate containing 2 ml of ES cells medium. Medium was changed the next day. 
2.2.1.7. Methylcellulose ES Cell Differentiation (adapted from Wiles and Keller, 
1991) 
A single ES cell suspension was obtained as above and cells centrifuged at 
1 ,200xg for 3 minutes. The cell pellet was resuspended in ES cell medium and the 
cells counted in a haemocytometer. 10 
3  ES cells were added to 1.5 ml 
methylcellulose mix (0.9% methylcellulose (Metachem Diagnostics); 10% FCS 
(Metachem Diagnostics); 340mM monothiolglycerol; lU/mI erythropoietin 
(Boehringer); 10mg/mi insulin; 11-3 (Boehringer); glutamine in IMDM+10% FCS) in 
35mm plates. Plates were incubated in 7.5% CO2 at 37 0C in a humidified incubator 
(Heraeus) for 12 days. 
2.2.2. ACM Organ Culture 
AGM organ cultures were carried out as described previously (Medvinsky and 
Dzierzak 1996). AGM were dissected from El 1 embryos into PBS + 7% FCS and grown in 
organ cultures as described. Durapore 0.65 tm filters (Millipore) supported by stainless 
steel stands were placed in 6 well plates containing 2.5mls of myelo-cult medium (Stem 
Cell Technology) supplemented with 10 -6 M hydrocortisone hemi-succinate (Sigma) . The 
level of the culture medium was adjusted such that the filter was at the gas-liquid interface. 




All mice were housed and bred within the University of Edinburgh, according 
to the provisions of the Animals (Scientific Procedures) Act (UK) 1986. Mice were 
housed in a stabilised environment with a 14 hours light/10 hours dark cycle 
(midpoint 12 0' clock, midnight). They were provided with a constant supply of 
water and chow food. As standard practice, litters from natural matings were left 
with parents until 3 weeks of age when they were weaned by separating the offspring 
from their parents. At weaning animals were sexed and tail tips taken for genotyping. 
At 6 weeks of age mice could be used for mating. 
a4 integrin' mice were obtained from Jackson Laboratories. 
2.3.2. Isolation of Tissues 
All animals were culled by the schedule 1 method of cervical dislocation. 
For collection of tissues from embryos at specific stages of gestation, matings 
were set up overnight and the females examined for the presence of a vaginal plug 
the next morning. If a vaginal plug was found, the stage of gestation was marked as 0 
days post coitus or E0. Pregnant females at the correct stage of gestation were 
sacrificed and the uterus dissected into PBS+7%FCS. Subsequently the embryos 
were dissected from the uterus and all the extraembryonic tissues removed with the 
exception of the yolk sac. Embryonic tissues were dissected out, with tungsten 
needles sharpened by electrolysis, into PBS+7%FCS. Embryonic peripheral blood 
was placed straight on ice. 
Adult tissues were dissected free of connective tissues and fat into 
PBS+7%FCS. BM  was isolated by aspirating femurs with 26 gauge needle and 
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placed directly on ice. Adult peripheral blood was obtained either by bleeding from 
the tail vein or by cardiac puncture with 26 gauge needle. Peripheral blood was 
collected into PBS+ 200p.g/mIEDTA. 
2.3.3. Transplant of Cells Into Irradiated Recipients 
Cells were isolated directly from tissues (section 2.3.2) or after FACS sorting 
(section 2.4.3.) as described. Organs for transplant were obtained from (CBAxC57BL/6) Fl 
embryos or adult mice. Cells were resuspended in ice-cold PBS at appropriate 
concentrations and transplanted via tail vein injection into (CBAxC57BL/6) Fl female 
recipients. Recipient mice were irradiated at 9.5 Gr split into two doses separated by a 3 
hour interval in the Cs source at a rate of 21.6 radlmin. The volume of cell suspension 
transplanted did not exceed 400tl per recipient. 
2xl04  female adult bone marrow cells were included in each transplant for short-
term radio-protection. All recipient mice received neomycin (0.16g/l00ml) in acid drinking 
water for the first four weeks after irradiation. 
2.4. FACS 
2.4.1. Preparation of Cells 
Tissues were isolated from staged embryos or adult mice as described above 
(section 2.3.2.). To obtain single cell suspensions, embryonic tissues, AGM region, 
FL and YS were digested with 0.1% collagenase/dispase (Boehringer) in PBS+7% 
FCS at 370C, for 45 minutes with shaking. Cells were then centrifuged at 1,400rpm 
(Beckman GS-CR centrifuge) for 10 minutes and washed twice in PBS+7%FCS. 
Cells pellets were resuspended in PBS+1%BSA and placed on ice. Single cells 
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suspension from adult thymus and spleen were obtained directly by pressing the 
organ with a syringe plunger and collecting the cells released from the outer capsule. 
These cells and BM and PB cells were washed in PBS+7%FCS and cell pellets 
resuspended in PBS+1%BSA. 
Trypsinisation of ES cells into single cell suspensions was achieved as 
described previously (section 2.2.1.4.). Cells were centrifuged at 1,200rpm (MSE 
Mistral 2000 benchtop centrifuge) and resuspended in PBS+l%BSA and placed on 
ice. 
2.4.2. FACS Analysis 
Single cells suspension were obtained as described above, cells were counted 
in a haemocytometer and typically 2x10 5 cells placed in a well of a 96 well plate 
(round bottom). Plates were centrifuged at 900rpm (Heraeus Labofuge 400R 
benchtop centrifuge) for Imin and the supernatant removed. Cells were resuspended 
in 100M1  of PBS+1%BSA containing 0.2jig of the appropriate antibody or antibodies 
(i.e. I ig/l06 cells for each antibody). Cells were incubated at 4 0C for 30mins, 
centrifuged at 900rpm for Imin and washed 3 times in PBS+1% BSA. For secondary 
staining with streptavidin-conjugated fluorochromes, cells were resuspended in 
lOOjfl of PBS+l%BSA containing Streptavidin-PE at a dilution of 1:50 or 
Extravidin-FITC at a dilution of 1:200. Cells were incubated at 4 0C for 30 minutes 
and washed as before. 
After the final staining, cells were resuspended in 200p.l  PBS+1 %BSA for 
direct analysis or 200M1  PBS+1%BSA containing 0.025% parafornialdehyde and 
0.01% sodium azide if cells were to be analysed more than 12 hours later. Cells were 
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stored at 40C in the dark until analysis - no more than 5 days.Stained cells were 
analysed on Becton Dickinson FACScan Machine. FITC and PE labelled cells were 
identified in the FL-i and FL-2 channels respectively. FACS data was analysed using 
the Cell Quest program. 
2.4.3. FACS Sorting 
Single cells suspensions were obtained as described above. For BM the cell 
suspension was red cell lysed prior to incubation with antibody. 6 mis red cell lysis 
buffer (155mM NH4C1; iOmM KHCO3; 0.1mM EDTA) was added to iml of BM 
cell suspension and incubated for 5 minutes at room temperature. Cells were then 
washed twice in PBS+I%BSA. For all tissues, cells were counted and the cell 
concentration adjusted to 2x10 7  cells/ml PBS+i%BSA. Cells were incubated with 
the appropriate antibody at 0.51igAb/10 6 cells for 30 minutes at 4 0C. Cells were then 
washed 3 times in PBS+7%FCS and resuspended in PBS + 7% heat inactived FCS at 
2xlO7cells/ml and placed on ice. Cells were passed through Becton Dickinson 
FACSTAR machine at 4 0C and positive and negative populations recovered in PBS 
+7% heat inactivated FCS and placed on ice. A sample of the sorted populations was 
passed through the machine to check the purity of the sort. FACS sorting was carried 
out by Andrew Sanderson (ICAPB) 
2.4.4. Reagents 
a) Antibodies 
Antigen Host /Specificity Clone Conjugation Company! 
Catno. 
j3I integrinlCD29 hamster/rat Ha2!5 Biotin Pharmingen 
________  22632D 
a4 integrin!CD49d rat/mouse 9C10 FITC Pharmingen 
01734D 
in 
CD44 rat/mouse 1M7.8.1 FITC Caitag 
RMS 70 
CD44 rat/mouse 1M7 FITC Pharmingen 
01224D 
Mac-i/CD 1 lb rat/mouse M1/70. 15 FJTC Caltag 
RM2 801 
c-kit/CD 117 rat/mouse 2138 FITC Pharmingen  
01904D 
CD34 rat/mouse RAM34 FITC Pharmingen 
(49E8)  09434D 
B220/CD45R/Ly-5 rat/mouse RA3-6132 FITC Caltag 
RM2601 
human P 1 integrin/ mouse/human 2A4 PE Caltag 
CD29  MHCD2954 
Ly-9. 1 rat/mouse 3007 Biotin Pharmingen 
01192A 
b) Isotype Controls and Secondary Reagents 
Reagent Description Clone Conjugation Company/ 
Cat.no. 
rat IgG2a rat isotype R35-95 FITC Pharmingen 
11024C 
rat IgG2b rat isotype A95-1 FITC Pharmingen 
11184C 
rat IgG2a rat isotype LO-DNIP- FITC Caltag 
16  R2a01 
rat IgG2b rat isotype LO-DNP- FITC Caltag 
57  R2bOl 
mouse IgG- 1 mouse isotype MOPC-2 1 FITC Caltag 
MG1O1 
Hamster 1gM Hamster G235-1 Biotin Pharmingen 
11132C 
Extravidin-PE N/A N/A PE Sigma  
E4011 
Extravidin-FITC N/A N/A FITC Sigma 
 E276 
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Chapter 3: RESULTS 
Characterisation of 31 integrin expression in haemopoietic organs 
3.1. Introduction 
As the haemopoietic system develops during embryogenesis the main sites of 
haemopoiesis and the types of cell generated change (Dzierzak and Medvinsky, 
1995) (section 1.1.2.). Here, the expression of f31 integrin in the haemopoietic organs 
during development and in the adult BM is characterised. 
To assess 131 integrin expression during haemopoietic development, 
E9,10,11,12 haemopoietic organs, the AGM, FL, YS, PB and the adult BM, were 
analysed by FACS for 131 integrin expression and its co-expression with a4 integrin 
and the haemopoietic markers CD34, c-kit, CD44. At E9, definitive haemopoiesis 
has not been initiated and primitive haemopoietic cells, including progenitors, are 
present in the YS, circulation and AGM region. Definitive haemopoietic cells are not 
generated until late ElO in the AGM region, however these cells are rare and the 
majority of haemopoictic cells in the embryo at this time are still primitive 
haemopoietic cells. From Ell-E12 definitive haemopoiesis is established in the FL 
and multiple definitive haemopoietic lineages start to be generated. 
The expression of a4 integrin and its co-expression with 131 integrin is 
interesting since both these integrin subunits are essential for correct development of 
the definitive haemopoietic system, although neither seem to be required for 
primitive haemopoiesis (Arroyo etal., 1996; Hirsch et al., 1996). The requirement of 
a4 and 31 integrins for the correct establishment of definitive haemopoiesis suggests 
that they may be expressed on definitive haemopoietic stem cells, although this has 
not been shown. The expression of ct4 and 131 integrin on LTR-HSCs from different 
haemopoietic organs is investigated in Chapter 4. However, a4131 integrin, also 
known as VLA-4, is expressed on many adult haemopoietic progenitors including 
CFU-S (Coulombel ci al., 1997; Williams ci al., 1991), although its expression can 
be modulated as cells differentiate - for example it is expressed on BFU-E but is 
down regulated in CFU-E and erythroblasts (Coulombel ci al., 1997; Verfaille ci al., 
1991). 
The sialomucin CD34 is expressed on most, or all, LTR-HSC from the Eli 
AGM and Eli and E12 FL (Sanchez ci al., 1996). Similarly, the stem cells found in 
E9 YS and pSp region, which can repopulate new-born but not adult recipients, are 
found exclusively in the CD34+ population (Yoder ci al., 1997). It was initially 
thought that CD34 was also a marker for HSCs in the adult BM. However, it has 
since been shown that a significant proportion of adult BM HSCs do not express 
CD34 and that its expression may be a reflection of the cycling state of the stem cell. 
(Osawa et al., 1996; Sato ci al., 1999). CD34 is also expressed on a number of 
haemopoietic progenitors, as well as on endothelial cells, during development and in 
the adult (Young etal., 1995). It is expressed in the blood islands of the YS, in both 
the endothelial and haemopoietic cells, and in the FL and pSp (Young ci al., 1995). 
CD34 is also expressed in the clusters of haemopoietic cells that bud from the aortic 
endothelium in the human (Tavian ci al., 1996). This data suggests that CD34 might 
be expressed on the very earliest haemopoietic cells as they are formed, possibly 
from a common precursor with the endothelial cell lineage, the haemangioblast 
(section 1.1.2.5.) 
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CD, also an adhesion molecule, has many roles in haemopoiesis 
(Coulombel ci at., 1997; Ruiz et at., 1994). It is involved in the homing of 
progenitors to the BM and spleen and may co-operate with a4(31 integrin in 
promoting adhesion and migration of these progenitors (Verthille ci al., 1994; 
Vermeulen ci at., 1998). In addition, antibodies against CD44 can inhibit 
myelopoiesis and lymphopoiesis in in vitro long term bone marrow cultures (Miyake 
eat at., 1990). CD44 is expressed on LTR-HSC from the El 1 AGM, E13 FL and adult 
BM (Kumaravelu, P. eat at, unpublished data) and on many haemopoietic progenitors 
and mature cells (Coulombel eat at., 1997; Wilson, 1997). 
c-kit, a tyrosine kinase receptor, and its ligand, kit ligand (KL or SCF), have 
been shown to play important roles in haemopoiesis. The c-kit receptor is the product 
of the W gene and mice homozygous for mutations at this locus die perinatally from 
severe anaemia and also show impaired development of several haemopoietic 
lineages (Bernex eat at., 1996; Lyman and Jacobsen, 1998). KL is the product of the 
Steel gene and mice homozygous for mutations at this locus have a similar 
phenotype to W/W mice (Lyman and Jacobsen, 1998; Witte, 1990)]. All HSCs from 
El 1 AGM region, FL and adult BM express c-kit (Morrison eat at., 1995; Sanchez eat 
at., 1996; Zhao eat at., 2000) and it is also expressed on the surface of most 
haemopoietic progenitor cells, including CFU-S (Ogawa eat al., 1991). The c-kit/KL 
pathway has been shown to be involved in the maintenance, proliferation and 
differentiation of haemopoietic progenitors (Lyman and Jacobsen, 1998; Ogawa ci 
at., 1991; Okumura ci at., 1996). There is also evidence that the c-kit/KL signalling 
pathway can synergise with integrin function and signalling. The mobilisation of 
progenitors from the BM to the peripheral circulation, induced by administration of 
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anti-cz4131 or anti-VCAM antibodies, requires co-operative signalling through the kit 
receptor (Papayannopoulou ci al., 1998). KL has also been shown to play a role in 
integrin mediated signalling through FAK and in the enhanced adhesion of 
haemopoietic progenitors to fibronectin via a4131 and ct501 integrins (Takahira ci 
al., 1997). 
Assessment of the co-expression of 131 integrin with the above molecules is 
interesting, since as discussed, they all play important roles in haemopoiesis. CD34, 
CD44 and c-kit are markers for haemopoietic stem cells and therefore, the co-
expression of 131 integrin with these molecules would suggest that it is also expressed 
on LTR-HSCs. In addition, the co-expression of 31 integrin with CD44 and c-kit 
would support the hypothesis that these molecules co-operate with each other in 
regulating some haemopoietic processes. 
3.2. Results 
Haemopoietic organs were explanted from E9-B12 embryos and single cell 
suspensions obtained. Cells were incubated with antibodies against 01 integrin, cx4 
integrin, CD34, CD44, and c-kit, alone and in combination. Representative FACS 
plots are shown in figure 3.1. The average, taken from several experiments, of the 
percentage of cells expressing 131 integrin and co-expressing 131 integrin and a4 
integrin, CD34, CD44 or c-kit in the organs tested, is shown in bar charts in figure 
3.2. Data is presented as the percentage of cells co-expressing 131 integrin and the 
relevant marker in the organ as a whole. Since in all cases, all cells which expressed 
either cx4 integrin, CD34, CD44 or c-kit also expressed 131 integrin (figure 3.1), 
graphs showing the percentage of cells co-expressing these markers and (31 integrin, 
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are effectively the same as if the percentage of cells expressing only ct4 integrin, 
CD34, CD44 or c-kit were presented. 
3.2.1. 31 integrin expression, (figure 3.1,figure 3.2a) 
The percentage of cells expressing 01 integrin in the adult BM and in the 
AGM and FL is high (80-90%) and does not vary significantly at the different ages 
analysed. Expression is lower in the YS (45%-60 1/o) and again it doesn't vary 
significantly with age. However, expression of 131 integrin in the embryonic PB, does 
vary with the age of the embryo. The percentage of cells expressing (31 integrin 
decreases from 40% at E9 to around 2% at El 1 and El2. This may be a result of the 
down regulation of 01 integrin on existing cells, or of the generation of a different 
population of cells which does not express P  integrin. 
3.2.2. Expression of a4 integrin and its co-expression with 01 integrin (figure 
3. 1, figure 3.2b) 
The expression of a4 integrin is low in the AGM (2-7%), YS (1-6%) and PB 
(0.5-2%) and its expression does not vary in these organs with the age of the embryo. 
Expression of a4 integrin is higher in the FL, 30% - 72%. Although, from the 
average of cz4 integrin expression at different ages, it appears that ct4 integrin 
expression increases with age, the variations observed between different experiments 
make this difficult to conclude. It is expressed in 40-70% of cells in the adult BM. 
Co-staining of cells with anti-(31 integrin and anti-a4 integrin antibodies showed that 
all cells expressing c4 integrin co-express 01 integrin. This was true in all organs at 
all ages. 
Is 
Figure 3.1: Expression of 31 integrin in embryonic haemopoietic 
organs and adult BM 
Cells from haemopoietic organs were stained with anti-131 integrin 
antibody (i) or co-stained with anti-1 integrin antibody and anti-a4 
integrin (ii), anti-CD34 (iii), anti-CD44 (iv) and anti-c-kit (v) 
antibodies. The percentage of cells in the upper right quadrant 
represents the percentage of cells in the organ which co-express 131 
integrin and the second marker 
a) E9 
i) 	 ii) 	iii) 	iv) 	v) 
AGM 
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Figure 3.2. Expression of 131 integrin and its co-expression with haemopoietic 
markers in haemopoietic organs during development 
Cells were isolated from haemopoietic organs, AGM, FL, YS and PB at E9, ElO, 
Eli and El 2 and analysed by FACS for the expression of 131 integrin and the co-
expression of 131 integrin with a4 integrin, CD34, CD44 and c-kit. Data is 
presented as the percentage of cells in the organ as a whole which express 131 
integrin or co-express 131 integrin and a4integrin (b); CD34 (c); CD44 (d); c-kit 
(e). In all organs and at all ages, all cells which expressed (A integrin, CD34, 
CD44 or c-kit, co-expressed 131 integrin. 
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3.2.3. Expression of CD34 and its co-expression with 01 integrin (figure 3.1, 
figure 3.2c) 
CD34 is expressed at low levels in all organs: AGM (3-5%), FL (3-10%), YS 
(1-9%), PB (0.5%) and BM (2%), and its expression remains constant at different 
ages. In all cases all CD34+ cells co-express 131 integrin. 
3.2.4. Expression of CD44 and its co-expression with 131 integrin (figure 3.1, 
figure 3.2d) 
CD44 is expressed at low levels in the AGM, YS and PB, between 1% and 
7% and its expression does not appear to vary significantly with age. It is more 
highly expressed in the FL - 25-35% and in the BM where 85% cells express CD44. 
All cells which express CD44 co-express 131 integrin. 
3.2.5. Expression of c-kit and its co-expression with 131 integrin (figure 3. 1, figure 
3.2e) 
Expression of c-kit is low in the AGM (4-8%), YS (0.5-2.5%) and PB (0-
1.5%) and does not vary with the age of the embryo. c-kit is expressed at higher 
levels in the FL, between 10% and 29% and the level of expression is lower at E12 
than at ElO and Eli. c-kit is expressed in approximately 5% cells in the adult BM. 
Again, in all organs at all ages, cells which express c-kit, co-express 131 integrin. 
3.3 Discussion 
The high percentage of cells expressing 131 integrin in the AGM region, FL 
and YS at all ages tested and in the adult BM reflect the multiple roles of this 
molecule and the fact that it can dimerise with numerous a integrin subunits 
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(Brakebusch et al., 1997). The only significant difference in P1 integrin expression 
through the developmental stages studied, is in the PB, where expression decreases 
from approximately 40% at E9 to 10% at ElO and 1-2% at Eli and E12. During this 
time the shift between primitive to definitive haemopoiesis is occurring (Dzierzak 
and Medvinsky, 1995). It may be that 01 integrin is differentially expressed on 
definitive and primitive erythroid cells and their progenitors. 
The expression of cz4 integrin is more restricted than 31 integrin, especially 
in the AGM region, YS and PB where it is consistently below 10%. Expression is 
higher in the FL and BM where approximately 50% of cells express a4 integrin. a4 
integrin has previously been shown to be expressed on a number of haemopoietic 
progenitors and mature haemopoietic cells (Coulombel et al., 1997) and therefore the 
higher level of expression in the FL and BM may reflect the extensive haemopoiesis 
that occurs in these organs. All cells that express ct4 integrin co-express p1 integrin, 
in accordance with previous data that the cz4131 heterodimer is expressed on many 
haemopoietic cells (Coulombel et al., 1997; Papayannopoulou and Craddock, 1997; 
Wilson, 1997). 
In all organs and ages tested, 131 integrin is co-expressed in all cells which 
express CD34, CD44 and c-kit. The co-expression of 131 integrin with CD34, CD44 
and c-kit in the El 1 AGM, E12 FL and adult BM suggest that f31 integrin is 
expressed in some and maybe all LTR-HSCs from these organs. In addition, the co-
expression of 131 integrin and CD34 in the E9 YS and AGM suggest it is expressed in 
the stem cells from these organs which are capable of reconstituting new-born but 
not adult recipients. 
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Co-expression of 31 integrin and CD44 supports the hypothesis that these 
two adhesion molecules co-operate with each other in regulating haemopoietic 
processes such as the homing and migration of haemopoietic progenitors and 
possibly stem cells (Vermeulen et al., 1998). Similarly, the co-expression of PI 
integrin and c-kit is consistent with the hypothesis that co-operative signalling by 
these molecules and the activation of PI integrin by c-kit signalling regulates the 
migration and homing of haemopoietic progenitors (Papayannopoulou et al., 1998; 
Takahira et al., 1997). Co-expression of CD44 and c-kit with PI integrin during 
embryogenesis suggests that similar mechanisms of co-operation observed in the 
adult may also occur during development of the haemopoietic system. 
I7iI 
Chapter 4: RESULTS 
Expression of 31 integrin and cM integrin on LTR-HSCs 
4.1. Introduction 
Definitive haemopoietic stem cells reside in several anatomical sites during 
development of the definitive haemopoietic system, before haemopoiesis is 
established in the adult BM. LTR-HSCs are first localised in the AGM region of the 
embryo at El 1, they then migrate to the FL at E12 where haemopoiesis continues 
until E16, when LTR-HSCs migrate again to the adult BM (Dzierzak and 
Medvinsky, 1995; Robb, 1997; Section 1.1.2). LTR-HSCs are also found in the 
embryonic circulation and the numbers increase at times of colonisation of new 
haemopoietic organs suggesting that this is the main route via which LTR-HSCs 
migrate (Kumaravelu, P. ci al, unpublished data). Although, by definition, LTR-
HSCs have certain properties in common, such as the ability to fully reconstitute the 
haemopoietic system of an irradiated recipient, characterisation of HSCs at different 
developmental time points and spatial locations has revealed differences in the 
phenotype of these cells. For example, the proliferation/differentiation potential and 
expression of certain cell markers varies between LTR-HSCs from different organs 
(Morrison et al., 1995; Sanchez ci al., 1996; Yoder ci al., 1997). In addition, 
knockout studies have revealed genes that are differentially required for 
haemopoiesis at particular stages of development (Medvinsky and Dzierzak, 1998). 
PI integrin and ct4 integrin have been implicated in many processes in the 
haemopoietic system, both during development and in the adult (Papayaimopoulou 
and Craddock, 1997; Verfaille, 1998). In particular, knockout studies show that PI 
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integrin is required for the onset of definitive haemopoiesis, although the exact time 
point at which it is required remains unclear (Hirsch et al., 1996; Potocnik et at., 
2000), section 1.3.2.. It has been hypothesised that PI integrin is required for the 
migration of LTR-HSCs from the AGM region to the FL. However, it cannot be 
ruled out that 01 integrin is required for the differentiation or proliferation of these 
cells in the FL, or for the initial generation of LTR-HSCs in the AGM region. a4 
integrin knockout mice have severe defects in haemopoiesis but definitive 
haemopoiesis is not completely inhibited (Arroyo et at., 1999; Arroyo et at., 1996) 
(section 1.3.3.). It seems that a4 integrin is required differentially at different stages 
of development, possibly by mediating interactions of haemopoietie cells with 
certain microenvironments but not others. a4 PI integrin has also been implicated in 
the homing of adult haemopoietic progenitors to the bone marrow and in their 
subsequent migration and differentiation (Papayannopoulou and Craddock, 1997; 
Verfaille, 1998; Wilson, 1997);(section 1.2.4.). 
Despite plenty of evidence demonstrating the importance of PI integrin and 
ct4 integrin in the establishment and maintenance of definitive haemopoiesis, the 
expression of these molecules on LTR-HSCs has not been shown. Assessment of the 
expression of f31 integrin and cM integrin on LTR-HSCs from different haemopoietic 
organs at different stages of development may give more information on the roles of 
these molecules during development of the definitive haemopoietic system. 
In this chapter the expression of 31 integrin and cz4 integrin on LTR-HSCs 
from El I AGM, El 3 FL and PB and adult BM is investigated. These four time 
points represent the main stages of development of the definitive haemopoietic 
system. 
4.2. Experimental Scheme 
The expression of 131 integrin and ciA integrin on LTR-HSCs from cultured 
Eli AGM, E13 FL, E13 PB and adult BM was investigated. Cells from these organs 
were sorted by FACS on the basis of 131 integrin or cz4 integrin expression, and 
positive and negative cells transplanted into irradiated recipient mice. The ability of 
transplanted cells to reconstitute the haemopoietic system of irradiated recipients 
indicates the presence of definitive haemopoietic stem cells in the transplanted 
population. The fill experimental scheme is shown in figure 4.1. 
Haemopoietic organs were isolated from male embryos and adult mice. Eli 
AGM region were expianted and grown in organ culture for 3 days. During this time 
the sex of the embryos from which the AGM were dissected was determined by PCR 
analysis. E13 male embryos were selected by morphology of gonads, FL expianted 
and PB isolated by removal of the YS from the embryo body and collection of the 
blood released. BM was collected from femurs of male adult mice. AGM region after 
organ culture and FL after explantation, were digested with collagenase/dispase to 
obtain a single cell suspension. 
Single cell suspensions from all organs were incubated with either anti-131 
integrin or anti-cz4 integrin antibodies (section 2.4.4.) Cell populations positive and 
negative for 131 and a4 integrin expression were isolated by FACS sorting of stained 
cells. A sample of each sorted population was reanalysed by FACS to assess the 
purity of the sort and this was taken into account when analysing the data. Sorted 
populations were then transplanted, at various dilutions, to sublethally irradiated 
female recipients. 2x 104  female BM cells were also transplanted for short-term radio-
protection. As binding of the antibodies could affect the homing or proliferation of 
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transplanted LTR-HSC, in some experiments, stained but unsorted cells were 
transplanted to determine if the antibodies used affected the reconstituting ability of 
LTR-HSC. 
The peripheral blood of recipient mice was analysed 2 and 6 months after the 
transplant for the presence of cells of male donor origin, using PCR with primers 
specific for the Y chromosome (Medvinsky and Dzierzak, 1996). The PCR reaction 
also contained primers for myogenin to give an internal control for the amount of 
DNA present. For each PCR, standard mixes of male and female DNA (100% - 
0.1%) were amplified. This allows an estimation of the percentage contribution of 
donor cells to recipient haemopoietic systems. Recipients in which the donor cell 
contribution was estimated to be below 10% were not considered as having been 
reconstituted with donor cells. An example of a FACS sort and the subsequent PCR 
analysis of peripheral blood from recipient mice are shown in Figure 4.2. 
In order to compare the reconstituting ability of positive and negative cell 
populations directly, taking into account the proportion of each cell population in the 
organ as a whole, the numbers of cells transplanted from the AGM, FL and PB are 
expressed as embryo equivalents (e.e.) of positive and negative cells. For example, a 
Eli cultured AGM region contains 2x10 5 cells of which 95% are 131 integrin 
positive. Therefore, lc.e. of 31 integrin positive cells is 1.9x10 5 cells and le.e. of 131 
integrin negative cells is 10 4  cells. The number of cells transplanted from adult BM is 
expressed as an equivalent (e), where one equivalent of whole BM is 10 5 cells, in 
which there are approximately 10 LTR-HSCs (Kumaravelu, P. et a!, unpublished 
data). Actual numbers of cells transplanted from the BM are also shown. 
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Figure 4.1: Experimental scheme for analysis of expression of 1 integrin and cc 
integrin on haemopoietic stem cells 
Male haemopoietic organs were isolated from Eli, El 3 and adult mice. Solid tissues, 
i.e. AGM and FL were digested with collagenase/dispase to obtain single cell 
suspensions. Cells from all organs were incubated with anti-n 1 integrin or anti-a4 
integrin antibodies and then FACS sorted into positive and negative populations. 
Purified cell populations were transplanted to irradiated female recipients along with 
female BM cells for short term radio-protection. Peripheral blood of recipient mice 
was taken 2 and 6 months after transplant, genomic DNA isolated and analysed by 
PCR for the presence of Y chromosome specific sequences. The presence of male 
donor derived cells in the peripheral blood of recipients 6 months after transplant 
shows that LTR-HSC were present in the transplanted population. 
Male haemopoietic organs isolated 
El 1 AGM, E13 FL, E13 PB, Adult BM 
Digestion with collagenase/dispase 
Single cell suspension 
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Figure 4.2. FACS sort and subsequent PCR analysis of transplanted recipients 
FACS sort of E13 FL stained with anti-1 integrin Ab, showing purified 
positive and negative cell populations 
Y PCR analysis of genomic DNA from peripheral blood of recipients 
transplanted with f31 integrin positive and negative E13 FL cells. Each lane 
corresponds to an individual recipient. The presence of a band corresponding 
to Y DNA indicates reconstitution of the recipient haemopoietic system with 
donor cells. The number of cells transplanted to each recipient is indicated 
below the lanes. For example 1/2 recipients were reconstituted with donor cells 
when 1.4x 105 f31 integrin negative cells were transplanted. 
myo=myogenin 
A) 	 E13 FL stained with anti-1 integrin Ab 
1L 	8.0 







4.3.1 Effect of Anti-1 integrin and Anti-a4 integrin Antibodies On 
Engraftment of LTR-HSCs 
Anti-1 integrin antibody: 
Adult BM cells and E13 PB cells were incubated with anti-131 integrin 
antibody and transplanted unsorted, at different dilutions, into irradiated recipients. 
For BM experiments, unstained cells were also transplanted. Recipient mice were 
analysed 6 months later for the presence of donor derived haemopoietic cells, see 
Table 4.1. 
Incubation of BM cells with this particular anti-1 integrin antibody did not 
have any effect on the engraftment potential of LTR-HSCs. Similar numbers of 
recipients were reconstituted when the same number of stained and unstained cells 
was transplanted. This was true for all of the cell concentrations tested. Although 
unstained cells were not transplanted in E13 PB experiments, the reconstitution seen 
with stained E13 PB cells is consistent, when compared to data from our laboratory 
on the number of HSCs in E13 PB (Kumaravelu, P. et al, unpublished data), with the 
antibody having no significant effect on LTR-HSCs from this organ. 
Anti-(x4 integrin antibody 
Adult BM cells and E13 FL cells were incubated with anti-ct4 integrin antibody and 
transplanted unsorted into irradiated recipients. Unstained cells were also 
transplanted in the same experiments. Recipient mice were analysed as above, see 
Table 4.1. Anti-a4 integrin antibody did not have an effect on the reconstitution 
ability of LTR-HSCs from the adult BM or E13 FL. Similar numbers of mice were 
reconstituted with stained and unstained cells at a variety of concentrations. 
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Table 4.1: Effect of antibody binding on the reconstituting ability of LTR-HSCs 
Cells were isolated from male haemopoietic organs a) adult BM; b) FL; e) PB and 
incubated with anti-01 integrin or anti-a4 integrin antibodies or left untreated. 
Different dilutions of stained and unstained cells were transplanted to female 
irradiated recipients. The number of recipient mice reconstituted with the indicated 
number of donor cells is shown as a ratio to the total number of mice transplanted 
with that number of cells. 
Adult BM 
No. cells transplanted 
4x103 	 2x104 	 105 
Cells  
unstained 	 2/6 	 6/7 	 7/7 
• anti 131 integrin 	1/4 	 3/3 	 4/4 
Ab 
• anti cx4 integrin 	0/3 	 3/4 	 4/4 
Ab 
E13 FL 
No. cells transplanted 
5x103  104 10 
0.0005e.e. 0.001e.e. 0.Ole.e. 
Cells 
unstained 1/3 3/4 4/4 




2.8x105 6.6x105 	1.4x10 	2x106 3.2x106 
0.04ee 0.09ee 0.2ee 0.3ee 0.4ee 
Cells 
+ anti 131 integrin 0/2 1/2 	1/2 	1/1 2/2 
Ab 
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4.3.2. Expression of 131 integrin on LTR-HSCs 
Cells from the Eli AGM region, E13 FL, E13 PB and adult BM were sorted 
by FACS on the basis of 131 integrin expression and positive and negative cell 
populations transplanted to irradiated recipients. Recipient mice were analysed 6 
months later for the presence of donor derived haemopoietic cells using Y specific 
PCR analysis. The presence of donor derived cells in recipient mice 6 months after 
transplantation shows that LTR-HSCs were present in the transplanted cell 
population (for example, see figure 4.2). 
131 integrin positive cells from Eli AGM region were capable of 
reconstituting irradiated recipients, whereas 01 integrin negative cells were not, see 
Table 4.2a. This shows that LTR-HSCs in the AGM region express 131 integrin and 
suggests that there are no 131 integrin negative LTR-HSCs. The frequency of LTR-
HSCs in the 131 integrin positive cell population is consistent with all stem cells in 
the Eli AGM region expressing 131 integrin. It has been calculated that there are 
approximately 8 LTR-HSCs in the cultured Eli AGM (Kumaravelu, P. et a!, 
unpublished data). All recipients were reconstituted with 0.2 e.e. of 131 integrin 
positive cells and 1/3 were reconstituted with 0.03 e.e. 131 integrin positive cells. 
However, it cannot be ruled out that LTR-HSCs are present at a very low frequency 
in the 131 integrin negative population. As only 5% of cells in the AGM are negative 
for 131 integrin it is difficult to obtain large enough numbers to transplant enough 
negative cells to exclude this possibility. 
131 integrin positive cells from E13 FL were also capable of reconstituting 
irradiated recipients, showing that LTR-HSCs from E13 FL express 131 integrin. As 
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Table 4.2: Reconstitution of irradiated recipients with 131 integrin positive and 
negative cells. 
Cells from male haemopoietic organs: a) Eli AGM; b) E13 FL; c) E13 PB; d) adult 
BM; were FACS sorted on the basis of 31 integrin expression. Cell populations 
positive and negative for 131 integrin expression were transplanted to female 
irradiated recipients. On average, 20 AGM, 20 FL, 9 PB and BM from 6 femurs were 
pooled for each experiment. 
The number of animals reconstituted with donor cells, as assessed by Y specific 
PCR, in each group is shown as a ratio to the total number of mice transplanted with 
the number of cells indicated. For BM the actual number of cells transplanted, as 
well as the equivalent number (e.) is shown. Results are pooled data from two or 
more experiments. 
The percentage of cells positive and negative for 131 integrin expression in the organs 
as a whole are given in brackets. * = the total number of LTR-HSCs in each organ, as 
estimated by limiting dilution analysis (Kumaravelu, P. et a!, unpublished data). 
 
Eli AGM (Total no. of LTRHSCs=8)* 
	
0.008e 	0.03ee 	0.2ee 	0.3ee 	0.8ee 	l.lee 	1.6ee 
131 integrin 	0/3 	1/3 	3/3 	2/2 	3/3 	- 	3/3 
+ve (95%) 
131 integrin 	- 	- 	0/3 	- 	- 	0/3 	- 
-ye (5%) 
 
E13F (Total no. ofLTR-HSCs=)1 
0.01ee 	0.02ee 	0.04ee 	0.08ee 	0.1ee 	0.3ee 
131 integrin 	3/4 	2/2 	2/2 	3/3 	3/3 	- 
+ve (82%) 
131 integrin 	- 	- 	- 	- 	115 	0/3 
-ye (18%) 
C) 
E13 PB (Total no. Of LTRHSCs5)* 
0.02e 	0.05ee 	0.09ee 	0.1ee 	0.2ee 	0.5ee 
131 integrin 	- - - 2/3 0/2 1/2 
+ve (1%) 




Adult BM (Total no. of LTR-HSCs1 :10 )   
0.16e 	0.5e 	0.65e 	1.2e 	1.9e 	3.3e 	4e 	lie 
31 integrin 	2/2 - 3/3 2/2 - 3/3 6/6 - 
+ve (90%) 1.5x104 	 6x104 
	105 	 3x10 5 	3.6x10 5 
P 1 integrin 	- 	0/6 	- 	0/2 	0/1 	- 	- 	1/5 
-ye (10°4) 5x103 1.2x104 1.5x104 1.1x105 
106 
with the AGM region it appears that there are no or very few 131 integrin negative 
stem cells in the FL, see Table 4.2b. If LTR-HSCs were present in the 131 integrin 
negative population at the same frequency as in the FL as a whole then there should 
be approximately 85 LTR-HSCs in le.e. of f31 integrin negative cells. However, 0/3 
mice and 1/5 mice were reconstituted with 0.3 e.e. and 0.1 e.e. of 131 integrin 
negative cells respectively. The one mouse reconstituted with 131 integrin negative 
cells was probably due to contaminating 131 integrin positive cells or it may represent 
a very rare 131 integrin -ye HSC. 
Only 131 integrin positive cells from E13 PB were capable of reconstituting 
recipient mice, see Table 4.2c. No reconstitution was seen when f31 integrin negative 
cells were transplanted. The number of 01 integrin positive cells required to 
reconstitute recipient mice is also consistent with all of the LTR-HSCs being in the 
131 integrin positive population. There are approximately 5 stem cells in E13 PB as a 
whole and 2/3 mice were reconstituted with 0.1 e.e. of 131 integrin positive cells. 
Since only 1% of E13 PB cells express 31 integrin, selection of cells on the basis of 
31 integrin expression represents a significant enrichment of stem cell activity. 
In adult BM, LTR-HSC are again found to express j31 integrin, as shown by 
the ability of 131 integrin positive cells to reconstitute recipient mice. Reconstitution 
of recipients with 131 integrin negative cells was only detected when high numbers of 
negative cells were transplanted, see Table 4.2d. In this particular FACS sort the 31 
integrin negative population was only 30% pure. Therefore the number of 131 integrin 
positive cells present would have been 7x1 0 4  which could easily account for the 
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reconstitution seen. However it is impossible to rule out the possibility that there are 
some HSCs present at a very low frequency in the 131 integrin negative population. 
4.3.3. Expression of ct4 integrin On LTR-HSCs 
The expression of cz4 integrin on LTR-HSCs from Eli AGM, E13 FL, E13 
PB and adult BM was assessed in the same way as described above. 
cz4 integrin positive cells from Ell AGM region were capable of 
reconstituting irradiated recipients, showing that LTR-HSCs from this organ express 
a4 integrin, see Table 4.3a. No reconstitution was seen with cz4 integrin negative 
cells, even when 1.9 e.e of negative cells was transplanted. If LTR-HSCs were 
distributed at the same frequency in the a4 integrin positive and negative 
populations, 1.9 e.e. of negative cells would contain approximately 15 LTR-HSCs. 
Therefore, if HSCs are present in the cz4 integrin negative population they must be at 
a frequency at least fifteen times lower than in the AGM region as a whole. In 
addition, the number of a4 integrin positive cells required for reconstitution is 
consistent with all LTR-HSCs being in the ct4 integrin positive population. There are 
approximately eight present in whole cultured Eli AGM (Kumaravelu, P. et a!, 
unpublished data) and 3/3 recipients were reconstituted when 0.1. e.e. of a4 integrin 
positive cells was transplanted. 
Both cz4 integrin positive and negative cells from E13 FL are capable of 
reconstituting recipient mice, although the number of negative cells required is much 
higher than ct4 integrin positive cells, see Table 4.3b. 5/7 mice were reconstituted 
with 0.001e.e. of a4 integrin +ve cells whereas only 1/2 and 113 mice were 
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Table 4.3: Reconstitution of irradiated recipients with cz4 integrin positive and 
negative bells. 
Cells from male haemopoietic organs: a) Eli AGM; b) E13 FL; c) E13 PB; d) adult 
BM; were FACS sorted on the basis of a4 integrin expression. Cell populations 
positive and negative for a4 integrin expression were transplanted to female 
irradiated recipients. 
The number of animals reconstituted with donor cells, as assessed by Y specific 
PCR, in each group is shown as a ratio to the total number of mice transplanted with 
the number of cells indicated. For BM the actual number of cells transplanted, as 
well as the equivalent number (e.) is shown. Results are pooled data from two or 
more experiments. 
The percentage of cells positive and negative for (t4 integrin expression in the organs 
as a whole are given in brackets. * = the number of LTR-HSCs in each organ, as 
estimated by limiting dilution analysis (Kumaravelu, P. et al, unpublished data) 
 
Eli AGM (Total no. LTRHSCs=8)* 
Mee 	0.4ee 	0.6ee 	0.9ee 	1.lee 	1.9ee 
a4 integrin 	2/3 3/3 3/3 - 5/5 	- 
+ve(5%) 
(t4 integrin 	- 	- 	- 	0/3 	- 	0/3 
-ye (95%) 
 
E13 FL (total no. LTRHSCs=480)* 
	
0.001 	0.004 0.Olee 0.02ee 0.03ee 0.06ee 0.lee 	0.2ee 
e.e. e.e. 
a4 integrin 	5/7 	6/6 	- 	3/6 	3/3 	- 	- 	3/3 
+ve (75%) 
a4 integrin 	0/3 	- 	0/3 	- 	- 	1/2 	1/3 	3/3 
-ye (25%) 
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cz4 integrin 5/6 	6/6 
+ve (55%) 1.1x104 5x104 
a4 integrin 0/6 	- 
-ye (45%) 9.4x103 




2/3 	- 	2/3 	2/3 	1/3 
5x 1W 9x104 1.1x105 2.4x105 4.2x105 
C) 
E13 PB (Total no. LTRHSCs=5)*  
	
0.004ee 	0.005ee 	0.02ee 	0.03ee 	O.lee 	0.2ee 
cz4integrin 	- 	013 	1/3 	U/i 	- 
+ve(1%) 
(A integrin 	0/3 	- 	0/3 	- 	0/5 	- 
-ye (99%) 
d) 
Adult BM (Total no. LTR-HSCs=1 :1 4  cells) 
0.2e 	0.9e 	1.le 	1.8e 	2e 	3e 	5e 	11.5e 
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reconstituted with 0.06e.e. and 0.1 e.e of cz4 integrin negative cells respectively. 
However, 3/3 mice were reconstituted when 0.2 e.e of cz4 integrin negative cells was 
transplanted. There is a possibility that some of the mice reconstituted with a4 
integrin negative cells could have in fact been reconstituted with contaminating a4 
integrin positive cells. However when 0.2 e.e. of a4 integrin negative cells was 
transplanted, the purity of the sort was very high and the number of contaminating 
a4 integrin positive cells would only have been approximately 2x 
103.  Since 
transplantation of 5x 103  a4 integrin positive cells resulted in only 5/7 mice being 
reconstituted, it is less likely that the reconstitution seen with 0.2e.e. cz4 integrin 
negative cells is due entirely to the presence of contaminating a4 integrin positive 
cells. However, it is difficult to draw firm conclusions since the number of mice 
transplanted is small. Mice reconstituted with cx4 integrin -ye cells were checked for 
multilineage reconstitution by Y PCR on other haemopoietic organs and 
reconstitution was seen in all organs tested, i.e. the BM, spleen and thymus (data not 
shown). 
E13 PB LTR-HSCs were found in the a4 integrin positive population only, 
although large enough numbers of cz4 integrin negative cells were not transplanted to 
exclude the possibility that there are ct4 integrin negative LTR-HSC present at low 
frequency, see Table 4.3c. However, as only 1% of E13 PB cells express cz4 integrin 
and 3/3 mice were reconstituted with 0.2 c.c. of cz4 integrin ±ve cells, it is unlikely 
that there are any a4 integrin negative HSCs, since there are only five HSCs in total 
E13 PB (Kumaravelu, P. et al, unpublished data). 
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As was the case for E13 FL, in adult BM, both a4 integrin positive and 
negative populations were capable of reconstituting recipient mice, see Table 4.3d. 
Again the number of a4 integrin negative cells required for reconstitution is much 
greater than ct4 integrin positive cells. Not all mice were reconstituted with even 11.5 
e. of a4 integrin negative cells (4.2x10 5 cells), whereas 0.2 and 0.9 e of cz4 integrin 
positive cells reconstituted 2/2 and 6/6 mice respectively. Low enough numbers of 
a4 integrin positive cells were not transplanted to ascertain whether the 
reconstitution observed with ct4 integrin negative cells could be due to the presence 
of low numbers of contaminating a4 integrin positive cells. Therefore it is difficult to 
conclude if there are any ct4 integrin negative LTR-HSCs in the adult BM. 
4.4. Discussion 
The above data shows that 131 integrin and ct4 integrin are expressed on LTR-
HSCs from Eli AGM region, E13 FL, E13 PB and adult BM. As these organs and 
time points represent the main developmental stages of the definitive haemopoietic 
system, it can be concluded that 131 and a4 integrin are expressed on LTR-HSCs 
throughout the onset and establishment of definitive haemopoicsis. 
4.4.1. Expression of 131 integrin On LTR-HSCs 
LTR-HSC were found in the 131 integrin positive populations of all the organs 
tested, however LTR-1-ISC were not detected in the 31 integrin negative population 
from the Eli AGM region or E 1 PB. This is despite transplanting up to five times 
the equivalent numbers of negative compared to positive cells. When 131 intcgrin 
negative cells from the E13 FL were transplanted one mouse out of eight was 
reconstituted. This is most likely due to contaminating 131 integrin positive cells in 
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the transplanted population, since reconstitution was seen when 0.1 e.e of 131 integrin 
negative cells was transplanted but not when 0.3 e.e. 131 integrin negative cells was 
transplanted. Similarly, the reconstitution of one mouse with high numbers of 131 
integrin negative cells from the adult BM was probably due to contaminating PI 
integrin positive cells, since in this case the FACS sort was particularly impure. 
However it can not be ruled out that there a few f31 integrin negative LTR-HSCs in 
the FL and adult BM. It is very difficult to distinguish between these two possibilities 
using this experimental design. To detect LTR-HSCs which are present at a low 
frequency it is necessary to transplant large numbers of cells. As FACS sorts are 
never 100% pure, when transplanting large numbers of one cell population there will 
always be a significant number of contaminating cells. However, by increasing the 
number of recipients transplanted with each cell concentration it may be possible to 
draw stronger conclusions. 
The expression of 31 integrin on LTR-HSCs from organs at all stages of 
development and the seeming absence of 131 integrin negative LTR-HSCs, is 
consistent with previous data on the important roles of 131 integrin in both 
developmental and adult haemopoiesis (Arroyo et al., 1999; Coulombel et al., 1997; 
Hirsch et al., 1996). The phenotype observed in the 131 integrin knockout, i.e. that 
definitive haemopoiesis is completely blocked in the absence of 131 integrin, suggests 
that f31 integrin is important for the function of early LTR-HSCs (Hirsch et al., 
1996). It has been hypothesised that 131 integrin is required for the migration of LTR-
HSCs from the AGM region to the FL. However, it remains unclear whether 131 
integrirf' LTR-HSCs are generated in the AGM region. The finding here that 131 
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integrin is expressed on LTR-HSCs from the El 1 AGM does not help to resolve this 
issue. The expression of 131 integrin on LTR-HSC from Eli AGM region could 
mean that 131 integrin is required for the development of LTR-HSC in the AGM and 
therefore that the block in definitive haemopoiesis in the absence of 131 integrin is in 
the initiation of stem cell production in the AGM. Alternatively, 131 integrin may 
only be required for LTR-HSCs to leave the AGM region and colonise the FL and 
that LTR-HSCs would develop to that stage in the absence of 131 integrin. 
The expression of 131 integrin on LTR-HSCs from the adult BM is again 
consistent with work which shows that 131 integrin is involved in adult haemopoiesis 
(Coulombel et al., 1997; Papayannopoulou and Craddock, 1997). 131 integrin has 
been shown to be necessary for the migration and homing of haemopoietic 
progenitor cells and for their proliferation and differentiation (Verfaille, 1998) 
(section 1.2.4.). The data presented here shows for the first time that 131 integrin is 
expressed on LTR-HSCs, which suggests that 131 integrin may be required for the 
homing and localisation of LTR-HSCs as well as for progenitor cells, and possibly 
for their proliferation and differentiation. The requirement for 131 integrin in the 
homing of LTR-HSCs to the BM has been suggested before from studies on 
conditional 131 integrin knockout mice (Potocnik etal., 2000). 
4.4.2. Expression of cz4 integrin On LTR-HSCs 
ct4 integrin was also found to be expressed on LTR-HSCs at all 
developmental stages, although some cz4 integrin negative stem cells were detected 
in the E13 FL and possibly in the adult BM. However, many more ct4 integrin 
negative cells than cz4 integrin positive cells from E13 FL and adult BM were 
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required to reconstitute recipient, mice showing that if LTR-HSCs are present in the 
a4 integrin negative population, then they are less frequent than in the a4 integrin 
positive population. As for 131 integrin, the expression of a4 integrin on LTR-HSCs 
is in accordance with previous work showing its importance in definitive 
haemopoiesis (Coulombel et al., 1997; Papayannopoulou and Craddock, 1997). ct4 
integrin knockout mice have severe defects in definitive haemopoiesis, although it is 
not completely abolished (Arroyo et al., 1999; Arroyo et al., 1996). The E12 FL of 
a4 integrin mice is very pale and smaller in size than in wild-type littermates. 
Lymphopoiesis is severely affected in the BM and thymus after birth, although 
embryonic lymphopoiesis is largely unaffected. There is also a defect in the 
differentiation/proliferation balance in cz4 integrin progenitors, which results in the 
generation of very few terminally differentiated a4 integrin cells. This defect 
becomes more pronounced as development progresses. Therefore, cz4 integrin seems 
to be differentially required during development of the definitive haemopoietic 
system. 
The lack of cM integrin negative HSCs in the wild-type AGM may seem 
contradictory to the fact that in cz4 integrin knockout mice some haemopoiesis is 
seen in the FL and at later stages. However, true LTR-HSCs may not develop in the 
AGM region of a4 integrin mice. Instead defective cells may be generated which 
are capable of colonising the FL but are not capable of establishing complete 
definitive haemopoiesis. The generation of fully competent LTR-HSCs in the AGM 
region a4 integrin' mice is investigated in Chapter 5. Alternatively, another a 
subunit, possibly a5 integrin, may substitute for a4 integrin in a4 integrin' mice to 
a certain extent, but fails to substitute properly in the later stages of development. In 
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addition, it should be noted that, although ct4 integrin is expressed on LTR-HSCs 
from El 1 AGM region it may not be in an activated state (section 1.2.3.2.). 
The presence of LTR-HSCs that do not express a4 integrin in the E13 FL and 
possibly adult BM suggests that ct4 integrin is not absolutely required for LTR-HSC 
function in these tissues. Since ct4 integrin could be expressed in these cells after 
transplantation, it may be that a4 integrin is required for downstream differentiation 
and proliferation events in haemopoietic progenitor cells. As mentioned above, a4 
integrin haemopoietic progenitors are defective in their ability to complete 
differentiation. However, it is difficult to prove that a4 integrin negative HSCs do 
exist, due to the impossibility of obtaining 100% pure a4 integrin negative cell 
populations and the low numbers of a4 integrin positive cells required for 
reconstitution. 
4.3.3. Conclusions 
The expression of 31 integrin and a4 integrin on LTR-HSCs from all 
developmental stages of definitive haemopoietic system emphasises the importance 
of these integrin subunits in the initiation and maintenance of the definitive 
haemopoietic system. The expression of 131 integrin and ct4 integrin on adult LTR-
HSCs is also interesting since previous investigations on the function of these 
molecules in adult haemopoiesis have focused on progenitor cells rather than LTR-
HSCs (Coulombel et al., 1997; Papayannopoulou and Craddock, 1997). Showing 
that these molecules are expressed on LTR-HSCs suggests that many of the 
mechanisms in which cz4l integrin is involved in haemopoietic progenitors, such as 
homing and migration can be extrapolated to LTR-HSCs. 
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Chapter 5: RESULTS 
Analysis of cz4 integrin embryos for LTR-HSC activity 
5.1. Introduction 
cz4 integrin knockout mice die between El 1.5 and E12.5 due to two defects, 
the first a failure in allantois/chorion fusion and the second, severe cardiac 
haemorrhaging (Yang et al., 1995). The effect of knocking out the ct4 integrin gene 
on haemopoiesis has been studied in a4 integrin mice before E12.5 and thereafter 
in chimaeric mice, generated by injecting a4 integrin ES cells into wild-type, 
RAG1' and RAG2 blastocysts (Arroyo et al., 1999; Arroyo et al., 1996). 
Definitive haemopoiesis is not completely blocked in the absence of a4 integrin but 
it is defective. At E12.5 the FL of cz4 integrin mice is much smaller and paler than 
the wild-type equivalent, suggesting an early defect in definitive erythropoiesis. 
Erythroid and myeloid progenitors are detected in the FL throughout development at 
fairly constant numbers but the number of terminally differentiated cz4 integrin 
cells decreases with the age of the embryo. In adult chimaeric mice, cz4 integrin' 
erythrocytes are virtually absent and there are very few differentiated myeloid cells 
although, as in the FL, progenitor cells can be detected. Lymphopoiesis is also 
severely affected in the absence of cz4 integrin. From 4 weeks after birth no a4 
integrin T cells are detected due to the inability of T cell precursors to leave the BM 
and seed the thymus. B cell development is also severely affected after birth, with 
differentiation being blocked at the pro-B cell stage. However, during embryogenesis 
thymic precursors can migrate to and colonise the foetal thymus, producing mature 
cz4 integrin T cells and B cell development is also essentially normal. 
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These findings all point to a differential requirement for OA integrin at certain 
stages during development of the definitive haemopoietic system, possibly in the 
interaction of haemopoietic progenitors with specific haemopoietic 
microenvironments. Disruption of these interactions may lead to poor production of 
terminally differentiated cz4 integriri' cells in vivo, although progenitors can 
differentiate normally in vitro. 
The generation of true definitive HSCs has not been studied in ct4 integrin 
mice. It could be that LTR-HSCs develop normally in the absence of cz4 integrin and 
that all of the defects described above are due to defects at the progenitor cell level. 
Alternatively, it might be that the defects are a result of the generation of defective 
definitive haemopoietic stem cells in the absence of a4 integrin, which in turn 
generate defective progenitor cells. Data shown in the previous chapter suggests that 
a4 integrin may be required for the development of LTR-HSCs in the AGM region 
(section 4.3.3.) or for them to successfully migrate from this region and colonise the 
FL. It is therefore interesting to determine if fully competent LTR-HSCs are 
generated in the absence of cz4 integrin: Differences in the generation/proliferation of 
HSCs within the different haemopoietic organs, i.e. different microenvironrnents, of 
ciA integrin embryos may be apparent in comparison to wild-type embryos. This 
could give further information as to where the defects in haemopoiesis in the absence 
of a4 integrin first occur. 
To determine if definitive HSCs are generated in a4 integrin' embryos, the 
AGM region, foetal liver and YS were isolated from E12 cz4 integrin' embryos and 
transplanted into adult irradiated recipients. The peripheral blood and other 
haemopoietic organs of recipient mice were analysed up to 5 months after the 
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transplant for the contribution of a4 integrin cells. As described earlier (section 
4.2.) the presence of donor derived cells in the peripheral blood 5 months after 
transfer would show that HSCs were present in the transplanted population. 
5.2. Results 
5.2.1. Isolation of a4 integrin4  Embryonic Haemopoietic Organs and Transfer 
To Irradiated Recipients 
Mice heterozygous for the a4 integrin knockout locus (obtained from Jackson 
Laboratories) on C571316 and CBA backgrounds were interbred and embryos 
dissected out at E12.5. Embryos likely to be a4 integrin' were identified by 
morphology - i.e. presence of a small, pale foetal liver and to a lesser extent head 
abnormalities. The AGM region, FL and YS were obtained from these embryos, 
digested with collagenase/dispase where appropriate, and cell suspensions transferred 
to female irradiated recipients. 2x10 4 female BM cells were also transplanted for 
short-term radioprotection. The rest of the embryo body was retained to obtain 
genomic DNA. Embryos from which haemopoietic organs had been transplanted 
were retrospectively genotyped by PCR analysis of genomic DNA using two sets of 
primers, one which amplifies the wild-type a4 integrin allele and the other which is 
specific for the ct4 integrin knockout locus (Arroyo et al., 1996), (section 2.1.7.2.), 
see figure 5.1. The sex of homozygous null embryos was also determined using Y 
specific PCR. 
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Figure 5.1: PCR genotyping of a4 integrin embryos 
4— cL4 integriii 
wt—* 
M 	1 	2 	3 
-1+ wt a4 a4 
Genomic DNA was isolated from prospective a4 integrin embryos and amplified 
with two sets of primers; one specific for the a4 integrin wild-type locus giving a 
product of 250bp and one specific for the c.4 integrin knockout locus giving a 
product of 500bp. Lane 1 shows a wild-type embryo, giving only one product of 
250bp. Lane 2 shows a heterozygous embryo giving two products, one corresponding 
to the wild-type allele and the other to the knockout allele. Lane 3 shows a 
homozygous a4 integrin embryo which gives a product corresponding only to the 
knocked out allele. The unlabelled band is non-specific amplification. 
M= 1kb DNA ladder 
120 
5.2.2. Reconstitution of Recipient Mice With Cells From cz4 integrin 
Raemopoietic Organs 
The peripheral blood of recipient mice was analysed 2 or 5 months after 
transplant for the contribution of donor ct4 integrin' cells, see figure 5 .2a. Of the two 
a4 integrin embryos transplanted, one was male and the other female. Contribution 
of donor cells from the male a4 integrin embryo was assessed by Y PCR as 
previously (section 4.2). Contribution of cells from the female ct4 integrin embryo 
was assessed by PCR with primers specific for the cz4 knockout locus and for 
myogenin. Standard mixes of genomic DNA isolated from an ct4 integHn embryo 
and from a wild-type embryo were also amplified to allow an estimation of the level 
of donor cell contribution, see Figure 5.2b. 
Each a4 integrin FL was transplanted into two recipients, each recipient 
therefore receiving half of the FL. One out of the four recipient mice was 
reconstituted at a high level. The other three recipients were not reconstituted with 
donor cells. This shows that there are some HSCs in a4 integrin FL but there are 
many fewer than in a wild-type E12 FL which contains approximately 60 HSCs 
(Kumaravelu, P. et a!, unpublished data). 
Transplantation of whole ct4 integrin' AGM into one recipient resulted in a 
high level of reconstitution with donor cells. When the AGM region was split 
between two recipients only one recipient was reconstituted but again at a high level. 
This shows that there are HSCs in the E12 cz4 integrin AGM region which are 
capable of high level reconstitution. 
Transplantation of whole cz4 integrin' YS into one recipient resulted in 
reconstitution but at a lower level than seen with AGM cells, although it was above 
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Figure 5.2: Reconstitution of recipient mice with cells from (x4' 
embryonic haemopoietic organs: 
Each lane corresponds to a different recipient mouse and the (t4 
integrin organ from which the cells were transplanted is indicated 
below the lane. 
PCR analysis of blood from recipients 5 months after transplant 
with male cz4 integrin haemopoietic organs. The top band 
corresponds to Y DNA and its presence shows reconstitution with 
donor cells. The bottom band corresponds to myogenin and is an 
internal control for the amount of DNA present. 
PCR analysis of blood from recipients 2 months after transplant 
with female (z4 integrin haemopoietic organs. The top band 
corresponds to the cz4 integrin knockout locus and its presence shows 
reconstitution with donor cells. The bottom band corresponds to 
myogenin and is an internal control for the amount of DNA present. 
Y PCR analysis for the contribution of cz4 integñn' cells to other 
haemopoietic organs of recipients analysed in a). BM=bone marrow; 
Th=thymus; 	LN=lymph 	node; 	PP=Peyer's 	patches; 
SpB220=B220ce1ls from spleen; SpB220=B220 cells from spleen 
Y PCR analysis of blood from secondary recipients transplanted 
with BM cells from primary recipients analysed in a). Each lane 
corresponds to an individual recipient. The cc4 integrin embryonic 
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10%. When YS was split between two recipients only one was reconstituted, again 
at a low level but above 10%. This shows that there are HSCs present in the E12 cz4 
integrint YS, although they seem to be less potent than those derived from the E12 
AGM region. 
5.2.3. Multilineage Reconstitution and Secondary Transplant 
To assess the ability of the transplanted ct4 integrin cells to contribute to 
multiple haemopoietic lineages, the BM, thymus, lymph nodes, Peyer's patches and 
spleen from reconstituted primary recipients were analysed for the presence of donor 
derived cells. The thymus, lymph nodes and Peyer's patches were treated to release 
lymphocytes and leave the majority of the stroma behind. Spleen cells were stained 
with the B220 antibody as a marker for B cells and FACS sorted into B220 positive 
and negative populations. These two cell populations were analysed separately for 
contribution of donor cells, see Figure 5.2c. 
Cells transplanted from cz4 integrin FL, AGM and YS contributed to the 
thymus, lymph nodes, Peye?s patches and B220 and B220 compartments of the 
spleen. The level of contribution of donor cells from the AGM region and the YS 
was similar to that seen in the initial analysis of the peripheral blood, except to the 
Peyer's patches where it was lower. The contribution of a4 integrin FL derived 
cells to the haemopoietic organs was lower than seen in the peripheral blood - in 
some cases below 10% and no donor derived signal was observed in the BM. The 
contribution of ct4 integrin YS cells to the BM was also low, below 10%, whereas 
contribution of AGM derived cells to the BM was approximately the same as to other 
tissues. 
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To determine if the a4 integrin haemopoietic stem cells were still capable of 
homing to the BM and establishing haemopoiesis, BM from primary reconstituted 
recipients was transferred to secondary irradiated recipients. The peripheral blood of 
secondary recipients was analysed 3 months later for the presence of a4 integrin 
derived cells, see Figure 5.2d. FL a4 integrin stem cells were not capable of 
reconstituting secondary recipients. This is not surprising as no FL a4 integrin cells 
were detected by PCR analysis in the BM of the primary recipient. Only a very low 
level of secondary reconstitution, approximately 1%, was seen with AGM a4 
integrin' stem cells, although they contributed at a high level to the BM of the 
primary recipient. Twice as many BM cells from the primary recipient reconstituted 
with a4 integrin YS cells were transplanted to secondary recipients since the initial 
level of reconstitution seen in the peripheral blood was low. One secondary recipient 
was reconstituted with a4 integrin' YS cells at a level around 10% and the other two 
were reconstituted at a very low level - approximately 1%. 
5.3. Discussion 
The data presented here shows that haemopoietic stem cells, capable of 
reconstituting multiple lineages, are present in the AGM region of E12 ct4 integrin' 
embryos. Stem cells are also present in the E12 ct4 integrin FL and YS, although 
they do not appear to have the same potential as those from the AGM region. 
5.3.1 AGM ct4 integrin HSCs 
Cells from E12 a4 integrin AGM region are capable of multilineage 
reconstitution of irradiated recipients, showing that haemopoietic stem cells are 
present in this organ. Wild-type E12 AGM contains 2-3 HSCs (Kumaravelu, ci al, 
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unpublished data) and therefore the numbers of mice reconstituted with a4 integrin 
AGM cells is consistent with there being normal numbers of HSCs in E12 a4 
integrin' AGM. The presence of HSCs in the a4 integrin AGM region may have 
been predicted since in the absence of a4 integrin some definitive haemopoiesis, 
although defective, is observed in the FL and later on in the adult BM (Arroyo et at, 
1999; Arroyo et al., 1996). As the FL is a secondary haemopoietic organ, for 
haemopoiesis to occur there it must be seeded with stem or progenitor cells from 
another site. In wild-type embryos the origin of these haemopoietic stem cells is the 
AGM region (Medvinsky and Dzierzak, 1996). However, the presence of HSCs in 
the AGM region could be considered contradictory to the data presented in Chapter 4 
which showed that all HSCs in the wild-type El 1 AGM express a4 integrin. 
However, the HSCs that develop in a4 integrin' embryos are not fully functional as 
shown by their inability to reconstitute secondary recipients. Also, cz4 integrin may 
not be required for the generation of HSCs in the AGM region but for their 
subsequent migration from the AGM to the FL. In addition, in a4 integrin embryos, 
another a integrin subunit, such as a5 integrin, may compensate for a4 integrin.. 
a4 integrin AGM stem cells reconstituted the BM, thymus, lymph nodes, 
Peyer's patches and spleen B220 positive and negative cell populations of recipient 
mice. The ability of these cells to contribute to B and T cell populations is surprising 
since it was shown that in adult a4 integrin chimaeras there are virtually no a4 
integrin' B or T cells (Arroyo etal., 1996). It seems that in the adult, a4 integrin is 
required for migration of I cell progenitors from the BM to the thymus and that B 
cell development is blocked before the pro B cell phase (Arroyo et al., 1996). Both 
of these facts suggest that a4 integrin is required for the correct development of 
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lymphoid progenitors in the BM microenvironment. The contribution of embryonic 
haemopoietic stem cells to these lineages in adult recipients, shown here, 
demonstrates that cM integrin stem cells from the AGM region can interact with the 
adult BM generating progenitors that are able to develop normally in this 
microenvironment. In addition the ability of these cM integrin HSCs to migrate to 
the BM shows that at least for AGM HSCs a4 integrin is not required for homing to 
the BM. This is interesting since in adult mice a4 integrin has been shown, by the 
use of blocking antibodies, to be important in the homing of progenitor cells to the 
bone marrow (Papayannopoulou and Craddock, 1997) 
The lower, level contribution of a4 integrin" cells to the Peyer's patches as 
compared to other organs is consistent with cz4 integrin being required for the 
homing of T cells to the Peyer's patches and this contribution being due entirely to 
the presence of cz4 integrin" B cells. 
ct4 integrin AGM stem cells were not capable of reconstituting secondary 
recipients at a level above 1%. There could be two reasons for this. Firstly, the stem 
cells generated in the cz4 integrin" AGM region may not be capable of secondary 
reconstitution either because of an intrinsic defect or due to having been in the' adult 
BM microenvironment. Alternatively, the lack of u4 integrin may render these cells 
incapable of efficient competition with the wild-type HSCs present in the BM of the 
primary recipient, which would also have been transplanted to the secondary 
recipient. 
5.3.2. FL ct4 integrin HSCs 
Only 1/4 recipients were reconstituted with 0.5 a4 integrin" FL. This shows 
that there are significantly fewer HSCs in the E12 ciA integrin" FL than in a wild- 
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type E12 FL, which contains approximately 60 HSCs. This decrease in the number of 
stem cells could be due to the inability of cz4 integrin HSCs to leave the AGM or to 
home to and efficiently seed the FL. No accumulation of HSCs is observed in the 
E12 ct4 integrin' AGM region although this does not exclude the possibility that 
they are unable to leave the AGM region since they may not survive for long if they 
do not migrate. It would be interesting to investigate the presence of a4 integrin 
HSCs in the PB, since this is the route via which HSCs are thought to migrate from 
the AGM region to the FL. Alternatively, ct4 integrin HSCs may be unable to 
develop or survive in the E12 FL microenvironment. It should be noted that the FL 
stromal compartment will also be deficient in cz4 integrin and therefore may not 
function as normal. 
Multilineage analysis showed that cz4 integrin FL cells can contribute to the 
thymus, lymph nodes, Peyer's patches and B220 positive and negative cell 
populations of the spleen. However, the level of reconstitution, except in the spleen, 
is lower than seen in the peripheral blood. A donor derived signal is not observed in 
the BM showing that the contribution of donor cells to this organ is below 10%. This 
suggests the possibility, along with the higher level of contribution of donor cells to 
the spleen, that ct4 integrin HSCs from the FL may home preferentially to the 
spleen and that haemopoiesis occurs there rather than in the bone marrow of the 
recipient. It could be that a4 integrin is required for the homing of FL HSCs to the 
BM of recipients but not to the spleen. It has been shown that a4j3 1 integrin is not 
required for the homing of adult haemopoietic progenitors to the spleen 
(Papayannopoulou et al., 1995; Vermeulen et al., 1998). It would have been 
interesting to transplant spleen cells from this recipient to secondary recipients to see 
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if these cells were capable of reconstitution. It seems that a4 integrin is not required 
for the homing of AGM stem cells to the BM (section 5.3.1) and this may therefore 
represent a developmental difference between AGM and FL HSCs. Unsurprisingly, 
as no donor signal is observed in the BM, secondary recipients were not reconstituted 
with cz4 integrin cells when BM was transplanted from this primary recipient. 
The above data suggest that the few cx4 integrin haemopoietic stem cells 
that are observed in the ct4 integrin FL are compromised and can not be defined as 
definitive haemopoietic stem cells. However, these cells are still capable of 
contributing to B and T cell lineages in the adult recipient suggesting that they are 
more competent than the ct4 integrin' stem and progenitor cells present later in 
development in adult cz4 integrin4 chimaeras (Arroyo et al., 1999). 
5.3.3. YS ct4 integrin' HSCs 
HSCs are also detected in the E12 a4 integrin YS, although their numbers 
or reconstitution ability seem to be decreased as compared to wild-type E12 YS. In 
the wild-type situation, the AGM region is thought to seed the YS with definitive 
HSCs, although it has not been ruled out that the YS can generate definitive HSCs 
itself (Kumaravelu, et a!, unpublished data). Therefore, the decreased ability of YS 
cells to reconstitute recipients as compared to wild-type YS cells could be due to a 
defect in the input of HSCs from the AGM region, in the interaction of these cells 
with the YS microenvironment or in the generation of HSCs by the YS. 
Multilineage analysis again showed that ct4 integrin YS cells contributed to 
all organs tested, although contribution to the BM was lower than in the other tissues. 
Contribution into the other organs was at approximately the same level as in the 
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peripheral blood. This again suggests that these HSCs may be homing preferentially 
to the spleen. 
5.3.4. Implications For The Role of a4 integrin In Definitive Haemopoiesis 
Previous studies of others, on a4 integrin' embryos and ct4 integrin 
chimaeras, have revealed that in the absence of cz4 .integrin some definitive 
haemopoiesis occurs but that it is defective. The defects become more pronounced as 
development progresses and in the adult there are very few fully differentiated u4 
integrin haetnopoietic cells, with the lymphoid and erythroid lineages being most 
severely affected. a4 integrin' T cell precursors are unable to leave the BM and seed 
the thymus leading to the absence of mature a4 integrin I cells. However, prior to 
birth there are normal numbers of cz4 integrin cells in the thymus, suggesting that 
there is no defect in the homing of T cell progenitors from the FL. Similarly, the 
development of ct4 integrin B cells is essentially normal in the embryo but in the 
adult is arrested before the pro-B cell phase (Arroyo et al., 1999; Arroyo ci al., 
1996). 
The data presented here, shows that in the absence of cz4 integrin HSCs can 
develop relatively normally in the AGM region, although they do not appear to have 
the full potential of true definitive haemopoietic stem cells, as they cannot 
reconstitute secondary recipients at a high level. However, in the E12 cz4 integrin 
FL defects are already apparent, as shown by a severe decrease in the number of 
HSCs present compared to wild-type FL and in their reduced potential to reconstitute 
recipient mice. In particular, they appear unable to contribute to the BM. Therefore, 
it can be concluded that cz4 integrin is required for the correct establishment of 
definitive haemopoiesis at the early FL stage. The exact role of ct4 integrin is unclear 
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though, as it could be required for the migration and homing of HSCs from the AGM 
region to the FL or for the correct development of HSCs once they reach the FL. The 
generation of a conditional ct4 integrin knockout could help to answer this question. 
For example, by knocking out a4 integrin at E12 it would be possible to see if the 
HSCs that had colonised the FL were able to survive and develop normally in that 
environment. The study of Ell a4 integrin embryos and the development of a4 
integrin HSCs in AGM organ culture would also be informative. In addition, by 
determining whether there are a4 integrin HSCs in the PB and whether there is an 
accumulation of these cells as compared to wild-type, would give information on 
whether x4 integrin HSCs are capable of leaving the AGM region. 
The ability of a4 integrin HSCs from the AGM region, and to some extent 
the YS, to contribute to the B and T cell populations and the BM of adult recipients, 
suggest, that these embryonic a4 integrin HSCs are able to interact relatively 
normally with the adult BM microenvironment, generating T cell progenitors that 
can seed the thymus and B cell progenitors that are able to differentiate to form B 
cells. This suggests that the increasing defects in the generation of differentiated cells 
observed as development progresses in cz4 integrin chimaeras (Arroyo et al., 1999) 
are due to defects at the stem cell level rather that an intrinsic inability of a4 
integrin progenitor cells to interact with the adult BM microenvironment. The data 
presented here, suggests a situation whereby ct4 integrin HSCs, or immature 
progenitor cells, lose some potential as they mature during development of the 
haemopoietic system and interact with different microenvironments, i.e. migrate 
from the AGM region to the FL and then to the BM. In the transplant experiments 
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described here, a4 integdn' AGM HSCs bypassed the FL maturation phase as they 
were transplanted directly to adult recipients. 
To summarise, taking together the data presented here and the previous work 
of others, a4 integrin is required at an early stage in the definitive haemopoietic 
system, for the correct establishment of FL haemopoiesis. Haemopoiesis does 
continue beyond this time point, although it becomes progressively defective, until 1 
month after birth terminally differentiated a4 integrin' cells of some lineages are 
essentially absent. It seem that cz4 integrin' HSCs lose potential during development 
of the definitive haemopoietic system, possibly because they are unable to interact 
correctly with the FL and BM microenvironments, and then generate defective 
progenitor cells which are unable to proliferate or differentiate properly in the adult 
BM. 
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Chapter 6: RESULTS 
31 integrin ES cells 
6.1. Introduction 
ES cells are pluripotent cells derived from the inner cell mass of E3.5 mouse 
blastocysts (Robertson, 1987). Upon introduction into recipient blastocysts they are 
able to contribute to all tissues of resulting chimaeras and can be transmitted through 
the germline (Bradley et al., 1984). In addition, they can be differentiated in vitro to 
a number of cell lineages including multiple haemopoietic lineages (Keller, 1995; 
Keller et al., 1993). The generation of erythrocytes, macrophages, mast cells, 
neutrophils, B and T cells, as well as different types of progenitor cell, has been 
demonstrated upon ES cell differentiation in vitro (Hole, 1999), (section 1.1.3). 
As discussed previously, 31 integrin ES cells show some defects in 
migration and adhesion in vitro (Fassler et al., 1995). However, they are capable of 
integrating into wild-type blastocysts at a low level, resulting in the generation of 
viable chimaeric mice (Fassler and Meyer, 1995). The contribution of 131 integrin 
ES cells varies between tissues and they are completely absent from the foetal liver 
and adult haemopoietic organs (Hirsch et al., 1996). However, 131 integrin ES cells 
can contribute to YS haemopoiesis, as shown by the presence of 131 integrin 
erythrocytes and committed progenitors. P 1 integrin progenitor cells are also found 
in the PB and pSp/AGM region up to at least E1 5.5. In addition, it has been shown 
that 131 integrin ES cells are capable of differentiating in vitro to form B 
lymphocytes that express the recombinase activating genes RAG-i and RAG-2 and 
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both VHDJH and VKJK rearrangements in the immunoglobulin heavy and light-chain 
genes respectively (Hirsch et al., 1996). 
Here, the ability of 131 integrin ES cells to differentiate in vitro is studied 
further and the possibility of rescuing the phenotype of 01 integrin ES cells by 
expressing a human 31 integrin transgene is also investigated. 
6.2. Results 
6.2.1. Differentiation of 131 integrin ES Cells In Methlycellulose 
To establish whether 131 integrin ES cells are capable of differentiating in 
vitro to form myeloid and erythroid cells, 31 integrin ES cells, clone G201 (Fassler 
et al., 1995), were grown in methylcellulose in the presence of 11-3, erythropoietin, 
insulin, KL and in the absence of LIF. Under these conditions, wild-type ES cells 
differentiate to form colonies containing erythroid and macrophage cells (Wiles and 
Keller, 1991). The behaviour of 131 integrin ES cells in this assay was 
indistinguishable from that of wild-type and 131 integrin ES cells, in that they 
readily formed colonies containing erythroid cells and containing both erythroid and 
macrophage cells, see figure 6.1. Therefore, it seems that 131 integrin is not required 
for the differentiation of ES cells to the erythroid and macrophage lineages in vitro. It 
is difficult to deduce if there is any reduction or increase in the numbers of 
haemopoietic colonies formed as this varies between different clones of ES cells and 
is also dependent on the passage number of the cells. 
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Figure 6.1: In vitro differentiation of 131 integrin ES cells in methylcellulose 
a) 	 b) 




Colonies derived from 131 integrin ES cells upon differentiation in methylcellulose 
in the presence of 11-3, SCF, erythropoietin, insulin and in the absence of LIF. a) 
colony containing erythroid cells; b) colony containing both erythroid and 
macrophage cells as assessed by comparison to published pictures (Wiles and Keller, 
1991). 131 integrin ES cell derived colonies were indistinguishable from those 
derived from wild-type or 131 integrin-/+ ES cells. 
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6.2.2. Expression of human 131 integrin in 131 integrin ES Cells 
In order to determine whether the phenotype of the PI integrin knockout 
could be rescued by re-expression of 131 integrin, a transgene carrying human [31 
intcgrin cDNA was constructed and introduced into [31 integrin ES cells. 
6.2.2.1. Construction of Human 131 integrin Transgene 
The structure of the human [31 integrin transgene is shown in figure 6.2. The 
cloning strategy for generation of the transgene is shown in Appendix 2 and 
described in section 2.1.8.2. Human 01 integrin cDNA, isoform A, was placed under 
the control of the CAG (chicken j3actin+CMV early enhancer) promoter. An IRES 
(internal ribosome entry site)-Puro cassette was placed downstream of the eDNA to 
enable selection of cells which have incorporated and are expressing the transgene. 
The human 31 integrin/IRES-puro cassette was flanked by Frt sites to enable 
removal of the transgene by Fip mediated recombination. A GFP gene was placed 
downstream of the Frt site flanked cassette and would therefore be expressed under 
control of the CAG promoter upon Flp mediated removal of the human [31 intcgrin 
6.2.2.2. Generation of 131 integrin ES Cells Expressing Human [31 integrin 
131 integrin ES cells, clone G201 (Fassler etal., 1995), were obtained from 
Reinhard Fassler, Sweden. 4.5x10 7 G201 ES cells were electroporated with the 
human [31 integrin transgene, cells selected in puromycin and colonies picked 14 
days later. Individual colonies were expanded and analysed by FACS for the 
expression of human [31 integrin using an antibody which specifically recognises 
human 131 integrin and does not cross react with mouse [131 intcgrin, see figure 6.3. Of 
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Figure 6.3. Morphology of 0201 ES cells and 0201 ES cells 
expressing human l I integrin 
A) Morphology and expression of human PI integrin in G201 cells 
transfected with human P 1 integrin transgene. B) Parental 0201 ES 
cells are shown as comparison. 
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the five puromycin resistant colonies obtained, all expressed human PI integrin - 
termed G201+huf3l. All five clones, of G201+hu1 ES cells had a different 
morphology than untransfected G201 ES cells. G201 ES cells do not spread out and 
form a monolayer but tend to grow in clumps. G201+huj3l ES cells appeared similar 
to wild-type ES cells and formed a monolayer on gelatinised plastic, see figure 6.3. 
6.2.3. Contribution of f31 integrit' ES Cells Expressing Human 31 integrin 
(G201+huf3l) To Definitive Haemopoiesis 
6.2.3.1. Generation of G201+hul3l/wt Chimaeras 
To determine if expression of human 131 integrin could rescue the ability of 
131 integrin' ES cells to contribute to definitive haemopoiesis in chimaeras, two 
clones of G201+huj3l ES cells (clones 2 and 18) were injected into wild-type 
blastocysts by Jan Ure (CGR). G201 ES cells were also injected as a control. The 
number of chimaeras born and the levels of chimaerism obtained are shown in Table 
6.1. 
No chimaeras were obtained when G201 ES cells were injected into 
blastocysts. This is in agreement with data from the laboratory which produced these 
ES cells; only one chimaera was born for approximately every 35 blastocysts 
injected (Hirsch et al., 1998). In contrast, when G201+huj3l ES cells were injected 
into blastocysts, approximately half of the pups born were chimaeric (9/19). The 




Clone 	no. pups born 	no. chimaeras 	% chimaerism 
(by coat colour) 
G201± huI3l 
Clone 18 	 6 	 3 	 5-30% 
G201+ huf3l 
Clone 2 	 13 	 6 	 10-30% 
G201 	 27 	 0 	 0% 
The total number of pups born from injection of each cell line into wild-type 
blastocysts is shown along with the number of these pups that were chimaeric, as 
assessed by coat colour contribution. 0201z01 integrin ES cells, clone G201; 
G201+huI31=1 integrin ES cells, clone G201, expressing human PI integrin 
cDNA under the CAG promoter. 
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6.2.3.2. Contribution of G201+hul3l ES Cells To Definitive Haemopoiesis 
To assess the contribution of G201+huj3l ES cells to definitive haemopoiesis 
in the chimaeras generated as described above (6.2.3.1.) three methods were used. 
Firstly, the haemopoietic organs, PB, BM, thymus and spleen from a 
G201+hu[31 chimaera were analysed by FACS for the expression of human 131 
integrin. Cells expressing human 131 integrin, and therefore derived from (1201 +hu13 1 
integrin ES cells, were observed in all organs tested, apart from the thymus, figure 
6.4i. The co-expression of human 131 integrin and CD45 was also investigated in 
order to show that the cells expressing human 131 integrin in these organs were 
contributing to the haemopoietic cell compartment and not only to the stromal cell 
compartment, see figure 6.4ii. When cells were co-stained for human 131 integrin and 
CD45, cells positive for both human [31 integrin and CD45 were not observed above 
background levels. However, no cells expressing only [31 integrin were seen either. 
Therefore, it seems that it is difficult to carry out co-staining with these two 
antibodies. As a consequence it is not possible to determine if the cells expressing 
human [31 integrin are indeed haemopoietic cells. 
In order to overcome this problem, haemopoietic organs from 0201+hu[31 
chimaeras were analysed by FACS for the expression of the Ly9. 1 antigen. Ly9. I is 
expressed on lymphocytes from 129 but not C57131/6 mice. Since G201 ES cells 
were derived from 129 mice and the recipient blastocysts are C5713I/6, this provides 
a means to test for the presence of ES cell derived lymphocytes. Where appropriate, 
the co-expression of Ly9.1 with B220 and Mac-i was also assessed, to determine ES 
cell contribution to the B-cell and macrophage lineages respectively. Haemopoietic 
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Figure 6.4: Expression of human DI integrin in haemopoietic tissues of a 
G201 +huI3 1 chimaera 
Cells from haemopoietic organs of a G201+hu31 integrin chimaera were stained 
with anti-hu[11 integrin antibody (i) and co-stained with anti-hu(31 integrin and 
CD45 antibodies (ii) 
BM cells from a wild-type C57B1/6 mouse were stained with anti-huI3l integrin 
antibody (i) and co-stained with anti-hu31 integrin and CD45 antibodies(ii) 
A) G201+hu1chimaera (5% chimaeric as assessed by coat colour) 
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control. A representative example of this FACS analysis is shown in Figure 6.5. 
Results for all chimaeras tested are shown in Table 6.2. 
FACS analysis of G20 1 +hu 1 chimaeras showed that a low percentage of 
cells in the BM and spleen, between 1.5% and 5.0%, expressed Ly9. 1 in all the 
chimaeras tested. In addition, a proportion of these cells co-expressed the lineage 
specific markers B220 and Mac-I. Expression of Ly9.1 in the thymus was generally 
lower, between 0% and 1.6%, and wasn't much above background levels found upon 
staining the haemopoietic organs of a wild-type C57131/6 mouse with the Ly9.1 
antibody. Expression in the peripheral blood was slightly higher than in the thymus, 
0.6%-2.5%, but in general lower than in the BM and spleen, figure 6.5, Table 6.2 
Unexpectedly, analysis of two mice born from the injection of G201 ES cells, 
that did not appear to be chimaeric by coat colour assessment, showed staining with 
the Ly9.1 antibody above background levels, figure 6.5, table 6.2. There could be 
two reasons for this. Firstly, these mice may have been very low-level chimaeras that 
was not detectable by coat colour assessment and G201 ES cells contributed at this 
low level to definitive haemopoiesis. This would be in contradiction to previous 
reports that PI integrin ES cells can not contribute to definitive haemopoiesis 
(Hirsch et al., 1996). Alternatively, the staining observed could be non-specific. 
This positive staining with Ly9.i antibody in G201 mice makes it difficult to 
interpret the FACS results from G201+huI3l chimaeras. However, it is clear that if 
G201 +huf3l cells are contributing to definitive haemopoiesis, they are contributing at 
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Figure 6.5: Contribution of ES cells to haemopoietic organs of 
G20 1 +h43 I integrin chimaeras assessed by Ly9. 1 expression 
Cells from haemopoietic organs of G201+hu1 chimaeras, A; G201 
chimaeras, B; were stained with Ly9. 1 antibody which is specific for 
129 derived lymphocytes (i) and co-stained with Ly9.1 and anti-CD45 
(ii), B220 (iii) and Mac-1(iv) antibodies. Haemopoietic organs of a 
C57B116 mouse were stained with Ly9.1 antibody (C) as a control. 
A) G201+huI3l chimaera (20% chimaeric, as assessed by coat colour) 
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Table 6.2: FACS analysis of haemopoietic organs from G201+hu1/wt chimaeras for 
expression of Ly9. 1 marker and its co-expression with B220 and Mac-I markers. 
Tissue 	Chimaera % cells expressing 
(% chimaerism) Ly9.1 Ly9.1 + B220 	Ly9.1 + Mac-i 
G201+hul31 a (20%) 4.9 1.0 1.4 
G201+hu31 b (20%) 4.8 0.8 0.8 
G201+hu1 c(30%) 2.0 LU 0.5 
BM 	G201+hu1 d(30%) 2.0 1.5 1.0 
G201 1(0%) 2.0 0.0 1.5 
G201 2 (0%) 0.3 0.5 2.0 
C57B1/6 0.8 - - 
G201+huI3l a 3.5 1.0 - 
G201+hul3l b 3.5 - - 
G201+hu31 c 3.7 0.7 - 
Spleen 	G201+hu31d 1.5 0.8 - 
G201 1 3.0 0.5 - 
G2012 1.6 1.5 - 
C57B1/6 1.0 - - 
G201+huI3l a 0.5 	 - 	 - 
G201+hu1b 1.6 - - 
G201+huI3l c 1.5 	 - 	 - 
Thymus 	G201+huI3l d 0.0 - - 
G201 1 0.5 	 - 	 - 
G2012 0.2 - - 
BI/6 0.6 	 - 	 - 
G201+hul a 3.0 - 	 - 
G201+hul3l b 0.6 	 - - 
G201+hul c 1.5 - 	 - 
PB 	G201+huI3I d 15 	 - - 
G2011 0.5 - 	 - 
G2012 - 	 - - 
81/6 1.0 - 	 - 
The percentage of cells expressing Ly9.1 in each of the haemopoietic organs, the 
bone marrow(BM), spleen, thymus and peripheral blood (PB) are shown for each 
G201+hu31/wt chimaera analysed (G201+huF31 a-d, the percentage of chimaerisrn as 
assessed by coat colour is shown in brackets next to individual chimaeras).The 
percentage of cells co-expressing Ly9.1 and 8220 and Ly9.1 and Mac-i is shown for 
some organs. Also shown is the percentage of cells which stained positive for Ly9. I 
in the haemopoietic organs of two mice born from the injection of G201 ES cells into 
wt blastocysts (G201 Cl and C2) which did not appear to be chiniaeric by coat 
colour assessment and of a wild-type C57B1/6 adult mouse. 
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a level well below that of the overall chimaerism assessed by coat colour, which is 
20%-30%. 
Finally, ES cell contribution to the haemopoietic organs, which were 
analysed by FACS, was also assessed by PCR. All of the chimaeras tested were 
female and as the ES cells were derived from a male blastocyst it is possible to 
determine ES cell contribution using a Y chromosome specific PCR reaction, as used 
to assess the contribution of male donor cells to the haemopoietic system of 
irradiated female recipients in Chapter 4. Genomic DNA was prepared from 
haemopoietic organs and amplified using primers specific for the Y chromosome. As 
previously, primers for myogenin were included in the PCR reaction as an internal 
control for the amount of DNA present and standard mixes of male and female DNA 
were amplified to allow estimation of the percentage contribution of ES cells to the 
haemopoietic organs, figure 6.6. 
Assessment of ES cell contribution to the haemopoietic organs of chimaeras 
using Y specific PCR gave different results to the FACS analysis described above, 
see figure 6.6. A positive signal, showing the presence of ES cell derived progeny, 
was obtained in all tissues analysed from G201+hul chimaeras, except from, in 
some cases, the thymus and BM. The intensity of the signal, which relates to the 
percentage of ES cell contribution, varied from tissue to tissue and was consistently 
highest in the spleen. Contribution at a level above approximately 10% was not seen 
in any of the organs from any of the chimaeras. Analysis of CD45 expression in 
organs from which genomic DNA was isolated, show that in the case of the spleen 
and thymus, approximately 100% of cells expressed CD45. This shows that the ES 
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Figure 6.6: Y PCR analysis of haemopoietic tissues from G201+hu1 
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a-d are female chimaeras from injection ofG201+hu31integrin ES 
cells into wt blastocysts. All chimaeras were between 20% and 30% 
chimaeric as assessed by coat colour contribution. 
G201/wt chimaeras 
Cl and C2 are female pups born from injection of G201 31 integrin 
ES cells into wt blastocysts. Both were 0% chimaeric as assessed by 
coat colour contribution. 
B=bone marrow; S=spleen; T=thymus; P=peripheral blood 
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cell derived signal is due to the presence of ES cell derived haemopoietic cells and 
not only due to contribution to the stromal cell compartment. In the case of the BM, 
approximately 80% of cells express CD45. As the ES cell contribution in the BM is 
on average about 1% as assessed by PCR this could be due to ES cell contribution 
solely to the non-haemopoietic cell compartment. 
PCR analysis of haemopoietic organs from 0201 mice showed no ES cell 
derived signal, figure 6.6b. As the PCR reaction is sensitive to a level of at least 1% 
this suggests that 0201 ES cells are not contributing to definitive haemopoiesis. 
Therefore it is likely that the staining seen with the Ly9.1 antibody in these organs 
was unspecific. 
6.3. Discussion 
The consequences of knocking out the 131 integrin gene in ES cells are 
apparent both in vitro and in vivo. In vitro the morphology, migratory and adherent 
properties of (31 integrin ES cells are altered as compared to wild-type ES cells 
(Fassler et al., 1995). In addition, (31 integrin ES cells have a reduced capacity to 
form chimaeras upon injection into wild-type blastocysts. The frequency of 
chimaeras born is reduced and ES cell contribution above 25% is not seen (Fassler et 
al., 1995; Hirsch etal., 1998). Moreover, (31 integrin ES cells can not contribute to 
definitive haemopoiesis, although (31 integrin progenitors are observed in the YS 
and PB (Hirsch et al., 1996). In addition, the ability of (31 integrin ES cells to 
differentiate in vitro to lymphopoietic cells is not impaired (Hirsch etal., 1996). 
Here, the ability of (31 integrin ES cells to differentiate into erythroid and 
myeloid lineages in in vitro methylccllulose assays was assessed. (31 integrin' ES 
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cells behaved in a manner indistinguishable from wild-type and f31 integrin ES 
cells in this assay, differentiating into both erythroid and macrophage cells. This 
gives further evidence that the ability of 131 integrin ES cells to differentiate in vitro 
to haemopoietic lineages is not impaired. As discussed previously, the differentiation 
of ES cells in vitro most likely models primitive YS haemopoiesis (Keller et al., 
1993). Therefore, the ability of 131 integrin' ES cells to differentiate to haemopoietic 
lineages in vitro would perhaps have been predicted as 131 integriii' ES cells can 
contribute to YS haemopoiesis in vivo (Hirsch et al., 1996). 
To ascertain if the ability of 131 integrin ES cells to generate chimaeras, and 
more specifically to contribute to definitive haemopoiesis, could be rescued, a human 
131 integrin transgene was introduced into 31 integrin ES cells. Several clones 
which expressed human 131 integrin were isolated, termed G201+hu131. G201+hu13l 
ES cells had a different morphology to untransfected G201 131 integrin ES cells and 
appear similar to wild-type ES cells, in that they form monolayers on gelatinised 
plastic, whereas G201 ES cells do not. This indicates that human 131 integrin can 
compensate, at least to some extent, for mouse 131 integrin in vitro. 
Injection of G201+hu13l ES cells into wild-type blastocysts revealed that they 
have an increased ability to generate chimaeras compared to G201 ES cells, 
approximately half of the pups born were chimaeric, 9/19, in contrast to 0/27 pups 
from the injection of G201 ES cells. However, 0201+hu13l ES cells did not 
contribute to chimaeras at levels higher than 30%, as assessed by coat colour. This is 
similar to the highest level of contribution observed by others with G201 ES cells 
(Fassler et al., 1995). Breeding of G20l+hu13l chimaeras did not result in germline 
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transmission. Breeding of 0201 chimaeras does not result in germline either, due to a 
defect in the migration of P 1 integrin primordial germ cells (Anderson et al., 1999). 
Therefore, the expression of human f31 integrin can not rescue this defect. The 
possible reasons for this are discussed below. 
Assessment of the contribution of G201+huI3l ES cells to definitive 
haemopoiesis gave slightly ambiguous results. Staining of definitive haemopoietic 
organs from G201+hu[31 chimaeras and mice born from the. injection of G201 ES 
cells, with the Ly9.1 antibody, which should be specific for ES cell derived 
lymphocytes gave similar results for both sets of mice. There was a low level of 
Ly9. 1 expression, between 0.5% and 5%, in the BM, spleen, thymus and PB of most 
of the mice tested. Analysis of the haemopoietic organs of a wild-type C57B116 
mouse gave a low level of background staining - maximum 0.7%. Since the G201 
chimaeras did not appear to be chimaeric by coat colour, this suggests that the Ly9.1 
staining observed in 0201 chimaeras, and therefore also in the G201+huIil 
chimaeras may have been non-specific. If this is the case, it is then difficult to 
determine if G201+huI3l cells are contributing to definitive haemopoiesis or not, 
since the levels of Ly9.1 expression in the haemopoietic organs of G201+huI3l 
chimaeras was not much higher than that seen in 0201 chimaeras. However, it can 
not be ruled out that the G201 mice were in fact very low level chimaeras, as coat 
colour assessment may not be a reflection of the level of chimaerism in other tissues, 
and that the staining seen in these mice is due to a low level contribution of 31 
integrin ES cells to definitive haemopoiesis. This would be in contradiction to 
previous studies in which 31 integrin ES cells were not found to contribute to adult 
definitive haemopoietic organs, even in chimaeras of up to 25% (Hirsch etal., 1996). 
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It would be necessary to analyse more mice, including C57131/6 mice to draw 
stronger conclusions about Ly9.1 staining, since the percentages of positive cells are 
low and there is often variation between FACS staining in different experiments. 
However, it is clear that if G201+hu1 cells are contributing to definitive 
haemopoiesis, they are contributing at a level well below that of the overall 
chimaerism assessed by coat colour, which is 20%-30%. 
When ES cell contribution to the same haemopoietic organs was assessed by 
PCR, differences between G201+hi431 chimaeras and G201 mice were observed. ES 
cell contribution was observed in all tissues of G201+hul3l chimaeras with the 
highest levels of contribution being in the spleen and the lowest in the thymus. FACS 
analysis showed that virtually 100% of the cells of the spleen and thymus from 
which genomic DNA was isolated, expressed CD45, a marker specific for 
haemopoietic cells. Therefore, since the approximate level of ES cell contribution to 
these tissues as assessed by PCR is between 1 and 10%, this shows that G201+huj3l 
ES cells are contributing to haemopoietic cells and not only to stromal cells. In the 
BM, approximately 90% of cells express CD45, after red cell lysis. As the ES cell 
contribution in the BM is on average approximately 1% as assessed by semi-
quantitative PCR, ES cells may be contributing solely to the non-haemopoietic cell 
compartment. This could explain why the signal from the spleen is always higher 
than that obtained from the BM, thymus and PB. It may be that the spleen is 
colonised by G201+huI3l progenitors during embryogenesis and haemopoiesis 
continues there throughout adult life. In contrast, G201+hul3l stem cells may fail to 
colonise the BM efficiently, resulting in a defect in ES cell derived BM 
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haemopoiesis and in the input of ES cell derived haemopoietic cells from the BM to 
the thymus and the PB, leading to a lower level of contribution to these tissues. 
The analysis of haemopoietic organs from G201 mice by PCR did not show 
an ES cell derived signal in any of the organs tested. This therefore shows a 
difference between the G201+hu13l and G201 mice, as would be expected as the 
G201 mice did not appear to be chimaeric. However the absence of an ES cell 
derived signal in the G201 mice does not correlate with the FACS data. When cells 
were analysed by FACS, signals above 2% were obtained in 0201 organs. However 
as can be seen from the amplification of the standard mixes of DNA, the PCR is 
sensitive to at least 1%. This again suggests that the staining observed with the Ly9. 1 
antibody was unspecific. 
From the above data it can be seen that the expression of human 131 integrin 
in 31 integrin ES cells can rescue the phenotype of these cells to some extent but 
not in all areas. The morphology of 131 integrin' ES cells in vitro is restored to that 
of wild-type ES cells and the frequency with which they can generate chimaeras is 
increased on expression of human 131 integrin. In addition, it appears that to some 
extent 31 intcgrin ES cells expressing human 131 integrin can contribute to 
definitive haemopoiesis in chimaeras, although the rescue is not complete. However, 
these cells are not capable of transmission through the germline or of generating high 
percentage chimaeras. 
There could be several reasons for the incomplete rescue of 0201 131 integrin 
ES cells with the human 131 integrin transgene. Firstly, human 131 integrin may not 
be able to substitute for mouse 131 integrin in all of its roles. For example, 
dimerisation with some a integrin subunits may be impaired or ligand binding 
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specificities and avidity may be altered. Alternatively, downstream signalling events 
triggered by 131 integrins may be affected, or modulation of the integrin activation 
state by the cells, i.e. inside—out signalling. For example modulation of integrin 
activation states is required for cells to migrate and adhere in appropriate places 
(section 1.2.3.). 
Secondly, the CAG promoter under which the human 131 integrin eDNA is 
expressed may not be active in all of the tissues in which 131 integrin is required. In 
addition, expression from the CAG promoter is not regulated and therefore 131 
integrin may be inappropriately expressed in certain tissues or at particular stages of 
development. The expression of 131 integrin has been shown to be regulated during 
the differentiation of human epidermal stem cells (Zhu et al., 1999) and on 
haemopoietic progenitors as they differentiate (Coulombel etal., 1997), or indirectly 
shown by a change in their adhesive properties (Verfaille etal., 1991). Therefore the 
ability of G201+hu13l ES cells to differentiate into all lineages in chimaeras may be 
impaired as the expression of 131 integrin is not regulated in these cells. It would be 
interesting to investigate the ability ofG2Ol+hu13l ES cells to differentiate in vitro to 
ascertain if there is a perturbation of the ability of the cells to differentiate or 
proliferate correctly. 
Finally the G201 ES cell clone may have been irreversibly compromised by 
being expanded in the absence of 131 integrin. Equally, these cells may have 
undergone other mutations during their generation and maintenance. This is an 
important question, since the previous work on the, involvement of P 1 integrin in 
definitive haemopoiesis was carried out using this clone (Hirsch et al., 1996; 
Potocnik et al., 2000). Therefore it still remains unclear as to whether these cells are 
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fully competent apart from the absence of P1 integrin. To fully address this question 
it would be necessary to restore mouse 131 integrin expression under the endogenous 
131 integrin promoter. 
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Chapter 7: RESULTS 
Generation of a reversible 31 integrin knockout allele 
7.1. Introduction 
We aimed to generate a 131 integrin knockout that could be reactivated at 
specific times. By reactivating 131 integrin at various times during development of the 
definitive haemopoietic system it would be possible to determine the time point at 
which re-expression of 131 integrin is capable of rescuing definitive haemopoiesis and 
therefore the time point that 01 integrin is required for establishment of the definitive 
haemopoietic system. 
Mice null for 131 integrin die at E5.5, before the onset of primitive or 
definitive haemopoiesis. However, studies of chimaeras, generated by injection of 131 
integrin ES cells into wild-type blastocysts, have shown that 131 integrin ES cells 
are unable to contribute to definitive haemopoiesis, as shown by the absence of these 
cells from the FL or any of the adult haemopoietic organs. It has been proposed that 
in the absence of 131 integrin, HSCs are able to develop and differentiate normally 
and that the block in definitive haemopoiesis is due to the inability of 131 integrin' 
HSCs to migrate to and colonise the FL (Hirsch et al., 1996; Potocnik et al., 
2000);(section 1.3.2.). 
This hypothesis has been supported by further studies on 131 integrin7wt 
chimaeras and conditional 131 integrin knockout mice (Potocnik etal., 2000);(section 
1.3.2.). Briefly, it was discovered that in 131 integrin'7wt chimaeras, [31 integrin 
haemopoietic progenitors, that express the stem cell markers c-kit and AA4. 1 and 
that are lineage negative, accumulate in the PB from E13.5-E15.5. These cells are 
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able to differentiate in aggregate FL cultures generating B lymphoid, erythroid and 
myeloid cells. In addition, they are able to form spleen colonies in recipient mice but 
only when injected directly into the spleen. This shows that 131 integrin progenitors 
are able to differentiate in the FL and spleen microenvironments but are unable to 
home to these organs. The generation of a conditional 131 integrin knockout allowed 
the role of 131 integrin in the homing of adult HSCs to be studied. Adult BM cells 
were isolated from these mice and the Il integrin gene removed in vitro by the 
expression of Cre recombinase after infection with a Cre expressing retrovirus. 131 
integrin cells were isolated by FACS sorting and transplanted into irradiated 
recipients. These cells were unable to rescue irradiated recipients, again suggesting 
that 131 integrin is required for the migration and homing of HSCs. 
The above data provides evidence in support of the hypothesis that in the 
absence of 131 integrin, HSCs are unable to migrate to and colonise the FL but are 
competent for differentiation and proliferation in the FL microenvironment. 
However, several questions remain unanswered. The cells isolated from the PB may 
not have been true definitive HSCs but instead immature progenitors cells, possibly 
derived from the YS. It is clear that HSCs from different organs and at different 
stages of development have different properties (Dzierzak and Medvinsky, 1995), 
(section 1.1.2.) and therefore the ability of PB progenitor cells to differentiate in the 
FL environment does not necessarily mean that definitive HSCs could survive or 
develop normally in the absence 131 integrin in the FL. In addition, there is no 
evidence that 131 integrin 1  HSCs are generated in the AGM region or that the block 
in definitive haemopoiesis is not at an even earlier stage of development i.e. in the 
generation of pre-definitive HSCs. 
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By studying f31 integrin chimaeras or conditional 131 integrin knockout mice 
it is not possible to resolve these issues, due to the inability of 131 integrin HSCs to 
home to the BM in adult irradiated recipients (Potocnik et al., 2000). Since this is the 
only true assay for definitive HSCs, these cells cannot be identified in the absence of 
31 integrin. By generating a 131 integrin knockout in which (31 integrin can be 
reactivated it should be possible to circumvent this problem. In this case, cells could 
develop in the absence of f31 integrin but to assay for the presence of (31 integrin 
HSCs in different organs, one of the 01 integrin alleles could first be reactivated, 
rendering these cells competent to reconstitute irradiated recipient mice. By 
reactivating 131 integrin at different times and in different organs during development 
it should be possible to, in effect, rescue definitive haemopoiesis and therefore 
determine the point at which (31 integrin is essential for establishment of the 
haemopoietic system. 
7.2. Experimental Strategy 
The strategy proposed involves the generation of a reversible 01 integrin 
knockout in which one of the knocked out (31 integrin alleles can be reactivated at a 
specified time. As (31 integrin' embryos die before the onset of definitive 
haemopoiesis, studies will be carried out on chimaeras generated by the injection of 
reversible 31 integrin' (01' ( ')) ES cells into wild-type blastocysts. 
The generation of (310  ES cells requires targeting the two 31 integrin 
alleles with different targeting constructs in two rounds of targeting. The structures 
of the targeting constructs are shown in figure 7.1. 
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Figure 7.1: A) Structure of targeting constructs for generation of reversible 
131 integrin knockout 
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Genomic structure of part of the 131 integrin wild-type allele, including part 
of intron I, exon II, intron II, exon HI and part of intron III. 
p131 CreERc targeting construct which contains a CreERc/floxed tkneo 
cassette replacing the first 7 nucleotides of exonil. The 5' homology arm is 
4.7kb and extends from the BamHI site in intron II to the start of exon II. The 
3' homolgy arm is 2.9kb and extends from the 8th nucleotide of exon II to the 
Sail site in intron III 
pHHI.6 targeting construct which contains a foxed geo cassette inserted 
into the intron TI exon II boundary, downstream of the splice acceptor site but 
upstream of the first ATG. The 5  homology arm is 4.7kb and extends from the 
BamHI site in intron Ito the splice acceptor site in exon IT. The 3' homology 
arm is 2.9kb long and extends from the ATG of exon II to the Sail site in 
intronill 
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B) Cre mediated recombination at pHI -I 1.6 targeted allele in 1 integrin-I-(R) cells, 
resulting in a reactivated 3 1 integrin allele 
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The first targeting vector - 13lCreERc - contains a cassette, which encodes a Cre-
TBD (tamoxifen binding domain) fusion protein, replacing part of the coding region 
of 131 integrin, including the first ATG. Therefore, successful targeting with this 
construct will inactivate the 131 integrin allele. The Cre-TBD fusion protein will be 
expressed under the endogenous 131 integrin promoter. However, the presence of the 
TBD domain renders Cre inactive in the absence of tamoxifen. Therefore the activity 
of Crc in targeted cells can be regulated. The construct also contains a neotk 
selection cassette flanked by mutant loxP sites (loxP511)(Hoess et al., 1986), which 
will be removed by Cre mediated recombination prior to the second round of 
targeting. LoxP511 sites are unable to recombine with wild-type loxP sites (Hoess et 
al., 1986). 
The second targeting construct, pHH1 .6, contains a promoterless 3geo (lacZ/neo 
fusion) gene, flanked by two loxP sites, inserted into the intronllexonll boundary of 
31 integrin. Exonil is the first expressed exon of 131 integrin and therefore the 
presence of this cassette should prevent the expression of 131 integrin. The cassette is 
placed directly upstream of the first ATG start codon but downstream of the splice 
acceptor site, ensuring that the cassette cannot be spliced out. 
It will be possible to reactivate the 131 integrin allele targeted with pHHl.6 by 
inducing Cre activity in 131-/-(R) cells by the addition of tamoxifen. Crc will catalyse 
recombination between the two loxP sites, resulting in excision of the 13geo cassette, 
leaving one loxP site upstream of the coding region of 131 integrin. It is anticipated 
that this will leave an active allele, figure. 7.1b. 
In order to examine the role of 131 integrin in the onset of definitive 
haemopoiesis the haemopoietic organs - AGM region, FL, PB and YS - will be 
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isolated from J31 integrin ' /wt chimaeras at various times during the onset and 
establishment of definitive haemopoiesis. Tamoxifen will be added to the organs in 
order to reactivate the pFIH1.6 targeted f31 integrin allele. Cells will then be 
transplanted into irradiated recipient mice and the presence of Of intcgrin 4+ LTR-
HSC and CFU-S assessed. An outline of this experimental scheme is shown in figure 
7.2. Firstly, this will enable determination of whether HSCs are being generated in 
the AGM region in the absence of P i integrin. By treating Eli . AGM from p1 
integrin ° /wt chimaeras, before or after organ culture, with tamoxifen and then 
transplanting cells to irradiated recipients it will be possible to establish whether p1 
integrin HSCs have been generated. If HSCs are generated in the absence of fll 
integrin it will then be possible to determine whether they are able to leave the AGM 
region and enter the PB and subsequently if they are able to migrate to the FL and 
YS or whether they accumulate in the PB. Again this can be achieved by treating 
cells from these organs with tamoxifen and then transplanting them into irradiated 
recipients. 
7.3. Results 
7.3.1. Generation of Targeting Constructs 
The J3 1 CreERc targeting construct, shown in figure 7.1, was received from 
Reinhard Fassler, Lund, Sweden. 
The cloning strategy for generation of the targeting construct pHH1.6 is 
shown in Appendix 1 and described in section 2.1.8.1. 
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Figure 7.2: Experimental strategy for reversible 0 1 integrin knockout 
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7.3.2. Generation of 31 integrin' ES Cells 
E14 ES cells were eleetroporated with the 31CreERc targeting construct and 
cells grown in the presence of G418. After 14 days in selection, 200 G418 resistant 
colonies were picked and screened by Southern Blot analysis for the presence of a 
correctly targeted allele. Genomic DNA was digested with EcoRl and BamHI and 
hybridised to a 2.9 kb 3' genomic probe which is situated directly downstream of the 
targeting construct. The wild-type allele should give a band of 6.2kb and a 
successfully targeted allele, a band of 7.5kb. A representative Southern Blot is shown 
in Figure 7.3. In total, 31/56 clones had a successfully targeted allele. 
Three successfully targeted clones were selected (clones 36, 33 and 44) and 
assayed for Cre function - i.e. whether it was active and whether there was any 
background activity in the absence of tamoxifen. To achieve this, cells were treated 
with different concentrations (ijiM, 2 ,.tM, 4 1iM and 10 jiM) of tamoxifen, or left 
untreated, for 24 hours and then plated at low density in the presence of gancyclovir. 
Cells in which Cre is active should undergo site specific recombination between the 
two loxPSIl sites, resulting in excision of the neotk cassette, rendering these cells 
resistant to gancyclovir. Cells in which no recombination has taken place will be 
sensitive to gancyclovir. 
Concentrations of tamoxifen of 41.tM and 1 Oj.iM were toxic to the cells. Similar 
numbers of GancR  colonies were obtained when cells were treated with 1pM and 
2 pM tamoxifen, although slightly fewer colonies were obtained with a concentration 
2 pM. As cells were not checked for viability before plating in gancyclovir it maybe 
that 2 pM tamoxifen is slightly toxic to cells. On average, the treatment of cells with 
1pM or 2pM tamoxifen resulted in approximately 2% cells forming gancyclovir 
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Figure 7.3: Southern blot analysis of E14 ES cells targeted with 
p131 CreERc 
Genomic DNA was digested with EcoRI and BarnHI and probed 
with a 2.9kb 3tSalI-BarnHI fragment. 
Genornic structure of wild-type and targeted allele with expected 
size of band after digestion with Barn HI and EcoRI and 
hybridisation to 3' probe indicated. 
Southern Blot. Lane 1 and 2 show clones correctly targeted with 
131 CreERc gving a band of 6.2kb corresponding to the wild-type 
allele and a band of 7.5kb corresponding to a targeted allele. Lane 3 
shows a clones that has not been targeted, showing only a band 
corresponding to the wild-type allele. 
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Table 7.1. Gre mediated recombination in 131 integrin cells in the presence or 
absence of tamoxifen. 
No. GancR colonies  
5x1021cm2 












Clone 44 97 0 1130 6 1470 7 
Clone 34 49 0 _______  
Clone 37 97 0 ______  
Clone 123 64 1 
Clone 112 240 0 
[31 integrin " cells targeted with the (31 CreERc targeting construct were treated with 
tamoxifen or left untreated and then plated, at the densities shown, in the presence of 
gancyclovir. The number of gancyclovir resistant (Ganc' t) colonies, which represents 
the number of cells in which Cre mediated recombination has occurred were counted. 
All assays were carried out in triplicate and numbers given are an average of the 
number of colonies in the 3 wells or plates. 
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resistant colonies, Table 7.1 Although plating efficiency is not taken into account, 
this still represents a low level of recombination. In the absence of tamoxifen, no 
colonies were obtained in gancyclovir when cells are plated at a density of Sxl 0 2/cm2 
in 6 well plates. However, when cells were plated at a similar density in 10cm plates 
(i.e. larger numbers of cells) and at a higher density (1x10 3/cm2) very few cells, less 
than 0.5%, formed GancR colonies. This data shows that Cre is active in targeted 
cells when they are treated with tamoxifen and that there is minimal background Cre 
activity in the absence of tamoxifen. 
In order to remove the neotk selection cassette prior to the second round of 
targeting, a further three 31CreERc targeted clones (123, 125, 112) were treated with 
1 .tM tamoxifen and plated in gancyclovir. Untreated cells were also plated in 
gancyclovir to check that these particular clones had no Cre activity in the absence of 
tamoxifen (Table 7.1). Twelve gancyclovir resistant colonies were picked from each 
of the three original clones and checked by Southern Blot analysis for correct 
recombination, figure 7.4. Genomic DNA was digested with BamHl and EcoRl and 
hybridised to the same genomic probe used previously. A 3lCreERc targeted, 
recombined allele should give a band of 5.8 kb and the wild-type allele will give a 
band of 6.2. All of the gancyclovir resistant colonies tested gave bands consistent 
with correct recombination between loxPS 11 sites and excision of the neotk cassette. 
All GancR  colonies were also sensitive to G418. 
A mixture of these recombined clones was then electroporated with the 
second targeting construct, pHHl .6. Cells were grown in the presence of G418 and 
after 14 days in selection 100 colonies were picked. Clones were again tested for 
homologous recombination by Southern Blot analysis, figure 7.5. Genomic DNA 
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Fig.7.4: Southern Blot analysis of recombined l3lCreERc clones 
Genomic DNA from gancyclovir resistant clones was digested with 
BamHl and EcoRI and hybridised with 2.9kb 3' genomic fragment. 
Genomic structure of wild-type and tartgeted, recombined allele 
with expected size of band after digestion with BamHI and EcoRI 
and hybridisation to the 3' probe indicated. 
Southern Blot with all lanes showing bands of 6.2kb 
corresponding to wild-type allele 5.8kb corresponding to 
recombined 131 CreErc allele. 
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was digested with BamHl and hybridised to the 3' genomic probe used previously. A 
wild-type allele will give a band of 10.5 kb, a 31CreERe targeted, recombined allele, 
a band of 5.8kb and an HH1.6 targeted allele should give a band of 7.5kb. The three 
expected targeting events were observed. Out of the 20 clones shown in figure 7.5, 
two had retargeted the same allele (clones 2 and 25) giving bands of 10.5kb and 
7.5kb, two had the two alleles targeted with different constructs, i.e. were double 
knockouts (clones 12 and 17), giving bands of 5.8kb and 7.5 kb and missing a wild-
type band. The rest of the clones were not targeted on the second allele and gave 
bands of 5.8kb and 10.5kb. Out of a total of 55 clones tested 7 were double knockout 
by Southern Blot analysis. 
Clones that appeared to be double knockouts by Southern Blot analysis were 
analysed by FACS for the expression of PI integrin, figure 7.6. Clones which were 
not targeted on the second allele were also analysed as a control. Those clones which 
appeared to be double knockouts by Southern Blot analysis do not express f1 
integrin on the cell surface whereas those which had not been targeted with HHI .6 or 
were retargeted on the same allele do express P1 integrin. 
Interestingly, the morphology of the 31 integrin 	ES cells was similar to 
that of G201 131 integrin ES cells produced by Reinhard Fassler, Sweden (see 
section 6.2.2.2.), in that they do not spread out and form monolayers on gelatinised 
plastic as do wild-type ES cells, figure 7.7. 
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Fi2.7.5: Southern blot analysis of 131 integHn cells targeted with 
pHH1.6 
Genomic DNA was digested with BamHI and hybridised to a 2.9kb 
3' SalI-BamHlgenomic probe. 
Genomic structure of wild-type and targeted alleles with expected 
size of band after digestion with BarnHl and hybridisation to 3' 
probe indicated. 
Southern Blot. Lane 2 shows a clone retargeted on the same 
allele, giving bands of 7.5kb and 10.5 kb; lane 12 shows a clone 
targeted on two alleles with different constructs, i.e. a double 
knockout, giving bands of 5.8kb and 7.5kb; lane 3 shows a clone in 
which the second allele has not been targeted, giving bands of 5.8kb 
and 10.5kb. 
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Fig.7.5: Southern blot analysis of P l integrin cells targeted with 
pHHl.6 
Genomic DNA was digested with BamHI and hybridised to a 2.9kb 
3 'SalI-BamHlgenomic probe. 
Genomic structure of wild-type and targeted alleles with expected 
size of band after digestion with Bam}ll and hybridisation to 3' 
probe indicated. 
Southern Blot. Lane 2 shows a clone retargeted on the same 
allele, giving bands of 7.5kb and 10.5 kb; lane 12 shows a clone 
targeted on two alleles with different constructs, i.e. a double 
knockout, giving bands of 5.8kb and 7.5kb; lane 3 shows a clone in 
which the second allele has not been targeted, giving bands of 5.8kb 
and 10.5kb. 
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Figure 7.6. FACS analysis of ES cells targeted with 13lCreERc and HH1.6 
131 integrin 
Cells targeted with p13lCreERc and pHH1 .6 were analysed by FACS for the 
expression of 131 iritegrin. Clones 12 and 58 appeared to have been targeted on 
both alleles by Southern blot analysis and do not express 131 integrin. Clone 8 was 
targeted with only f31 CreERc and clone 2 was retargeted on the same allele. Both 
these clones express 131 integrin. 
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A) P 1 integrin 	ES cells; B) E14 wild-type ES cells 
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7.3.3. Reactivation of 131 integrin 
To attempt to reactivate the second targeted 131 integrin allele three 131" 	ES cell 
clones (12, 58 and 63) were treated with tamoxifen. Treatment with tamoxifen 
should activate Cre, resulting in recombination between the loxP sites of the HH 1.6 
targeted allele, removing the geo cassette and leaving an active 131 integrin allele 
(figure. 7.1). Cells were treated with either one, or two doses at 24 hour intervals, of 
I jsM and 21.tM tamoxifen. Treated cells were then analysed by FACS for the 
expression of 131 integrin on the cell surface. No expression of 131 integrin was 
observed after tamoxifen treatment in any of the three clones. There could be two 
reasons for this: either recombination between loxP sites had not taken place, or 
recombination had occurred but for some reason the 131 integrin allele was not 
reactivated. Since the level of recombination seen in 131 integrin' cells after 
treatment with tamoxifen was only approximately 2% (section 7.3.2.), to determine 
whether recombination between loxP sites in pHH1.6 targeted allele was possible, a 
Cre expressing plasmid was introduced into 13l'' clones 58 and 12. It was thought 
that this would be a more efficient way of inducing recombination and therefore 
determining the reason why 31 integrin was not being expressed. Colonies were 
picked after the transfection and tested for sensitivity to G418. Cells in which 
recombination had occurred would lose the geo cassette rendering them sensitive to 
G418. G418 sensitive clones were then checked by Southern Blot analysis to confirm 
that recombination had occurred, figure 7.8. Genomic DNA was digested with 
BainHI and hybridised to the 3' genomic probe used previously. The 13lCreERc 
targeted allele will give a band of 5.8 kb and the recombined HHI.6 targeted allele 
will give a band of 10.5kb, since the allele is essentially returned to wild-type 
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Figure 7.8. Southern Blot analysis of 	ES cells treated with Cre 
Genomic DNA from G418 1  and G4181 clones of 
1/(R) ES cells 
transfected with Cre expressing plasmid was digested with BamHI and 
hybridised to a 2.9kb 3' genomic probe. 
Genomic structure of targeted loci showing size of bands expected 
upon BamHI digestion and hybridisation to 3'genomic probe shown. 
Southern Blot. Lanes 1-4 show G418s clones, giving bands of 10.5kb 
and 5.8 kb showing that recombination has occurred excising the geo 
cassette. Lanes 5-6 show G418 R  clones, giving bands of 7.5kb and 5.8kb 
showing that recombination has not occurred. 
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structure. This analysis showed that all clones that were G418 sensitive had 
undergone recombination. However, FACS analysis of these clones showed that they 
did not express 131 integrin. This shows that failure of cells to re-express 131 integnn 
is not due to an inability of cells to undergo recombination between loxP sites. 
However, it is not clear whether Cre-TBD can be activated in these cells since the 
response of cells to tamoxifen was not studied further. 
To investigate the reason for the lack of I1 integrin expression from the 
recombined HH1.6 targeted allele, RNA was isolated from cells which had 
undergone recombination and analysed by RT-PCR with primers to Exon I and III. 
RNA from unrecombined 131 integrin' ES cells and from 131 integrin' ES cells 
was also amplified, figure 7.9. Wild-type niRNA should give a band of 520bp. The 
two targeted alleles should not give a signal since both targeting cassettes contain pA 
sites before Exon III. However, a recombined HH1 .6 targeted allele should give a 
band of 550bp since it will contain a loxP site in addition to fill integrin sequences. 
RT-PCR analysis confirmed that there was no expression of fill integrin in the double 
knockout cells as no signal was obtained from these cells. However, it also revealed 
that in recombined cells there was expression of fill integrin RNA but that it was 
shorter than RNA expressed from a wild-type allele (compare lane 4 with lane 5 in 
Figure 7.9) 
RT-PCR products from fill integrin cells and recombined fill integrin' 
cells were then sequenced, see figure 7.10. The sequence from fill integrin-/+ cells 
matched the published cDNA sequence showing normal expression of fill integrin in 
these cells, which is also confirmed by FACS analysis (see 7.3.2.). However, the 
sequence of RT-PCR products from recombined 3l 	cells showed that RNA 
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Figure 7.9: RT-PCR analysis of recombined 13l' ES cells 
Structure of genomic loci, mRNA and expected sizes of RT-PCR products 
RT-PCR analysis. Top gel: Lanes 1 and 2 show amplification from 13i 	ES 
cells, clones 12 and 58, confirming that there is no expression of 131 integrin in 
these cells. Lane 3 shows amplification from recombined 131 -' ES cells. A PCR 
product is obtained but is smaller than the predicted size of 550bp and is also 
smaller than product obtained from 131 " ES cells, lane 4, which represents wild-
type expression. Bottom gel: 13actin amplification as control for presence of RNA 
520bp RT-PCR product 
ii) HHI .6 targeted allele 
No RT-PCR product 
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Figure 7.10: Comparison of segeunce of RT-PCR products from 131 integrin 
ES cells and recombined 131 integin ' ES cells 
- 131 integrin ES cells 
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expressed from the recombined allele is missing ExonlI. The rest of the sequence 
matches that of the wild-type RNA. This would explain why 131 integrin is not 
expressed in recombined clones. It also suggests that Exon II is spliced out from the 
recombined RNA. This could be due to the presence of the remaining loxP site so 
close to the splice acceptor site of Exon II. 
7.4. Discussion 
The generation of a ii integrin knockout, in which one of the 131 integrin 
alleles can be reactivated at specific times and in specific organs should make it 
possible to determine the point at which 131 integrin is required for the establishment 
of definitive haemopoiesis. 
Here, the generation of such a system was attempted by producing 131 
integrin ES cells by two rounds of targeting with two different targeting constructs. 
The first construct contains a cassette encoding a Cre-TBD protein that is regulatable 
by the addition of tamoxifen. Targeting of a 131 integrin allele with this construct 
inactivates the allele. The second targeting construct contains a geo 'stop' cassette, 
flanked by loxP sites, inserted into the introni/exonil boundary of 131 integrin, 
downstream of the splice acceptor site but upstream of the first ATG. The presence 
of this cassette prevents expression of 131 integrin. However, upon Cre mediated 
recombination between the flanking loxP sites, the geo cassette is removed and the 
131 integrin allele should be reactivated. Cells targeted on different alleles with these 
constructs were termed 131 integrin''t ES cells. 
The generation of 31 integrin 	ES cells by two rounds of targeting yielded 
a high proportion of double targeted clones. This is in contrast to previous reports 
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that the isolation of PI integrin ES cells was very difficult (Reinhard Fassler, 
personal communication). In fact, it was originally proposed to transfect 131 integrin
7+ 
ES cells with a human 31 integrin transgene prior to the second round of targeting to 
facilitate the isolation of 131 integrin 	ES cells. However this proved to be 
unnecessary. 
The reasons for this higher incidence of obtaining PI integrin ES cells is 
unclear. There are two main differences between the strategy used here and those 
used previously by others (Fassler et al., 1995). Firstly, different ES cells were used 
for targeting. Here E14 ES cells were used which are derived from 129/01a strain, 
whereas in previous studies D3 ES cells were used which are derived from I 29/sv 
strain. However the DNA for the targeting construct was obtained from 1 291sv strain 
and therefore targeting should be more efficient in D3 ES cells. Secondly, E14 ES 
cells were grown on gelatin, whereas D3 cells were grown on feeders. It was 
reported that the phenotype of 31 integrin ES cells is more pronounced when grown 
on feeders rather than gelatin (Fassler etal., 1995). Therefore it is possible that it is 
easier to obtain 131 integrin' ES cell clones if electroporated cells are grown on 
gelatin because they adhere better than if grown on feeders. 
The 31 integrin ES cells generated here had a similar morphology to clone 
G201 131 integrin ES cells obtained from Reinhard Fassler. This is despite the fact 
that they are derived from different ES cell lines. G201 131 integrin ES cells were 
derived from D3 ES cells whereas E14 ES cells were used here. This shows that the 
morphology of G201 31 integrin ES cells is not a clone specific phenotype. 
Attempts to reactivate 31 integrin in f31 integrin 	ES cells by tamoxifen 
treatment were unsuccessful. Since the activity of Cre-TBD in tamoxifen treated 
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cells was known to be low (section 7.3.2.) it was unclear whether the lack of 131 
integrin expression was due to inactivity of Cre protein and therefore a lack of 
recombination between loxP sites and excision of the geo cassette, or to a problem 
with the recombined allele. In order to achieve more efficient recombination, a Cre 
expressing plasmid was introduced into 31 integrin'  ES cells. The activity of Cre-
TBD in 131 integrin ES cells was not investigated further. After transfection of 131 
integrin °  ES cells with the Cre expressing plasmid, clones in which recombination 
had occurred, as confirmed by Southern blot analysis, were obtained. However, these 
cells did not express 131 integrin. 
RT-PCR analysis of recombined 131 integrin 	ES cells showed that RNA 
was expressed from the recombined allele but that it was shorter than RNA expressed 
from a wild-type 131 integrin allele. Sequencing of the RT-PCR products showed that 
RNA from recombined 131 integrin' ES cells did not contain ExonlI, although 
Exonl and Exonill were present. This suggests that Exonil is being spliced out in 
these clones and that Exonl is splicing directly to Exonlil. This could be due to the 
presence of the remaining loxP site in close proximity to the splice acceptor site of 
Exonil. 
If this is indeed the case, in order to generate 131 integrin' ES cells in which 
one 131 integrin allele can be reactivated, it will be necessary to insert the removable 
stop cassette into a different location. Targeting to Exonl would prevent the 
expression of j31 integrin in the presence of the stop cassette. However the stop 
cassette could be placed well away from the splice donor site, reducing the 
probability of splicing being affected. Also, disruption of the sequence of Exonl by 
the loxP site that would remain after recombination, may not be critical since Exonl 
is not expressed. Although there is no evidence here that the loxP site in Exonil 
would have affected translation, its close proximity to the ATO start codon suggests 
that this is a strong possibility. Alternatively the stop cassette could be placed in 
intronl upstream of Exonil. This would require the presence of a strong splice 
acceptor in the transgene to prevent the cassette being spliced out and 131 integrin 
being expressed in the absence of recombination. 
In order to generate an efficient system it would also be necessary to 
reconsider how Cre is introduced into the system. Although Cre activity from the 
31CreERc targeted allele was not assessed in 31 integrin<  ES cells, when 131 
integthn' cells were treated with tamoxifen the level of recombination achieved was 
very low. This could be because Cre was not expressed at a high level in these cells. 
However, Cre expression was driven by the endogenous 131 integrin promoter and 131 
integrin is expressed at a high level in ES cells. Alternatively the Cre-TBD fusion 
protein may not very responsive to tamoxifen in this system. It may be that Cre could 
be more efficiently introduced by another method, such as via a Cre expressing 
adenoviral vector. 
Despite the problems described above, the overall proposed experimental 
scheme of the reversible 31 integrin knockout remains valid since it is the only way 
of determining conclusively the time point at which 131 integrin is required for 
establishment of the definitive haemopoietic system. However, it will be necessary to 
reconsider the design of the targeting constructs and the method by which 
reactivation of 31 integrin is achieved. Similar strategies that involve the activation 
of a transgene by removal of a loxp flanked stop cassette have proved successful (D. 
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Gilchrist, personal communication), however reactivation of an endogenous allele 
clearly requires careful design. 
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Chapter 8: CONCLUSIONS 
The establishment and maintenance of the definitive haemopoietic system 
requires the orderly migration, homing, proliferation and differentiation of definitive 
haemopoietic stem cells and their progeny. The interaction of these cells with the 
haemopoietic microenvironments of different haemopoietic organs is thought to be 
important for the regulation of these processes. Of particular interest here is the 
mechanism by which definitive haemopoiesis originates in the mouse embryo. The 
first definitive haemopoietic stem cells arise in the AGM region at late ElO but then 
migrate to FL from Eli to E13, via the circulation. Definitive haemopoiesis is 
established in the liver at this time where it continues until shortly after birth. 
Adhesion molecules, including integrins and selectins are thought to be very 
important in regulating definitive haemopoiesis both in the adult and in the embryo. 
The a4131 integrin has been shown to have roles in the homing, proliferation and 
differentiation of haemopoietic progenitors in the adult. The cz4 and 131 integrin 
subunits have also been shown to be critical for the correct establishment of 
definitive haemopoiesis in the mouse embryo. However the precise time points at 
which these molecules are required is uncertain. 
The aim of this thesis was to further define the roles of ct4 and 0 1 integrins in 
the definitive haemopoietic system, in particular their roles in the initial stages of 
definitive haemopoiesis in the mouse embryo. Several strategies were employed to 
achieve this goal. 
Firstly the expression of a4 and (31 integrin on LTR-HSCs was determined. 
LTR-l-ISCs from the Eli AGM, E13 FL, E13 PB and adult BM were analysed, as 
11*3 
these four points represent the main developmental stages of the definitive 
haemopoietic system. LTR-HSCs are first generated in the AGM region at late 
ElO/early Eli. They then migrate to the FL, probably via the circulation from Eli—
E13. The liver becomes the main site of definitive haemopoiesis during this time and 
the numbers of HSCs increase in this organ until BiG. From shortly after birth LTR-
HSCs are located in the BM and this is the main site of definitive haemopoiesis in 
the adult. 131 and cz4 integrin were found to be expressed on LTR-HSCs from all 
these organs and in general LTR-HSCs that were negative for 131 integrin or a4 
integrin expression were not observed.. The exception may be the E13 FL where a 
few a4 integrin negative LTR-HSCs were identified, although the nature of the 
experiments undertaken makes it impossible to rule out the existence of very low 
numbers of 131 integrin and a4 integrin negative HSCs in other organs. The 
expression of ct4 and 131 integrin on all, or nearly all, LTR-HSCs at these 
developmental time points emphasises the importance of these molecules in the 
establishment and maintenance of the haemopoietic system. However, since they are 
expressed on LTR-HSCs throughout development, it does not help to distinguish the 
time point at which these molecules are required for the onset of definitive 
haemopoiesis. For example, the expression of 131 integrin on AGM LTR-HSCs could 
be required for the generation of these cells or for them to migrate from the AGM 
region. 
The requirement of cx4 integrin for definitive haemopoiesis was further 
investigated in ct4 integrin embryos. a4 integrin' mice die at around E12 but by 
this stage, in wild-type embryos, LTR-HSCs have colonised the FL and there are 
approximately 60 LTR-HSCs in the FL at this time. LTR-HSCs are still present in 
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the wild-type E12 AGM and also in the E12 YS. Therefore by investigating the 
presence of HSCs in the haemopoietic organs of E12 a4 integrin embryos it is 
possible to determine if a4 integrin is required for the generation of true HSCs in the 
AGM and to determine if they can establish themselves in the FL. We found that 
essentially normal LTR-HSCs are generated in the AGM in the absence of cz4 
integrin, although their ability to reconstitute secondary recipients is unclear. 
Conversely, there were many fewer ct4 integrin HSCs in the E12 cz4 integrin FL as 
compared to wild-type. This shows a requirement for cz4 integrin in establishing 
definitive haemopoiesis in the FL but not in the generation of a4 integrin HSCs in 
the AGM region. However, it is not clear whether ct4 integrin is required for the 
migration of HSCs to the FL or for their subsequent proliferation/differentiation or 
survival in the FL microenvironment. 
It has also been suggested that PI integrin is required for the migration of 
LTR-HSCs from the AGM to the FL and that this is the reason for the complete 
block in definitive haemopoiesis observed in the absence of 131 integrin. Therefore 
ct413 1 integrin may be a crucial molecule for the correct migration of LTR-HSCs 
from the AGM region. It has already been shown that a4131 integrin is essential for 
the correct homing and retention of progenitor cells in the adult BM and 131 integrin 
has been shown to be essential for the homing of adult LTR-HSCs to the BM upon 
transplant into irradiated recipients. However, the ability of cz4 integrin' AGM LTR-
HSCs to home to the BM of irradiated recipients suggests that ct4 integrin is not 
required for the homing of early embryonic haemopoietic stem cells to the BM. This 
could be a specific feature of AGM LTR-HSCs. 
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HSCs from a4 integrin AGM region, and to some extent from the FL and 
YS were capable of contributing to multiple lineages in the adult mouse, including 
the B and T cell lineages. It has previously been hypothesised that a4 integrin 
progenitor cells are unable to interact correctly with adult BM microenvironment and 
proliferate/differentiate normally. However, the ability of embryonic haemopoietic 
stem cells to generate multiple lineages in the BM argues against an intrinsic 
inability of ct4 integrin progenitors to interact properly with the BM 
microenvironment. Rather, it suggests that the few remaining cz4 integdn HSCs that 
survive in the FL and presumably in the adult BM become progressively defective as 
development progresses and as a consequence generate defective progenitor cells. 
Although 131 integrin may be involved in the migration of LTR-HSCs from 
the AGM region to the FL it is not clear if this is the earliest time point at which 131 
integrin is required for definitive haemopoiesis. 131 integrin may also be required for 
the generation of HSCs in the AGM region from pre-definitive HSCs. Since 131 
integrin HSCs are unable to home to the BM of irradiated recipients it is not 
possible to determine if 131 integrin HSCs are generated in the AGM region, as it 
would not be possible to assay for them. To overcome this problem we proposed to 
generate a reversible 31 integrin knockout in which 131 integrin could be reactivated 
at specific times during development of the haemopoietic system. In this way, by 
reactivating 131 integrin expression prior to transplant into irradiated recipients, as the 
assay for LTR-HSCs, the presence of 131 integrin LTR-HSCs in the haemopoietic 
organs could be assessed. Unfortunately, the particular strategy proposed was not 
successful, as 31 integrin was not expressed from the reactivated allele. Therefore 
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the role of [31 integrin in the onset of definitive haemopoiesis remains undefined. It 
would be worth redesigning parts of this scheme since it seems to be the only method 
to answer this crucial question 
In conclusion, a role for a4 integrin in the establishment of FL haemopoiesis 
but not in the generation of LTR-HSCs in the AGM region has been revealed, 
although the exact mechanisms in which a4 integrin is involved remain unclear. 
However the data presented here, along with that from other groups suggest that the 
ct4[3 I integrin is required for the migration of LTR-HSCs from the AGM region and 
their colonisation of the FL. [31 integrin may also be involved at earlier stages in the 
definitive haemopoietic system, i.e. in the generation of LTR-HSCs in the AGM 
region. Further studies, possibly the generation of reversible knockout mice, are 
required to further define the role of a4 and [31 integrin in establishment of the 
definitive haemopoietic system. 
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